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Summary 
 
Cancer is the second most frequent cause of death in Germany1. Patients with 
cancer experience multiple symptoms throughout the different stages of their illness, with 
pain as one of the most frequent symptoms. Pain is defined as "an unpleasant sensory and 
emotional experience associated with actual or potential tissue damage, or described in 
terms of such damage"2. Cancer pain can occur at any time but the incidence increases 
over the course of the illness. Cancer pain management is to a great extent based on 
pharmacologic and non pharmacologic therapy3. Despite effective treatment options, pain 
control is not adequate in over 40% of patients with cancer4. 
The undertreatment of cancer pain has led researchers to determine the factors that 
impede effective pain management. Besides inadequate assessment and treatment, 
several patient-related barriers interfere with optimal pain management5. Patient-related 
barriers towards cancer pain management include cognitive (e.g., concerns about 
analgesic use), affective (e.g., stress, depression), sensory (e.g., experience of side 
effects), as well as practical components6,7. Oncology treatment takes place primarily in the 
outpatient setting. Therefore, patients and their family caregivers (FCs) need to implement 
cancer pain management mainly by themselves. Self-management consists of those 
strategies that patients and FCs perform in daily life to manage illness and treatment to 
avoid functional regression and health deterioration8. For optimal pain self-management, 
oncology patients and their FCs need to acquire and process a complex array of 
knowledge and skills (i.e., how to obtain, take, and titrate various analgesic medications, 
deal with side effects, and what to do if pain is not relieved)3. In view of the complexity of 
these impediments to adequate pain treatment, interventions to support cancer pain self-
management are warranted. 
Effects of interventions that were designed to support cancer pain self-management 
were examined in three systematic reviews9-11. It was shown that from 1962 to 2009, 
cancer pain self-management interventions gained increasing attention but were still an 
understudied approach. While improvements in pain were reported in all three systematic 
reviews, effects were moderate. Moreover, significant heterogeneity in study designs, 
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methods, and types of interventions may have weakened the findings. In addition, it was 
not possible to determine which components of interventions were most effective. To our 
knowledge, a detailed description and evaluation of components of cancer pain self-
management interventions had not been done. Furthermore, only a few studies evaluated 
how patients’ and their FCs’ experienced cancer pain self-management interventions6,12. 
Interventions designed to support cancer pain self-management are largely 
unknown in German speaking populations. Therefore, the work of Miaskowski’s PRO-
SELF© Pain Control Program (PCP) research group13,14 provided the basis for this thesis. 
The PRO-SELF© PCP was built on three key strategies (i.e., provision of information using 
academic detailing15, skill building, and ongoing nurse coaching) and consisted of 
structured and tailored components. Patients and FCs were provided 3 visits and 3 phone 
calls over six weeks by a specially trained nurse. A randomized controlled trial (RCT) with 
174 patients showed that the overall effects of the PRO-SELF© PCP represented 
statistically significant but moderate decreases in pain intensity scores. Therefore, based 
on the convergence of findings from quantitative16 and qualitative6 subanalyses, 
modifications to the Program resulted in the PRO-SELF© Plus PCP. 
The overall aims of this mixed methods research project were twofold: first, to 
analyze the state of knowledge regarding interventions designed to support pain self-
management of patients with cancer; and second, to translate, adapt, improve, and pilot 
test a state of the art intervention designed to support self-management of cancer patients 
and their FCs in a German speaking population.  
To address the first aim, a systematic review of experimental and quasi-
experimental studies was performed to describe the structure and content components, as 
well as the efficacy of various components of cancer pain self-management interventions. 
Intervention components were categorized using content analysis and evaluated based on 
the effect sizes that were reported. Based on 34 publications (i.e., 24 interventions), seven 
structure (e.g., mode of delivery) and 16 content components (e.g., information about 
cancer pain and its treatment) were identified. No single component was found to have a 
discernable influence on effect sizes. To our knowledge, this review was the first that 
provided a detailed overview of the various structural and content components of cancer 
pain self-management interventions. However, because of a variety of limitations, the most 
efficacious intervention components remain to be determined in future studies17. 
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To address the second aim, the German PRO-Self© Plus PCP was tested in a pilot 
study. In a first phase, instruments from the PRO-Self© Plus PCP were translated and 
intervention and study procedures were revised successfully resulting in the German PRO-
Self© Plus PCP (see Chapter 4). To evaluate the latter, a nested concurrent mixed 
methods approach18 was applied, in which a pilot RCT was combined with two qualitative 
substudies. The pilot study was guided by two theoretical frameworks: symptom 
management theory19 and social cognitive theory20. 
The purpose of the pilot RCT was to evaluate feasibility and effect sizes for the 
German PRO-Self© Plus PCP for the planning of a multi-center RCT. Thirty-nine oncology 
outpatients with cancer-related pain were randomized to the intervention (n = 19) or control 
(n = 20) groups. Patients in the intervention group received the Program consisting of 6 
visits and 4 phone calls over ten weeks. Patients in the control group received the same 
number of visits and phone calls and usual care. Primary outcomes were average and 
worst pain intensity. Secondary outcomes included pain-related knowledge, opioid intake, 
and self-efficacy. Data were collected at enrollment, weeks 6, 10, 14, and 22 after 
randomization. Findings from the pilot RCT were reported in two manuscripts. 
The purposes of the first manuscript were to describe the methods used and the 
lessons learned during the pilot study, as well as the adaptations that were made for a 
larger clinical trial. During the study, inclusion criteria were expanded. In addition, the 
intervention may be improved by further adaptations (e.g., closer tailoring to patients’ pain 
situation, inclusion of self-management support for nausea and vomiting). Furthermore, 
coaching cancer patients across a complex treatment team was an important function of 
the intervention. The pilot study proved to be useful to adapt study procedures, balance 
burden and benefit for participants, and customize the intervention to patients’ needs and 
abilities in order to improve feasibility and efficacy21. 
In the second manuscript, quantitative findings from the German PRO-Self© Plus pilot 
RCT were reported. The group by time effect was statistically significant for knowledge 
scores (week 10: p = 0.04; week 22: p < 0.01), but not for pain, opioid intake, or self-efficacy. 
The mean difference at week 10 between the intervention and the control groups was -0.55 
(Cohen’s d = -0.26) for average pain and -0.73 (d = -0.29) for worst pain. At week 22, it was 
-0.51 (d = -0.35) for average pain and -0.47 (d = -0.20) for worst pain. It was the first study to 
evaluate the PRO-Self© Plus PCP for feasibility and potential effects in a German speaking 
population. While pain management related knowledge improved significantly, effect size 
calculations showed low to moderate reductions in average and worst pain22. 
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The purpose of the first qualitative substudy was to explore how patients and FCs 
experienced intervention and study procedures of the German PRO-Self© Plus PCP pilot 
RCT. Debriefing interviews were conducted with nine patients and four FCs who finished 
the intervention. Interviews were transcribed verbatim, and analyzed using content 
analysis23. Findings confirmed that for patients and FCs, a trustful relationship with the 
intervention nurse was of utmost importance. Furthermore, the intervention’s focus on 
cancer pain self-management was novel for and appreciated by the participants. The 
intervention nurse’s expertise with pain self-management as well as her caring attitude, the 
discussion of everyday problems, and sufficient time to discuss problems repeatedly 
resulted in a high satisfaction of the participants and a meaningful pain reduction for most 
patients in this substudy (see Chapter 7). 
The purpose of the second qualitative study was to explore decision-making 
processes of four women and four men in the intervention group concerning their pain 
medications. Audiotaped protocols of the 10-week intervention and debriefing interviews 
provided data for a secondary analysis which was done using content analysis23. Findings 
showed that cancer patients stayed ambivalent about the use of analgesics over the whole 
course of the intervention. Their need for adequate pain relief contrasted with their desire to 
avoid analgesic medications. Despite positive experiences with analgesics, decisions were 
reconsidered and overturned. Individually tailored counseling helped these patients adopt 
new attitudes towards analgesics and gradually reduce their pain levels24.  
To conclude this research project, methods were critically appraised to determine 
their appropriateness. For the systematic review, a narrative approach was chosen 
because a quantitative meta-analytic approach was considered to be inappropriate given 
the heterogeneity of intervention components and research methods. The narrative 
approach was appropriate to provide the basis for future trials to evaluate specific 
intervention components.  
For the pilot study, the combination of qualitative and quantitative methods was 
found to be highly appropriate to evaluate the PRO-Self© Plus PCP for feasibility and for its 
potential to reduce cancer pain. Compared to other cancer pain self-management 
interventions that were summarized in a meta-analysis10 and in our systematic review, the 
German PRO-Self© Plus PCP was an intensive and comprehensive intervention in terms 
of both its structure and its content. In this context, reductions in pain intensity scores in the 
German PRO-Self© Plus pilot RCT were relatively small. Reasons for the small effect sizes 
might include that patients’ overall opioid intake was low. However, it could not be 
determined whether the low opioid intake was due to a lack of patients’ adherence to the 
Summary 
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intervention or because clinicians did not adapt the analgesic prescriptions. Therefore, the 
assessment of patients’ adherence with the intervention and the quality of the analgesic 
prescription should be included in future research.  
Furthermore, it was hypothesized that the interventions efficacy may be improved 
by addressing patient-related barriers more comprehensively; tailoring the number, timing, 
and duration of the intervention more closely to the patients’ needs; including symptoms 
that severely impact pain self-management; guiding the patients more closely across the 
complex treatment team; and, with the patient’s permission, including direct contact of 
research staff with the clinician in case the patient should become unable to self-manage 
their pain and FC support was not available. 
This research project has several limitations. In our systematic review, the 
description of the intervention components did not include unpublished components 
because the analysis was based on available publications. Furthermore, because of the 
small sample, low recruitment, and high attrition, findings from the mixed methods study 
need to be interpreted with caution. In addition, all of the study visits for both the 
intervention and the control groups were performed by the same nurse, which may have 
resulted in an occasional unintentional contamination in the control group.  
In summary, the systematic review in this thesis is the first to provide a 
comprehensive overview of components of cancer pain self-management interventions in 
view of their potential to reduce cancer pain. Furthermore, with the pilot study, the PRO-
Self© Plus PCP was tested for the first time in a German speaking population. The transfer 
and evaluation of the Program were performed successfully. In the pilot RCT pain self-
management related knowledge increased significantly and it was possible to calculate 
effect sizes for the intervention’s potential for pain reduction. Findings demonstrated 
patients’ high satisfaction with the German PRO-Self© Plus PCP and showed how patients 
remained highly ambivalent regarding analgesic intake even if they decided to take 
analgesics. Even though the effects were rather small, findings from this mixed methods 
research project provided valuable data on how to improve the intervention and plan a 
larger multicenter RCT. 
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Introduction 
 
Despite effective treatment options1,2, pain control is not adequate in over 40% of 
patients with cancer3-6. For optimal pain management, patients and their family caregivers 
(FCs) need to use self-management strategies on a daily basis. Interventions to support 
pain self-management in patients with cancer were shown to be effective but they need 
additional improvements because the effects to date are moderate7. Furthermore, little is 
known about which components of the intervention are most effective. In addition, little is 
known about the implementation and efficacy of an intervention that was developed for 
oncology patients in the United States (U. S.) in a German population. 
In this project, we attempted to address these gaps. The two main elements of the 
research project are a systematic review in which components of interventions designed to 
support cancer pain self-management were analyzed and a pilot study in which an 
intervention for cancer pain self-management support was tested. In the pilot study, a 
mixed methods approach was used combining a randomized controlled pilot trial (pilot 
RCT) with two qualitative substudies. This doctoral thesis is divided into 9 chapters. In 
Chapter 1, an introduction to cancer pain, its treatment, barriers to effective cancer pain 
self-management, and interventions to support cancer pain self-management are 
presented. In addition, the PRO-SELF© Plus Pain Control Program (PCP) which served as 
the basis for this study is described, as well as a symptom management model and an 
adult learning theory that provided the theoretical foundation for this research project. In 
Chapter 2, the aims of this thesis are described. Chapter 3 is the systematic review: “A 
Systematic Evaluation of Content, Structure, and Efficacy of Interventions to Improve 
Patients’ Self-Management of Cancer Pain”8. In this systematic review, studies of 
interventions designed to support cancer pain self-management were analyzed regarding 
their various components and efficacy of these interventions. In Chapter 4 an explanation 
is provided about how, in the first phase of this project, the PRO-Self© Plus PCP was 
translated and adapted for the pilot RCT, resulting in the German PRO-Self© Plus PCP.  
Chapters 5 - 8 describe the results of the pilot RCT. Chapter 5 contains the 
manuscript: “Supporting Self-Management of Pain in Cancer Patients: Methods and 
Lessons Learned from a Randomized Controlled Pilot Study”9. In this paper, the lessons 
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that were learned during the pilot RCT that tested an intervention designed to support 
cancer pain self-management are described. In Chapter 6, the main quantitative findings 
from the pilot RCT are reported in the manuscript: “Results of a Pilot Study of a Self-
Management Intervention for Cancer Pain”10. In Chapter 7, findings from the qualitative 
substudy of the experiences of patients and FCs with the intervention and study 
procedures are summarized. In Chapter 8, findings from the qualitative substudy of 
patients’ decision processes about analgesic intake over the course of the 10-week 
intervention period are reported in the manuscript: “Entscheidungswege onkologischer 
Patienten bezüglich Schmerzmedikamenten [Oncology patients’ decision-making 
processes concerning their pain medication at home]”11. Chapter 9 is a synthesis and 
critical discussion of the findings and an outline of the implications for a future research 
project that is being planned. 
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Chapter 1 
 
 
Background 
 
Epidemiology of Cancer, Definition of Pain,  
and Prevalence of Cancer Pain 
In Germany, in 2006, an estimated 425’000 patients were diagnosed with cancer 
while approximately 210’000 patients (25% of all cases of death) died from this disease12. 
In oncology patients, pain can occur at any time but the incidence increases over the 
course of the illness. Twenty-eight percent of oncology patients experience pain at the time 
of diagnosis, while in advanced cancer, 40 % to 80% experience pain5,13,14. 
The most commonly used definition of pain is the one developed by the 
International Association for the Study of Pain. Pain is defined as "an unpleasant sensory 
and emotional experience arising from actual or potential tissue damage or described in 
terms of such damage"15. Pain that occurs during the course of cancer can be categorized 
into three types, pain related to: the cancer itself, to cancer treatment, or unrelated to the 
cancer diagnosis16. Tumors can invade adjacent tissues and cause pain. Treatment-related 
pain includes painful peripheral neuropathy from chemotherapeutic agents (e.g., 
vincristine), radiation-induced neural damage, or postsurgical pain syndromes (e.g., from 
amputation or thoracotomy). Furthermore, people with cancer can experience pain that is 
not related to cancer (e.g., peripheral neuropathy from diabetes, migraine, or low back 
pain). Pain associated with direct tumor involvement is the most common cause of cancer 
pain with bone pain being the most common type17. The occurrence of pain depends on the 
patient’s cancer diagnosis. While prevalence rates vary between publications, the 
prevalence of pain is frequently reported to be highest in patients with the following cancer 
diagnoses: head and neck (67–91%); prostate (56–94%), uterine (30–90%), genitourinary 
(58–90%), breast (40–89%), pancreatic (72–85%), and lung cancer (27–76%)18,19.
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While effective treatment options exist, more than 40% of patients with cancer do not 
achieve adequate pain control6,8. In a recently completed descriptive prospective study, 
Spichiger et al.20 confirmed these findings in the Swiss setting. At baseline, 49% (N = 77) of 
cancer outpatients reported an average pain score of 2.2 (on a scale from 0 = no pain to 
4 = very strong pain). After three chemotherapy cycles, 55% (n = 53) of patients reported 
an average pain score of 2.1. 
Apart from tumor type and disease status, pain is influenced by demographic and 
clinical factors. For example, women report higher pain scores than men21. In addition, 
higher pain levels were associated with higher levels of fatigue, sleep disturbance, 
depression and anxiety22-24. Furthermore, pain is negatively related with quality of life (QoL) 
and functional status25. 
Treatment of Cancer Pain 
Effective pain management is based on four critical requirements: (1) detection of 
pain, (2) correct prescriptions and availability of medical treatments including analgesics1,2, 
(3) the patient’s ability to put optimal pain management into practice of everyday life26, and 
(4) the patient’s willingness to adhere to medical treatments27. Adequate pain treatment 
includes, if possible, treatment of the underlying causes of cancer pain and treatment of the 
pain itself1,2. State of the art treatment of cancer pain is outlined in international 
guidelines1,2. In these guidelines, cancer pain treatment recommendations are based on 
individual pain intensity, and consist of non-opioid and opioid analgesics. Palliative cancer 
therapy, adjuvant drugs, and other therapeutic measures may be integrated in the pain 
treatment regimen. In the guidelines the recommendation is that analgesics should be 
administered orally whenever possible and that basic treatment should consist of extended 
release agents with short-acting rescue doses when pain worsens temporarily or with 
worsening disease. Furthermore, a simplified analgesic regimen is recommended to 
improve adherence to analgesic medications1,2. 
Patients and their FCs play a central role in cancer pain management. Because 
oncology treatment takes place to a large extent in the outpatient setting, pain is managed 
primarily at home. As a result, patients and their FCs need to be able to integrate pain self-
management into their daily life in order to achieve adequate pain control. Self-
management consists of those strategies that patients and FCs perform in daily life to 
manage illness and treatment to avoid functional regression and health deterioration28. Pain 
self-management requires patients’ and their FCs’ active involvement in their care. For 
cancer pain self-management, patients must learn how to get their prescribed medication, 
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how and when to take it, how to monitor pain, and they must be able to react appropriately 
if pain is not alleviated1,2,26. While implementing pain management strategies at home and 
insecurity about the use of correct pain management strategies were found to be critical 
issues for patients and their FCs, only a few studies have evaluated the complex processes 
of pain self-management from the patients’ and their FCs’ perspectives26,29. 
Pain self-management is influenced greatly by demographic and individual factors 
such as previous experiences with illness, cognitive status, and socio-economic status30. 
While cognition can be impaired significantly in patients with cancer, for example because 
of fatigue or brain metastasis31, the ability to concentrate, memorize, pay attention and 
execute tasks is vital for learning the necessary skills for pain management32. Cognitive 
deficits affect patients' understanding of disease and treatment requirements and limit their 
functional capacity and ability to implement treatment plans including pain management. 
For example, poor cognition has been shown to negatively affect medication taking33.  
Barriers to Effective Pain Management  
The undertreatment of cancer pain, despite the availability of effective treatment 
options, has led researchers to attempt to determine the factors that impede effective pain 
management. Such factors are commonly referred to as barriers to pain management. To 
date, three types of barriers to effective pain management have been identified: 
(1) misconceptions and lack of knowledge on the part of health care professionals, 
(2) patient barriers, and (3) system barriers. While a variety of approaches have been tested 
to overcome some of the clinician and system barriers, the majority of these studies have 
not produced significant improvements in cancer pain management34-37. Rather than trying 
to decrease system and clinician barriers, this thesis focuses on changing the knowledge 
and behavior of patients and their FCs in relation to cancer pain management. This 
approach is justified because studies have shown that oncology patients take only 56% of 
their prescribed analgesics38,39. Furthermore, in some settings, oncology outpatients receive 
their pain management from their primary physicians and these primary physicians may 
neither be oncology specialists nor within reach of local educational intervention programs40. 
It is of vital importance for research and clinical practice to examine patient-related 
barriers towards cancer pain self-management in detail. So far, known patient-related 
barriers included cognitive, affective, and sensory barriers, as well as practical 
components26,27. While cognitive barriers have been studied extensively41,42, research on 
affective, sensory, and practical barriers has been conducted more recently26,27. Cognitive 
barriers include concerns about analgesic use, concerns about communication with 
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clinicians, and pessimistic beliefs about the possibility of adequate pain control (see Table 
1). Most of these cognitive barriers are not specific to patients with cancer but instead 
derive from beliefs about pain or analgesic medications that are rooted deeply in society. 
For example a Christian society’s understanding that willful suffering will lead to salvation 
may underlie a high willingness to tolerate pain43. 
Table 1: Cognitive Patient-Related Barriers Towards Cancer Pain Self-Management27 
Analgesic use 
 fear of addiction 
 fear of drug tolerance 
 fear of side effects 
 fear that analgesics mask pain as a sign of disease progression 
 concerns about family reaction to pain  
 concerns about the credibility of the need for opioid analgesics 
 lack of trust in treatment and clinicians 
 general dislike of taking pills 
Communication about pain 
 willingness to tolerate pain 
 wish to be a good patient 
 wish not to distract physicians from more important tasks such as treating the 
underlying disease 
Pessimistic beliefs about the possibility to control pain in general 
 belief that cancer pain is inevitable  
 belief that analgesic medications are not efficient 
Affective barriers relate to emotional changes in oncology patients with pain. They 
include mood disorders such as depression, anxiety, mood fluctuations, and stress that are 
frequent in patients with cancer pain. Affective barriers are interrelated with cognitive 
barriers even though a causal relationship with pain self-management and cognitive 
barriers has not yet been established27. Sensory barriers refer to the need for an optimal 
balance between an analgesic’s effect and its side effects. Side effects from analgesic 
medications are distressing for patients with cancer pain and can lead patients to conclude 
that pain treatment is making them sick instead of alleviating their pain42,44. The occurrence 
of side effects depends largely on the type of analgesic medication. For non-opioids, such 
as acetylsalicylic acid or diclofenac, the most frequent side effects include gastrointestinal 
complications such as gastritis16. For opioids, the most frequent side effects include 
constipation, nausea, pruritus, or sedation2,16. 
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The practical patient-related barriers to cancer pain self-management relate to 
difficulties with everyday implementation of pain relieving strategies. In their systematic 
exploratory review, Jacobsen et al.27 identified adherence to the prescribed analgesic 
regimen and communication with clinicians as practical barriers. In addition, in their 
qualitative study, Schumacher et al.26 found seven types of practical barriers: acquisition of 
the prescribed medication, accessing information, tailoring prescribed medication to 
individual needs, managing side effects, processing information cognitively, managing new 
pain, and simultaneously managing multiple symptoms. 
Interventions to Support Cancer Pain Self-Management 
It can be assumed that, in the complex process of pain self-management, patients 
and their FCs can greatly profit from supportive interventions. Three systematic reviews that 
examined the effect of interventions that support cancer pain self-management from 1962 to 
2009 showed that these interventions are gaining increasing attention but are still 
understudied approaches7,45,46. These reviews are described in detail in Chapter 3 of this 
thesis. In brief, the first comprehensive systematic review, showed that only eight intervention 
studies were published between 1962 and 1999 that focused on patients and FCs to 
enhance cancer pain self-management45. Only two of these studies were randomized 
controlled trials (RCT). Improvements in pain were reported, but effects were moderate. A 
second review evaluated the effects of six experimental studies of interventions for pain self-
management on pain intensity46. An important finding of this systematic review was that 
larger effect sizes were noted when patients (1) were not randomized, (2) reported pain 
verbally to the person who conducted the intervention, and (3) had average or present pain 
intensity scores of ≤ 3 (on a 0 to 10 numeric rating scale [NRS] with 0 = no pain and 
10 = maximum pain) at the time of enrollment (floor effect). A medium effect size for pain 
intensity (d = 0.4) was found, when controlling for these three factors. The last review was a 
meta-analysis of 21 experimental studies examining the efficacy of interventions that targeted 
patients’ and/or FCs’ management of cancer pain7. The overall effect on average pain 
intensity was a statistically significant 1.1-point reduction (95% CI: -1.8/-0.41). Moreover, the 
overall effect on pain management related knowledge was statistically significant. In all three 
systematic reviews, significant heterogeneity, arising from differences in study designs, 
methods, and types of interventions, may have weakened the findings. Furthermore, it was 
not possible to determine which components of interventions were most effective. 
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One of the studies in Bennett’s7 meta-analysis will be discussed in detail, because the 
intervention that was tested in this dissertation, namely the PRO-SELF© Plus PCP, was 
based on that study47. This intervention was designed to decrease cancer pain through 
supporting oncology patients’ and FCs’ pain self-management48. This Program was chosen 
for three reasons. First, the Program was found to be effective in a large RCT in the U. S.47. 
Second, adaptations were published that were based on extensive qualitative and 
quantitative analyses which indicated that the revised version might show improved 
effects26,49. Third, the authors of the PRO-SELF© Plus PCP agreed to collaborate closely in 
order to implement the PRO-SELF© Plus PCP in a German speaking population. 
Details of the PRO-SELF© Plus PCP are described in Chapters 4, 5 and 6 of this 
thesis. In brief, the PRO-SELF© PCP was based on three key strategies: (1) provision of 
information using academic detailing50, (2) skill building, and (3) ongoing nurse coaching. 
The Program consisted of structured and tailored components. To test the Program’s 
efficacy, 174 patients were randomized to standard care (n=81) or the PRO-SELF© PCP 
(n=93). The standard care group received the patient version of the Cancer Pain Guideline 
published by the Agency for Health Care Policy and Research51 and were seen for data 
collection by a nurse in their homes at 3 time points and had 3 phone calls between the 
home visits over 6 weeks. Patients in the PRO-Self© PCP group received 3 visits and 3 
phone calls by specially trained oncology nurses over a 6 week period. Patients in both 
groups participated either alone (55%) or with a FC (45%).  
While the overall effects of the PRO-SELF© PCP represented a statistically 
significant decrease in pain intensity scores and significant improvements in analgesic 
prescriptions, a more detailed evaluation of the efficacy of the intervention within the PRO-
Self© PCP group revealed that only 50% of these patients had a complete response 
(defined as ≥ 30% decrease in pain intensity scores), 25% had a partial response (defined 
as a decrease in pain intensity scores between 0 and 30%), and 25% did not respond to 
the educational intervention49. Statistical analyses revealed no differences between the 
demographic or clinical characteristics of the three groups. The authors hypothesized that 
the dose of the intervention may not have been adequate to achieve a ≥ 30% reduction in 
average and worst pain intensity scores for every patient. 
 Through a qualitative study of the audio-taped interactions between patients, FCs, 
and intervention nurses, numerous difficulties were identified in the implementation of the 
pain management regimen in patients’ daily life26. While some of these difficulties were 
addressed in the nurse coaching/problem-solving component of the intervention, the 
qualitative analysis revealed that problem-solving was a process that took place over time 
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and that the majority of patients were still actively involved in problem-solving to achieve 
better pain control at the final home visit. With this convergence of quantitative and 
qualitative evidence, the authors concluded that patients needed additional time to achieve 
optimal pain control (i.e., a higher dose). In addition, the previous study of the PRO-SELF© 
PCP did not determine if the behavior changes that occurred as a result of the intervention 
were sustained once the study ended47. 
Based on these findings the authors modified the intervention to enhance its 
efficacy which resulted in the PRO-SELF© Plus PCP. A second RCT is currently underway 
in which low dose PRO-SELF© Plus PCP is being compared with high dose PRO-SELF© 
Plus PCP. For both doses of the PRO-SELF© Plus PCP, the PRO-SELF© PCP was 
expanded to a period of ten weeks and the number of visits and phone calls was increased 
resulting in a higher dose of the intervention in both groups compared with the original 
PRO-SELF© PCP. The low dose intervention consists of 4 visits and 6 phone calls (8.0 
hours over 10 weeks). The high dose intervention consists of 6 visits and 10 phone calls 
(12.3 hours over 10 weeks). As described in Chapter 4, this study is based on the low dose 
PRO-SELF© Plus PCP which includes weekly contacts over ten weeks. We chose this 
version in order to test an increased dose compared to the original PRO-SELF© PCP and 
at the same time balance costs with expected benefits. Adaptations to the Program were 
made in close collaboration with the PRO-SELF© study group at the University of California 
in San Francisco (UCSF). Furthermore, in this thesis, we were guided by two theoretical 
frameworks: symptom management theory (SMT)52 and social cognitive theory53. 
Theoretical Framework 
The overall framework for this study was the SMT which was developed by Dodd et 
al.54 and refined in 200852 at UCSF (Figure 1). SMT is described as a mid range theory that 
guides researchers in the planning of interventions in the complex environment of symptom 
management. In this model, a symptom such as cancer pain, is defined as a “subjective 
experience reflecting changes in the biopsychosocial functioning, sensation, or cognition of 
an individual”52. The three dimensions of the SMT that influence each other reciprocally 
include symptom experience, symptom management strategies, and symptom status 
outcomes. The “Symptom Experience” dimension includes the individual’s perceptions, 
evaluation, and responses to a symptom. The “Symptom Management Strategies” 
dimension includes both the self-management strategies individuals do for themselves and 
the treatments that clinicians prescribe. It also includes questions that relate to the 
structure and content of self care activities (e.g., how, when, where, or how much). The 
“Symptom Status Outcomes” dimension specifies that outcomes emerge from the symptom 
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management strategies, as well as from the symptom experience. In this model, the 
“Symptom Status Outcomes” dimension focuses on eight outcomes (i.e., functional status, 
emotional status, self-care, costs, QoL, morbidity, co-morbidity, mortality). However, these 
eight outcomes only provide examples of symptom-related outcomes instead of being all 
inclusive. Clinicians and researchers can select these and other outcomes depending on 
their targeted symptom and purpose. According to SMT, “Symptom Status Outcomes” are 
directly depending on adherence to symptom management strategies (i.e., whether an 
intended person actually uses an assigned symptom management strategy). SMT states 
that nonadherence (illustrated by the broken arrow between “Symptom Management 
Strategies” and “Symptom Outcome Status”) occurs if interventions are too challenging for 
the person or are applied inconsistently. In order to allow for the major impact of contextual 
factors, the model places symptom management within the context of the domains of the 
person (e.g., age, gender, socio economic status, mood), health- and illness-related factors 
(e.g., kind and status of disease), and the environment (e.g., setting, social support). 
Figure 1: Symptom Management Theory 
 
 
 
 
 
 
 
 
 
 
 
 
Note: Reprinted with permission from Humphreys J, Lee KA, Carrieri-Kohlmann V, et al. Theory of 
symptom management. In Smith MJ, Liehr PR (eds): Middle range theory for nursing. New York, Springer, 
2008, pp 145-158. 
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In order to frame the content and structure of the intervention, adult learning theory 
was chosen as a theoretical foundation. More specifically, Bandura’s social cognitive theory 
was chosen as conceptual framework53. This theory was used because it is one of the most 
frequently used paradigms in health promotion today. It establishes that human behavior is 
influenced and affected reciprocally by the individual (i.e., a person’s expectations, beliefs, 
self-perception, goals, capabilities, intentions, and emotional responses form and guide 
behavior), their behavior (i.e., a person’s behavior will determine the environment to which 
the person is exposed, and behavior is, in turn modified by that environment), and the 
environment (i.e., expectations, beliefs, and cognitive competencies are developed and 
modified by social influences and physical structures within the environment). 
According to social cognitive theory, each individual possesses a self-regulating 
system that affects learning. As part of this self-regulatory system, Bandura55 introduced 
the concept of self-efficacy. Bandura defines self-efficacy as one's belief in one's ability to 
succeed in specific situations. Individuals accumulate perceptions about their performance 
(experience) that influence their self-belief. In other words, the achievements or failures 
that people experience are closely related to the ways that they have learned to view 
themselves and their relationships with others. The thoughts that result from this 
interrelationship become a mediator between knowledge and behavior and influence an 
individual’s ability to complete a task and reach an attainable goal, affect the level of 
resilience the individual develops, and can become the motivational drive that accompanies 
action. These experiences are processed, stored, and used by the self-efficacy beliefs 
system, which in turn affects future experiences, thoughts, behavior, and environment. 
According to social cognitive theory, methods for increasing self-efficacy include mastery 
experience (i.e., enabling the person to reach a desirable and attainable goal in order to 
build a sense of success), improving physical and emotional states, or verbal persuasion 
(e.g., encouragement by another person to induce efforts towards behavior change)56. 
Placing the PRO-SELF© Plus PCP within  
the Theoretical Framework 
Details of the intervention and study procedures are described in Chapters 4 and 5 
of this thesis. However, in order to place the German PRO-SELF© Plus PCP within the 
context of the theoretical frameworks, some of its key features are described briefly in the 
following paragraphs. Consistent with SMT, in this research project cancer pain was viewed 
as a complex and multidimensional experience that included patients’ responses to and 
evaluation of the pain experience52. In addition, pain was not expected to be a solitary 
symptom experienced by oncology patients but to be frequently accompanied by other 
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symptoms that may be closely related to the patient’s disease, pain, or treatment (e.g., 
constipation as side effect of treatment with opioids). Within the “Symptom Management 
Strategies” dimension, the intervention in this research project focused on supporting 
patients’ pain self-management which means that patients and FCs were viewed as key 
players in cancer pain management: While a specifically trained intervention nurse 
provided support for the patients and their FCs, actual pain self-management strategies 
were supposed to be performed by the patients and their FCs. Furthermore, a goal of the 
intervention was to indirectly influence the pain management strategies prescribed by 
clinicians by teaching patients how to communicate with their treating clinicians if pain 
control was not sufficient. Furthermore, for the intervention, essential structure and content 
components (e.g., dose, setting, content of the intervention) were clearly defined. 
Within the “Symptom Status Outcomes” dimension, cancer pain was established as 
key outcome of the German PRO-Self© Plus PCP. Because of the significant impact that 
cancer pain has on patients’ QoL and daily function57, these variables were measured as 
secondary outcomes. Furthermore, concurrent symptoms that were expected to be closely 
related with pain were included in this project58,59: Common side effects of analgesic 
medication (e.g., constipation) were addressed as part of the intervention and measured as 
secondary outcomes of the study. Other symptoms that have been shown to occur 
frequently in oncology patients (e.g., fatigue) were measured and included as covariates in 
the quantitative analysis60,61. Furthermore, demographic and clinical data (e.g., age, 
gender, socio-economic status, mood status) were included in order to control for their 
potential influence on pain self-management. The pilot RCT was positioned within the 
context of the domains of the person (i.e., by taking into account the patients’ age, socio 
economic status, and mood status), health- and illness-related factors (i.e., by taking into 
account the kind and status of disease and the patients’ cognitive status) and the 
environment (i.e., by meeting the patients in their home setting and including FCs). 
Furthermore, the PRO-SELF© Plus PCP was designed in accordance with social 
cognitive theory53. The individual patient’s pain self-management was addressed within the 
three key features of the Program by supporting patients’ and FCs’ expectations (e.g., 
ongoing coaching that included individual goal setting) and capabilities (e.g., provision of 
information, skills building). In addition, by using the academic detailing approach which 
allowed the intervention nurse to focus the education on a patient’s and FC’s individual 
knowledge deficits48,50, the provision of information was based on previous experiences of 
patients and their FCs with common patient-related barriers towards pain self-
management41,62. Changes in these patient-related barriers were assessed and included in 
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the analysis while patients’ and FCs’ intentions and emotional responses to the barriers 
were addressed during discussions by the intervention nurse.  
Regarding the patients’ behavior, pain self-management strategies were discussed 
with patients and FCs, noted in a weekly pain and side effect management plan, and 
evaluated. The patient’s social and physical environment was expected to have a large 
influence on their pain self-management, therefore the intervention took place within the 
patients’ homes and FCs were explicitly included. Furthermore, self-efficacy was addressed 
in the intervention and assessed in the study. Verbal persuasion was used repeatedly to 
increase patients’ and FCs’ self-efficacy as part of the nurse coaching component of the 
PRO-SELF© Plus PCP by the specially trained intervention nurse. Furthermore, in order to 
build up positive mastery experience of patients and their FCs, attainable goals were 
included in the intervention that were closely related to the patient’s daily activities.  
Identified Gaps and Rationale for this Project 
In summary, interventions that are designed to support oncology patients’ pain self-
management warrant additional investigation. To date, the heterogeneity in study and 
intervention designs prevent definitive conclusions about which components of these 
interventions are essential to improve pain self-management. 
The PRO-SELF© Plus PCP is a promising approach to support oncology patients’ 
pain self-management. Adaptations that were made based on qualitative and quantitative 
analyses from the original PRO-SELF© study need to be tested for efficacy. Furthermore, 
to our knowledge, the translation of a cancer pain self-management intervention from the 
U. S. into the German health care setting, which requires cultural and other adaptations, 
has not been examined. Prior to implementation of a large scale RCT, a pilot study is 
advisable in order to test an intervention’s feasibility and determine effect sizes63. Because 
patients and theirs FCs play a critical role in pain management, the patients’ perspective 
needs to be evaluated to establish an intervention’s feasibility. Furthermore, little is known 
about the processes that oncology patients and their FCs use to come to a decision about 
whether to take analgesic medication. With the research presented in this doctoral thesis 
these gaps are addressed. 
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Chapter 2 
 
 
Aims of the Research Project 
 
To promote optimal pain self-management in patients with cancer and their family 
caregivers (FCs), effective interventions are needed to overcome patient-related barriers 
towards pain self-management. The overall aims of this mixed methods research program 
were twofold: first, to analyze the state of knowledge regarding interventions designed to 
support pain self-management in patients with cancer; and second, to translate, adapt, 
improve, and evaluate a state of the art intervention designed to support self-management 
of cancer patients and their FCs in a German speaking context. 
To address the first aim, a systematic literature review was conducted in order to 
summarize evidence from experimental studies on components of interventions to support 
cancer pain self-management. In this review, the aim was to systematically describe structure 
and content components, as well as the efficacy of various components of interventions 
designed to improve patients’ and their FCs’ self-management of cancer pain.  
To pilot test the adapted German version of the PRO-SELF© Plus Pain Control 
Program (PCP), an intervention that was designed to support the pain self-management of 
patients with cancer and their FCs a nested concurrent mixed methods design was 
utilized1. In the main part of the pilot study a randomized controlled trial design was used 
and in two substudies, qualitative methods were applied (Figure 1). With this approach, 
topics that are traditionally addressed in pilot studies (e.g., attrition rates)2 were augmented 
with the contextual field-based patient perspective. Debriefing interviews with patients and 
FCs after the intervention and audiotapes of intervention sessions provided valuable data 
that helped determine how patients experienced the intervention and study procedures and 
to explore patients’ decision-making processes regarding analgesic intake. 
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Figure 1: Nested Concurrent Mixed Methods Design of Pilot Study1 
 
 
 
 
 
 
To prepare for the pilot RCT, instruments were translated and intervention and 
study procedures were revised in order to adapt the PRO-SELF© PLUS PCP for a German 
speaking population. The preparation phase was part of this thesis and is described in 
Chapter 4. 
Specific Aims of the Pilot RCT:  
1. To examine the feasibility of study procedures, including recruitment procedures, 
interventions, data collection and management, and the attrition rate. 
2. To establish effect sizes for the main outcome variables (i.e., worst and average 
intensity of pain) for subsequent power calculations. 
Specific Aims of the Qualitative Substudies of the Pilot RCT:  
1. To explore patients’ and FCs’ experiences with their pain management, with the 
educational intervention, and their view of burden and benefit from study 
participation. 
2. To explore patients’ decision-making processes regarding the intake of analgesic 
medications over the course of the 10-week intervention period. 
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Abstract 
Context: Cancer pain continues to be extensively under treated, despite established 
guidelines. While the efficacy of interventions that support patients’ self-management of 
cancer pain was demonstrated in several studies, the most effective components of these 
interventions remain unknown. 
Objectives: The purpose of this review of experimental and quasi-experimental 
studies was to systematically describe the structure and content components, as well as 
the efficacy of various components of interventions designed to improve patients’ self-
management of cancer pain.  
Methods: A systematic review of the literature was done that supplemented Bennett 
and colleagues’ meta-analysis (2009). Intervention components were categorized using 
content analysis. The intervention components were compared based on their calculated 
largest effect sizes (ESs) within each study (i.e., Hedges’ Gu for between group differences 
in pain intensity scores). 
Results: Based on 34 publications (i.e., 24 interventions), seven structure and 16 
content components were identified. In eleven studies with statistically significant ESs, the 
largest ESs within each study ranged from -1.87 to -0.44, which represented clinically 
meaningful effects. No single component was found to have a discernable influence on ES. 
Conclusions: This analysis provides researchers and clinicians with a detailed 
overview of the various structural and content components, as well as various 
combinations that were tested in intervention studies to improve cancer pain management. 
However, because of a variety of limitations, the most efficacious intervention components 
or combination of components remain to be determined in future studies. 
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Introduction 
Despite the availability of analgesics and established guidelines to maximize 
treatment efficacy1,2 cancer pain remains undertreated3-5. An extensive portion of this 
undertreatment can be attributed to patient factors or barriers that hinder effective pain 
management6,7. While many interventions to support patients’ self-management of cancer 
pain were developed and tested, it remains unclear which intervention components are 
most effective8-10. Therefore, the purpose of this review of experimental and quasi-
experimental studies was to systematically describe the structure and content components, 
as well as the efficacy of various components of interventions designed to improve patients’ 
self-management of cancer pain. 
Background 
Pain is one of the most frequent symptoms that oncology patients experience1,11. 
Even though effective treatments exist3,5, more than 40% of cancer patients experience 
moderate to severe pain2,12,13. Because of its deleterious effects on mood, functional status, 
and quality of life, pain control is an essential component of cancer treatment14,15. Established 
guidelines describe five steps that are crucial for optimal pain management by clinicians and 
patients: assessment, planning and implementation of actions, evaluation of these actions, 
and adaptations if pain management is inadequate3,5,16. While clinicians diagnose and treat 
pain, patients and their family caregivers (FCs) need to follow these five steps on a daily 
basis in order to achieve pain control. Cancer patients and their FCs need to apply complex 
self-management strategies, such as self-monitoring of pain and related symptoms, obtaining 
the prescribed pain medication, taking pain medication on a regular schedule, and using 
nonpharmacologic pain management strategies. Finally, patients need to evaluate the 
effectiveness of their strategies and make adaptations if necessary by titrating as needed 
medications and effectively communicating with their clinicians if their pain is not relieved16. 
If applied correctly, pain management can reduce pain in 95% of oncology 
patients12. However, an extensive portion of undertreatment of cancer pain is attributed to 
patient barriers. For example, oncology patients took only 56% to 70% of their medication 
despite being in severe pain, even if analgesics were prescribed correctly6,17. Patient 
barriers are multi-factorial and often a consequence of a lack of knowledge about cancer 
pain and its self-management6,18,19. For example, opioids are associated with fears and 
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misconceptions6,20,21. In addition, practical problems such as difficulties obtaining 
prescribed pain medication, difficulties tailoring medications to individual needs, or 
inadequate management of side effects were found to inhibit optimal pain control6,22. 
Lorig defines interventions that support patients’ self-management as a “set of 
planned activities designed to improve patients’ behaviors, health status, or both” (p. xiii) 
and describes self-management and its support as a complex process23. It is no longer 
sufficient for patients with cancer pain to learn and practice distinct skills. In addition, they 
need to manage their pain as part of daily life using advanced problem solving skills23,24. 
Often, interventions that are designed to support patients’ self-management are guided by 
theoretical frameworks that provide directions on how to change patients’ cognitions (i.e., 
alterations in persons’ knowledge, beliefs, and attitudes)23,25 and behaviors (i.e., alterations 
in persons’ actions and skills)25. In addition, affective aspects of an intervention have 
received more attention particularly in terms of the identification of specific factors that drive 
peoples’ actions25. It is increasingly important for patients to gain advanced skills in how to 
deal with the consequences of their disease within their social environment (e.g., problem 
solving and decision-making skills, skills to form effective partnerships with clinicians, and 
the achievement of confidence in being able to deal with problems)23. For this review, 
interventions were viewed as planned activities that support patients to achieve optimal 
pain control. Interventions that focused exclusively on the use of nonpharmacologic 
interventions (e.g., distraction, relaxation) were not included in this review. 
Based on three systematic reviews8-10, evidence on the efficacy of interventions to 
improve patients’ self-management of cancer pain has increased. In a 2001 systematic 
review, only eight interventions were evaluated and only two were randomized controlled 
trials (RCTs)8,26,27. Interventions varied greatly in type, duration, and content. Improvements 
in pain intensity were reported in five studies20,26-30, but most studies did not have 
appropriate control groups. In addition, in one RCT27 where effect sizes (ESs) were 
calculated, the ESs were small and not statistically significant (i.e., d = 0.20-0.25). 
However, Allard et al.8 concluded that interventions directed at patients and FCs may be 
effective in improving patients’ attitudes towards pain self-management. The authors 
emphasized the importance of using a pain diary to monitor pain. However, it is not clear 
how they reached this conclusion because none of the studies tested the effects of different 
components of the intervention. 
In a second review of six studies of interventions for pain self-management10 Devine 
noted that the interventions varied greatly in terms of type, duration, and content. Larger 
ESs were noted when patients were not randomized; patients reported pain verbally to the 
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person who conducted the intervention; and patients had average or present pain intensity 
scores of ≤ 3 (on a 0 to 10 numeric rating scale [NRS] with 0 = no pain and 10 = maximum 
pain) at the time of enrollment. A medium ES for pain intensity (d = 0.4) was found, while 
controlling for those three factors that had confounding effects on pain intensity. Devine 
concluded that interventions designed to support self-management of cancer pain 
frequently but not invariably reduced pain. 
In 2009, Bennett et al.9 published a meta-analysis of 21 experimental studies on the 
efficacy of interventions that targeted patients’ and/or FCs’ management of cancer pain. 
The overall effect on pain intensity in ten of 12 studies that used the same outcome 
measure (i.e., 0 to 10 NRS with 0 = no pain and 10 = maximum pain) was a statistically 
significant 1.1-point reduction (95% CI: -1.8/-0.41) in average pain, a statistically significant 
0.98-point reduction (95% CI: -1.68/-0.28) in least pain, a statistically significant 0.78-point 
reduction (95% CI: -1.21/-0.35) in worst pain, and a statistically significant 0.65-point 
reduction (95% CI: -1.21/-0.09) in current pain. In addition, the overall effect on pain 
management related knowledge and attitudes was statistically significant. Despite these 
findings, the authors concluded that the relationships between the interventions, improved 
knowledge and attitudes, medication adherence, decreased pain scores, and decreased 
pain interference with daily life remain unclear. Significant heterogeneity, arising from 
differences in study designs, as well as methods and types of interventions were present, 
which may have weakened the results. The authors hypothesized that other factors, 
including the specific components of the interventions, could have influenced their findings. 
In summary, over the past fifteen years, the number of studies and the proportion of 
RCTs have increased while outcome criteria have shifted from an improvement in patients’ 
knowledge about cancer pain management to a clinically significant decrease in pain 
intensity. While statistically significant decreases in pain intensity were found across 
studies the effects in terms of being clinically meaningful were in the moderate range (i.e., 
d = 0.2 to 0.4, weighted mean differences = 0.65 to 1.1). All systematic reviews8-10 
concluded that interventions varied greatly in terms of type, duration, and content. In 
addition, it was not possible to determine which types of interventions were most effective. 
In order to improve the efficacy of interventions for cancer pain management, it is essential 
to determine which structure and content components contribute to the best outcomes. A 
comprehensive evaluation of the efficacy of the components of interventions studied to 
date is a critical first step to optimize oncology patients’ ability to effectively manage pain. 
Therefore, in this systematic review, structure and content components of interventions 
tested to date to support adult oncology patients’ self-management of cancer pain were 
categorized and their efficacy evaluated. 
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Methods 
Review of the literature. Studies included in Bennett and colleagues’ 2009 meta-
analysis9 served as foundation for this review. This literature search was updated in 
Medline, CINAHL, and the Cochrane Library from December 2007 to November 2010 using 
the same search terms as Bennett et al.9. An additional search was performed within 
references of identified studies. 
Interventions to support oncology patients’ pain self-management were defined by 
Bennett et al.9 as “information, behavioral instructions, and advice in relation to management 
of cancer pain by means of verbal, written, audio- or video-taped or computer-aided 
modalities, which are given by a healthcare provider or peer, for example expert patients” (p. 
193). Trials were included if they met the following criteria: “experimental design with a 
comparison group (RCTs or controlled trials), where the control group received usual care or 
attention only; included adults with pain from active cancer and not pain from cancer 
treatment such as surgery or chemotherapy; used a patient-based educational intervention 
on an individual basis; assessed pain-related outcomes” (p. 193). Bennett et al.9 excluded 
studies that included psycho-behavioral methods in the intervention. For this review, the 
same inclusion and exclusion criteria were used. However, in this review, two studies that 
were included in Bennett et al. meta-analysis were excluded because they only evaluated 
interventions on relaxation, distraction, and massage but not on pharmacologic 
interventions31 or they did not report pain outcomes for a control group32. 
Bennett et al.9 assessed the studies’ validity using the following criteria: randomization 
method, groups’ baseline differences, groups treated similarly apart from the intervention, 
blinding of outcome assessors, reporting of outcomes for both groups, and the use of intent to 
treat analysis. These criteria were used to judge the additional studies included in this review.  
Categorization of intervention components. Based on the work of Mayring33, 
content analysis was used to categorize the structure and content components of the 
interventions. For each study, the first author categorized each of its intervention 
components. In the second step, the first and the last author collapsed these categories and 
refined them based on discussions with the third author. Finally, the last author read all of the 
publications and categorized the components of the intervention. Results were compared 
with the first author’s categorizations and disagreements were discussed until consensus 
was reached. Based on these analytical steps, components of interventions were categorized 
into seven structure components (see Table 1) and 16 content components (see Table 2).  
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Calculation of effect sizes. When possible, Hedges’ Gu, a unit free ES was 
calculated for between group effects for each pain intensity measure at each time-point34. If 
information was not sufficient in study publications, additional online information from 
Bennett et al.9 was used. Hedges’ Gu is a standardized mean difference parameter which 
differs from other commonly used ES calculations in that it contains a sample bias corrector 
which results in an unbiased estimation of effects especially for small studies35 The greater 
a negative ES differs from zero, the larger the difference in pain reduction is between the 
two groups in favor of the intervention group. A Gu of < -0.3 was considered a clinically 
meaningful ES in accordance with health outcomes research in oncology patients36,37. 
Furthermore, we defined a large ES as Gu < -0.8 and a medium ES as Gu -0.3 to -0.838. 
The largest ES within each study was used for evaluation.  
Because of the small number of studies, it was not possible to use quantitative 
methods (e.g., moderator analysis) to analyze the efficacy of single intervention 
components. Instead, by way of example, as shown in Table 3 for the structure component 
of FC involvement, smaller tables that included only statistically significant studies, were 
developed to evaluate for patterns or trends associated with a specific structure or content 
component of an intervention. For each of these analyses, the statistically significant 
studies were first grouped according to ESs and then examined visually for patterns for 
each of the defined intervention components based on their ES. 
Finally, components of studies with large ESs were summarized. Studies were 
categorized as statistically significant if the p-value was < 0.05 at any time-point for any 
pain intensity measure. 
Results 
Nineteen studies were included from Bennett et al. meta-analysis9. While additional 12 
studies were identified through the literature search, only five met the inclusion criteria. Four 
were found within databases39-42 and one by hand search43. Another ten papers were identified 
that contained additional information on seven of these studies44-53. Therefore, a total of 24 
studies (i.e., 24 interventions) and ten additional papers were included in this review. 
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Table 1. Structure Components of Interventions to Support Oncology Patients’ Pain Self-Management 
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I
 Mode  
of 
deliveryII 
Material 
given  
to 
patient 
Receiver 
of  
inter-
vention
Provider  
of  
intervention 
Inter-
action 
provider/ 
receiverIII
Structured 
and/or 
tailoredIV 
Intensity of interventionV 
Brief description  
of  
interventionVI 
Pain measurement method 
Time points  
of 
measurementVII
Effect size Gu (95% CI)VIII 
A
u
b
i
n
 
2
0
0
6
a
,
1
8
 
face-to-
face 
video 
 
booklet patient 
or 
patient 
and FC
specially  
trained home-
care nurses  
video: nr 
questions structured 
and 
tailored 
1 session: duration nr 
video: duration 15 minutes 
Interactive cognitive 
behavioral session at 
patients’ homes. HCPs were 
contacted directly by home-
care nurses if patients had 
contacted them with 
problems. 
average and worst pain 
intensity (time frame not 
specified) 
NRS: 0 (no pain) to 10 (worst 
imaginable pain) 
2 weeks T1/2 
 
 
4 weeks T2/2 
average pain* 
worst pain* 
 
average pain 
worst pain* 
-1.18 (-1.75/-0.62) 
-1.87 (-2.50/-1.25) 
 
-0.57 (-1.21/0.07) 
-1.25 (-1.93/-0.56) 
Y
i
l
d
i
r
i
m
 
2
0
0
9
4
3
 
face-to-
face 
slide 
presenta-
tion 
booklet  patient 2 PhD  
prepared 
registered 
nurses, 
physician 
questions
 
structured 
and 
tailored 
1st session: duration 30-40 
minutes 
2nd session after 3 days: 5-15 
minutes (“as required”) 
3rd session after 7 days: 5-15 
minutes (“as required”) 
Interactive cognitive  
sessions in patient’s room  
in hospital. 
present, worst and least pain 
intensity (timeframe not 
specified)  
NRS: 0 (no pain) to 10 (worst 
imaginable pain) 
2 weeks T1/3 
 
 
 
4 weeks T2/3 
 
 
 
8 weeks T3/3 
present pain* 
worst pain 
least pain* 
 
present pain* 
worst pain 
least pain* 
 
present pain* 
worst pain  
least pain* 
-1.29 (-1.97/-0.61) 
-0.49 (-1.12/0.14) 
-0.82 (-1.47/-0.18) 
 
-1.56 (-2.27/-0.85) 
-0.48 (-1.11/0.15) 
-0.82 (-1.47/-0.18) 
 
-1.48 (-2.18/-0.78) 
-0.37 (-1.00/0.25) 
-0.96 (-1.62/-0.31) 
L
a
i
 
2
0
0
4
5
9
 
face-to-
face 
booklet patient Master  
prepared 
oncology  
nurse 
questions structured 
and 
tailored 
5 sessions over 5 days: 
duration 10-15 minutes each 
Interactive cognitive session 
performed during 
hospitalization. 
average, least current and 
worst pain intensity (time frame 
not specified) 
NRS 0 (no pain) to 10 (worst 
imaginable pain) 
2 weeks T1/1 average pain  
least pain* 
current pain* 
worst pain 
-0.52 (-1.25/0.20) 
-0.94 (-1.70/-0.19) 
-0.87 (-1.62/-0.12) 
-0.08 (-0.79/0.64) 
O
l
i
v
e
r
 
2
0
0
1
4
7
,
5
5
 
face-to-
face 
booklet patient Master level 
psychology 
student or four 
year medical 
student 
inter-
action 
structured 
and 
tailored 
1 session: duration 20 
minutes 
Interactive cognitive 
behavioral session. 
average pain in past 2 weeks  
NRS: 0 (no pain) to 10 (worst 
imaginable pain) converted into 
0-100 scale 
2 weeks T1/1 average  
change pre-post 
compared 
between groups*  
-0.61 (-1.01/-0.21) 
V
a
l
l
i
è
r
e
s
 
2
0
0
6
1
9
 
nr booklet patient nr nr structured 1 session: duration nr Cognitive behavioral session. average and worst pain 
intensity in past 48 hours 
NRS: 0 (no pain) to 10 (worst 
pain) 
3 weeks T2/2 
 
(week 1 T1/2 nr)
average pain*  
worst pain 
-0.59 (-1.09/-0.09) 
-0.46 (-0.95/0.04) 
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of  
intervention 
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Intensity of interventionV 
Brief description  
of  
interventionVI 
Pain measurement method 
Time points  
of 
measurementVII
Effect size Gu (95% CI)VIII 
L
i
n
 
2
0
0
6
6
3
 
face-to-
face 
booklet patient 
and FC
research 
assistant 
questions structured 
and 
tailored 
1 session: duration 30-40 
minutes 
2 follow-up sessions after 2  
and 4 weeks: duration nr 
phone-number to call if 
questions arose 
Interactive cognitive session  
in private room at routine  
visits at outpatient clinic and 
two follow-up sessions to 
reinforce information. 
worst pain intensity in past 24 
hours 
NRS: 0 (no pain) to 10 (worst 
imaginable pain) 
2 weeks T1/2 
 
4 weeks T2/2 
worst pain 
 
worst pain* 
-0.16 (-0.67/0.34) 
 
-0.53 (-1.05/-0.02) 
M
i
a
s
k
o
w
s
k
i
 
2
0
0
4
5
0
,
6
0
 
face-to-
face 
phone 
call 
booklet  
pill box 
patient 
or 
patient 
and FC
specially  
trained  
oncology nurses 
inter-
action 
structured 
and 
tailored 
3 sessions over 6 weeks 
(week 1, 3, 6)  
1st session: mean duration 
107 minutes (including ~ 20 
minutes for study 
questionnaire) 
2nd session: mean duration  
48 minutes 
3rd session: mean duration  
69 minutes (including  
~ 20–30 minutes for study 
questionnaire and exit 
interview) 
3 phone calls over 6 weeks 
(week 2, 4, 5) mean duration 
13–16 minutes 
Interactive cognitive  
behavioral sessions at  
patient’s home or clinic and  
3 phone calls. 
average, worst and least pain 
intensity in past 24 hours 
NRS: 0 (no pain) to 10 
(excruciating pain) 
1 week T1/1 worst pain* 
average pain* 
least pain* 
-0.47 (-0.78/-0.16) 
-0.51 (-0.82/-0.21) 
-0.43 (-0.74/-0.12) 
K
e
e
f
e
 
2
0
0
5
6
2
 
face-to-
face  
video 
audio-
tapes 
booklet 
video 
audio-
tapes 
patient 
and FC
registered  
nurse-level  
nurse educator 
knowledgeable 
about cancer 
pain and skilled 
in coping skills 
training 
interventions 
video: nr 
inter-
action 
structured 
and 
tailored 
3 sessions over 
approximately 1-2 weeks: 
duration 45 to 60 minutes 
each (average length of 
sessions: 56 minutes [range 
20-90 minutes]; average 
number of days from first to 
last session: 14 days [range 
8-32 days]) 
videotape: duration nr (‘brief”)
Interactive cognitive  
behavioral sessions at  
patients’ homes. 
usual and worst pain intensity 
during past week 
NRS: 0 (no pain) 10 (worst 
imaginable pain) 
1 week T1/1 usual pain 
unadjusted*  
worst pain 
unadjusted 
-0.49 (-0.95/-0.04) 
 
-0.38 (-0.83/0.06) 
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I
 Mode  
of 
deliveryII 
Material 
given  
to 
patient 
Receiver 
of  
inter-
vention
Provider  
of  
intervention 
Inter-
action 
provider/ 
receiverIII
Structured 
and/or 
tailoredIV 
Intensity of interventionV 
Brief description  
of  
interventionVI 
Pain measurement method 
Time points  
of 
measurementVII
Effect size Gu (95% CI)VIII 
W
a
r
d
 
2
0
0
9
b
4
0
,
4
5
,
5
1
 
face-to-
face 
nr patient 
or  
patient 
and FC
5 Master  
prepared 
nurses, 2 
psychologists 
inter-
action 
structured 
and 
tailored 
1 session: duration 20-80 
minutes 
2 phone calls 2 and 4 weeks 
after the session: duration 5-
10 minutes 
Interactive cognitive  
behavioral session at a 
location that was convenient 
for the patient, usually at 
patients’ homes. Phone call  
for evaluation of strategies  
and revise plans. 
pain severity (composite T-
score of Z-scores of 5 values):  
pain duration during past week
VRS (never, sometimes, often, 
almost always, always) 
usual pain during past week 
VRS (none, mild, moderate, 
and severe) 
and of worst, least pain  
intensity during past week  
and pain now 
NRS 0 (no pain) to 10 (worst 
imaginable pain) 
5 weeks T1/2 
 
 
 
 
 
 
9 weeks T2/2 
pain severity: Solo 
vs. dyad 
pain severity: 
Dyad vs. control 
pain severity: 
Solo vs. control* 
 
pain severity: Solo 
vs. Dyad  
pain severity: 
Dyad vs. control 
pain severity: Solo 
vs. control 
0.38 (-0.05/0.82) 
 
-0.02 (-0.45/0.41) 
 
-0.44 (-0.88/-0.01) 
 
 
-0.29 (-0.75/0.16) 
 
-0.14 (-0.60/0.32) 
 
0.12 (-0.35/0.59) 
 
C
l
o
t
f
e
l
t
e
r
 
1
9
9
9
2
6
,
4
8
 
video booklet patient 
or  
patient 
and FC
nr no inter-
action 
structured video: duration 14 minutes Cognitive behavioral video 
presentation in office in  
private oncology practice. 
present pain intensity 
VAS: 0 mm (no pain) to 
100 mm (worst imaginable  
pain) 
2 weeks T1/1 present pain 
intensity* 
not calculated 
L
o
v
e
l
l
 
2
0
1
0
4
1
,
5
2
 
 
video booklet 
video 
patient 
or 
patient 
and FC
video: patients, 
caregiver, 
health 
professionals 
no inter-
action 
structured video: duration nr Cognitive behavioral booklet 
and video presentation at 
home. 
worst and average pain 
intensity 
NRS 0 (no pain) to 10 (worst 
imaginable pain) 
2 weeks T1/2  
(4 weeks T2/2  
nr: effects of the 
treatment groups 
were averaged 
across both 
post-
randomization 
time points) 
worst pain: video 
and booklet vs. 
control* 
worst pain: 
booklet vs. control 
worst pain video 
vs. control 
 
average pain: 
video and booklet 
vs. control* 
average pain: 
booklet vs. control 
average pain: 
video vs. control 
not calculated 
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 Mode  
of 
deliveryII 
Material 
given  
to 
patient 
Receiver 
of  
inter-
vention
Provider  
of  
intervention 
Inter-
action 
provider/ 
receiverIII
Structured 
and/or 
tailoredIV 
Intensity of interventionV 
Brief description  
of  
interventionVI 
Pain measurement method 
Time points  
of 
measurementVII
Effect size Gu (95% CI)VIII 
W
e
l
l
s
 
2
0
0
3
b
,
5
7
 
face-to-
face 
phone 
call 
written 
informa
tion 
patient 
and FC
session: not 
specified 
video: experts 
(physician and 
nurse) and 
patients 
weekly 
telephone calls: 
oncology nurse 
specialist 
 
 
ques-
tions 
(inter-
action in 
group 3) 
structured 
and 
tailored 
1 session: duration 20-30 
minutes 
group 2: access to a pain 
hotline: duration nr (only 18% 
of all patients in this group 
used the hotline) 
group 3: 4 weekly phone calls 
over the month following the 
educational session 
All groups: Interactive 
cognitive intervention  
session following a video 
presentation of 15-minutes. 
Group 2: Patients were 
encouraged to call a toll-free 
hotline if they had questions 
or concerns about pain 
control. 
Group 3: patients received 
phone calls to reinforce 
information of intervention. 
worst pain and average pain 
intensity in past 24 hours 
NRS 0 (no pain) to 10 (worst 
imaginable pain) 
1 month T1/6 
(T2 to T5 nr) 
data from 
Bennett 
 
 
 
 
 
 
6 months T6/6 
data from 
Bennett 
average pain: 
hotline vs. control 
average pain: 
phone calls vs. 
control 
worst pain: hotline 
vs. control 
worst pain: phone 
calls vs. control 
 
average pain 
hotline vs. 
control 
average pain: 
phone calls vs. 
control 
worst pain: hotline 
vs. control 
worst pain: phone 
calls vs. control 
-0.08 (-0.76/0.61) 
 
 
-0.28 (-0.99/0.43) 
 
-0.39 (-1.08/0.30) 
 
-0.41 (-1.12/0.30) 
 
 
0.71 (-0.27/1.69) 
 
 
0.30 (-0.59/1.18) 
 
 
0.46 (-0.51/1.42) 
 
0.40 (-0.49/1.29) 
v
a
n
 
d
e
r
 
P
e
e
t
 
2
0
0
8
2
7
,
3
9
,
4
4
 
face-to-
face 
 
booklet patient 
or 
patient 
and FC
palliative care 
nurses 
inter-
action 
structured 
and 
tailored 
3 sessions over 6 weeks 
(week 1, 3 and 6): duration 
60-90 minutes each 
Interactive cognitive  
behavioral sessions at  
patient’s home. Research  
staff contacted HCP in order  
to report findings and give 
advice if applicable. 
present pain intensity 
(timeframe not specified) 
NRS: 0 (no pain) to 10 (worst 
imaginable pain) 
4 weeks T1/2 
 
8 weeks T2/2 
present pain  
 
present pain  
-0.40 (-0.83/0.03) 
 
-0.28 (-0.71/0.16) 
Y
a
t
e
s
 
2
0
0
4
6
1
 
face-to-
face 
phone 
call 
 
booklet patient 2 experienced 
registered 
nurses 
inter-
action 
structured 
and 
tailored 
1 session: duration ~30 
minutes 
phone call 7 days after 
intervention session:  
duration ~15 minutes 
Interactive cognitive  
behavioral session at clinic  
visit at outpatient department. 
Phone call was made so that 
the patient could clarify 
questions and make 
comments. 
average pain intensity (time 
frame not specified) 
NRS: 0 (no pain) to 10 (worst 
imaginable pain) 
1 week T1/2 
 
13 weeks T2/2 
average pain  
 
average pain 
-0.30 (-0.60/0.01) 
 
-0.06 (-0.39/0.27) 
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 Mode  
of 
deliveryII 
Material 
given  
to 
patient 
Receiver 
of  
inter-
vention
Provider  
of  
intervention 
Inter-
action 
provider/ 
receiverIII
Structured 
and/or 
tailoredIV 
Intensity of interventionV 
Brief description  
of  
interventionVI 
Pain measurement method 
Time points  
of 
measurementVII
Effect size Gu (95% CI)VIII 
W
a
r
d
 
2
0
0
8
4
5
,
5
1
,
6
6
 
face-to-
face 
phone 
call 
booklet patient Master  
prepared 
oncology  
nurse 
inter-
action 
structured 
and 
tailored 
1 session: duration 20-60 
minutes 
phone call after 2 to 3 days: 
duration nr 
Interactive cognitive session  
in a private room at clinic visit. 
Phone call to give patients the 
opportunity to clarify  
questions and make 
comments. 
pain severity score (mean of 
least, and worst pain in past 
week and pain now) 
NRS: 0 (no pain) to 10 (worst 
imaginable pain) 
usual pain (time frame not 
specified) 
VRS: 0 (none), 1 (mild), 2 
(moderate) and 3 (severe pain) 
in the past week 
1 month T1/2 
 
 
 
2 months T2/2 
 
pain severity 
score  
usual pain  
 
pain severity 
score  
usual pain  
0.00 (-0.32/0.33) 
 
-0.28 (-0.60/0.05) 
 
-0.24 (-0.58/0.10) 
 
-0.10 (-0.44/0.23) 
D
e
 
W
i
t
 
1
9
9
7
2
7
,
4
4
 
face-to-
face 
phone 
call 
booklet 
audio 
tapes 
patient 3 nurses  
trained as  
pain  
counselors 
inter-
action 
structured 
and 
tailored 
1 session: duration 30-60 
minutes 
phone call 3 and 7 days post-
discharge: duration 5-15 
minutes each 
Interactive, cognitive 
behavioral intervention 
session provided in the 
hospital at day before 
discharge. 2 phone calls to 
reinforce information of 
session. 
average and current pain 
intensity in the past week 
NRS: 0 (no pain), 10 (pain as 
bad as you can imagine) 
8 weeks T3/3 
8 weeks T3/3 
data from 
Bennett 
(T1 to T7 nr) 
average pain 
current pain  
-0,25 (-0.51/0.01) 
-0.20 (-0.46/0.05) 
C
h
a
n
g
 
2
0
0
2
5
6
 
face-to-
face 
booklet patient research 
assistant 
ques-
tions 
structured 
and 
tailored 
1 session: duration 30-40 
minutes 
Interactive cognitive 
intervention session held at 
day of discharge in the 
patient’s room in hospital. 
pain intensity in past 24 hours  
NRS 0 (no pain) to 10 (worst 
imaginable pain) 
2 weeks T1/1 pain intensity 
not specified 
-0.24 (-0.89/0.41) 
W
i
l
k
i
e
 
2
0
1
0
4
2
,
5
3
 
face to 
face 
phone 
call 
video 
 
booklet 
lami-
nated 
pain 
diary 
grease 
pencil 
note 
card 
patient 4 research 
assistants with 
at least high 
school diploma, 
Bachelor, or 
Master degree, 
or one of  the 
authors 
video: trained 
actress with 
white coat 
inter-
action 
structured 
and 
tailored 
video: duration 12 minutes 
1 session week 2: duration 5-
10 minutes 
2 phone calls week 1 and 3: 
duration 5-10 minutes each 
Interactive cognitive 
behavioral sessions and 
phone calls. 
present pain intensity 
VAS: 0 mm (no pain) to 100 
mm (worst imaginable pain) 
1 week T1/1 present pain 0.24 (-0.08;0.56) 
W
a
r
d
 
2
0
0
0
4
5
,
4
9
,
1
5
,
5
4
 
face-to-
face 
phone 
call  
booklet patient research  
nurse 
inter-
action 
structured 
and 
tailored 
1 session: duration  
~25 minutes 
phone call 1 week post 
intervention: duration 5-10 
minutes 
Interactive cognitive 
intervention session; 10 
minutes giving information,  
up to 15 minutes discussion  
about questions and concerns. 
Phone call was made so that 
the patient could clarify 
questions. 
worst pain in the past week  
numeric rating scale 0 (no pain) 
to 10 (worst imaginable pain) 
1 month T1/2 
 
2 months T2/2 
worst pain 
 
worst pain  
-0.19 (-0.89/0.51) 
 
0.06 (-0.69/0.82) 
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 Mode  
of 
deliveryII 
Material 
given  
to 
patient 
Receiver 
of  
inter-
vention
Provider  
of  
intervention 
Inter-
action 
provider/ 
receiverIII
Structured 
and/or 
tailoredIV 
Intensity of interventionV 
Brief description  
of  
interventionVI 
Pain measurement method 
Time points  
of 
measurementVII
Effect size Gu (95% CI)VIII 
S
y
r
j
a
l
a
 
2
0
0
8
6
5
 
face-to-
face 
video  
phone 
call 
booklet 
individu
alized 
cards 
paper 
and 
pencil  
patient research  
nurse 
video: cancer 
patients with 
pain 
inter-
action 
structured 
and 
tailored 
1 session: duration 30-45 
minutes 
phone call after 3 days: 
duration 10 minutes 
video: duration 15 minutes 
Interactive cognitive  
behavioral session at  
oncology clinic or patient’s 
home after watching a video 
tape; a  
phone call was made to 
reinforce learning from 
session. Patients were given 
paper and pencil for questions 
they wanted to remember. 
average and worst pain 
intensity (time frame not 
specified) 
NRS: 0 (no pain) to 10 (worst 
imaginable pain) 
6 months T3/3 
(T1 and T2 nr) 
“significant at T1” 
data from 
Bennett 
average pain 
 
worst pain 
-0.18 (-0.59/0.23) 
 
0.15 (-0.27/0.56) 
W
a
r
d
 
2
0
0
9
a
6
7
 
phone 
call 
 
booklet  patient 43 Bachelor 
prepared 
nurses, health 
educators 
no inter-
action 
structured 
and 
tailored 
1 phone call: mean duration 
7 minutes 
Cognitive phone call by  
health educators of cancer 
information service call  
center. 
Pain severity: average of worst, 
least pain intensity during past 
week, and pain now 
NRS 0 (no pain) to 10 (worst 
imaginable pain) 
pain duration during past week, 
VRS (never, sometimes, often, 
almost always, always) 
4 weeks T1/1 pain severity 
intervention 
pain severity 
Item assessment 
-0.05 (-0.20/0.11) 
 
-0.07 (-0.22/0.08) 
R
i
m
e
r
 
1
9
8
7
2
9
 
face-to-
face 
booklet  
wallet 
sized 
cards 
patient oncology  
nurse 
inter-
action 
structured 
and 
tailored 
1 session: duration 15 
minutes 
Interactive cognitive 
intervention session at clinic 
visit. 
present pain intensity 
(timeframe not specified) 
VRS: 6-point (no, mild, 
discomforting, distressing, 
horrible, excruciating) 
4 weeks T1/1 not calculated not calculated 
A
n
d
e
r
s
o
n
 
2
0
0
4
5
8
 
face-to-
face 
video 
phone 
call 
booklet 
video 
patient 
or  
patient 
and FC
session: 
research nurse 
video: cancer 
patients 
representing 
targeted 
minority group 
(male/female, 
Hispanic/African 
American)  
ques-
tions 
structured 1 session: duration ~30 
minutes 
video: duration 20 minutes 
phone call 48 to 72 hours 
after intervention: duration  
not specified 
Interactive cognitive session 
after patients had been 
shown a video tape targeted 
at their specific minority 
group and gender at a 
scheduled clinic visit. Phone 
call to review patients’ pain 
control. 
worst pain intensity (time frame 
not specified) 
NRS 0 (no pain) to 10 (worst 
imaginable pain) 
2-4 weeks T1/3
6-7 weeks T2/3
8-10 weeks 
T3/3 
not calculated not calculated 
M
c
M
i
l
l
a
n
 
2
0
0
7
4
6
,
6
4
 
face-to-
face 
booklet 
assess
ment 
tools 
symp-
tom 
diary 
FC experienced 
registered  
nurse 
inter-
action 
structured 
and 
tailored 
3 sessions over nine-days:  
1st  session duration: 45 
minutes 
2nd and 3rd session: 30 
minutes each 
Interactive cognitive 
behavioral sessions for FCs 
at patients’ homes. 
present pain intensity 
NRS 0 (no pain) to 10 (worst 
pain) 
2 weeks T1/2 
4 weeks T2/2 
not calculated not calculated 
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Abbreviations Table 1 
HCP  health care provider 
FC  family caregiver 
NRS  numeric rating scale 
VRS  verbal rating scale 
VAS visual analogue scale 
nr not reported 
T Time point of measurement 
vs. versus 
Explanatory Notes Table 1 
I first author of main study is named; publications of the main study as well as studies on the same intervention in which additional information was found are referenced, main publication is 
printed bold 
II face-to-face, phone calls, video presentation, slide-presentation, audiotapes 
III  active participation in discussion was possible for patients during intervention (interaction), only questions could be asked by the patients (questions), or content was only presented to patients 
without any possibility for questions or discussion (no interaction) 
IV same for every patient (structured) and/or individualized for each patient (tailored) 
V number and duration of each session and phone call over which time period 
VI cognitive means information only, behavioral means also instructions how to do things (see Table 2) 
VII time points are indicated as T “number of actual time points of follow-up measurement”/”number of performed time points of follow-up measurement”; printed in bold are the time points at which 
the biggest effect size in each study occurred; “data from Bennett”: data were extracted from Bennett et al.9 online information 
VIII the biggest effect sizes in each study are printed bold; statistically significant effect sizes (p < 0.05) are marked with * 
a quasi-experimental design with non-equivalent groups 
b one group pre-test post-test design for intervention, RCT evaluated only telephone follow-up of intervention 
  
- 45 - 
Table 2. Content Components of Interventions to Support Oncology Patients’ Pain Self-Management 
  Cognitive: Information and recommendationsI 
Behavioral: 
instructions how to perform desired behaviorII 
Goalsetting Contact   
AuthorIII Year 
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p
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n
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v
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b
e
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i
o
r
a
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r
e
c
o
m
m
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d
a
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i
o
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m
i
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c
e
l
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a
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o
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X
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b
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F
C
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r
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g
u
l
a
r
l
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p
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Aubina,18 2006                  6 -1,87* 
Yildirim43 2009                  7 -1,56* 
Lai59 2004                  6 -0,94* 
Oliver47,55 2001                  5 -0,61* 
Vallières19 2006                  5 -0,59* 
Lin63 2006                  2 -0,53* 
Miaskowski50,60 2004                  9 -0,51* 
Keefe62 2005                  9 -0,49* 
Ward40,45,51 2009b                  7 -0,44* 
Clotfelter26,48 1999                  10 np* 
Lovell41,52 2010                  9 np* 
Wellsb,57 2003                  5 -0,41 
v.d. Peet27,39,44 2009                  11 -0,40 
Yates61 2004                  7 -0,30 
Ward45,51,66 2008                  3 -0,28 
deWit27,44 1997                  11 -0,25 
Chang56 2002                  2 -0,24 
Wilkie42,53 2010                  3 -0.24 
Ward45,49,51,54 2000                  3 -0,19 
Syrjala65 2008                  7 -0,18 
Ward67 2009a                  3 -0,07 
Rimer29 1987                  4 np 
Anderson58 2004                  3 np 
Mc Millan46,64 2007                  11 np 
Sum  12 20 7 23 16 12 18 3 2 7 5 4 4 10 3 2 3   
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Abbreviations Table 2 
np  not possible to calculate 
FCs  family caregivers 
Explanatory Notes Table 2 
I  information and advice so that a lay person could improve their knowledge on pain management  
II  behavioral instructions how to perform desired behavior means skill building via instructions so that a lay person could actually perform desired pain management 
III  first author of main study is named; publications of the main study as well as studies on the same intervention in which additional information was found are referenced, main publication is 
printed bold 
IV  includes pain definition, pain causes, pain timeline, pain consequences, pain cure/control, breakthrough pain, how medication works  
V  includes name and kind of medication, routes of administration, around the clock/as needed, schedule, dosing 
VI  includes physical (heat, cold, massage), cognitive (relaxation, distraction, imagery, deep breathing exercise, active pacing method) and other interventions (TENS, nerve block) 
VII  includes concerns about tolerance, addiction, fatalism, religious fatalism, being a good patient, side effects of medication are inevitable and unmanageable, masking signs of disease 
progression, distracting the clinicians from treating the disease, harming the immune system,  injections, respiratory depression 
VIII  includes constipation, vomiting, nausea, sedation, drowsiness, confusion, urinary retention, pruritus, postural hypotension, and suggestions for side effect management  
IX  includes information about compliance, medication intake, not stop medication abruptly 
X  includes explanation of pain measurement such as Visual Analogue Scale, stressing the importance of communication with the clinicians 
XI  includes information about not to drive a car, that occasional alcohol is OK with medication, that support groups and peer support can be helpful; support group addresses, recommendations on 
how to apply given information to one’s own situation, that it may take more than one HCP to manage pain 
XII  includes recommendations when and whom to call for help 
XIII  includes assessment in a pain diary on pain (intensity, location, quality, pattern, number of hours per day in pain, notes of any differences in pain), pain treatment (name, intake of medication, 
and use of alternative methods), and other information (symptoms or problems, effect of pain on sleep, family life, relationship with others, hours of sleep, unusual activities or exercise) 
XIV  includes skill building on tasks of pain management (such as an individualized pain management plan with specific instructions when and how to take medication) 
XV  includes skill building on how to apply alternative pain control methods such as deep breathing exercise, relaxation, massage 
XVI  includes skill building on how to manage side effects of pain medication such as constipation, nausea 
XVII  includes skill building on when, how and with which wording and arguments to communicate with clinicians, feedback on observed behaviour during clinic visits 
XVIII such as: “I want to sleep one night without waking up from my pain.” 
XIX  evaluation during a follow-up contact with intervention staff whether goals were reached 
XX intervention staff giving advice on pain medication or reporting effectiveness of current regimen 
XXI  effect sizes marked with * are statistically significant at a level of significance of 0.05 
 
a  quasi-experimental design with non-equivalent groups 
b  one group pre-test post-test design for intervention, RCT evaluated only telephone follow-up of intervention 
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Table 3: Example of the Method Used to Determine Pattern for Structure Component 
“FC Involvement” 
Author Year ES Patient Only Patient and FC Patient or Patient and FC 
Aubin 2006 -1,87   X 
Yildirim 2009 -1,56 X   
Lai 2004 -0,94 X   
Oliver 2001 -0,61 X   
Vallieres 2006 -0,59 X   
Lin 2006 -0,53  X  
Miaskowski 2004 -0,51   X 
Keefe 2005 -0,49  X  
Ward 2009b -0,44 X   
ES = effect size; FC = family caregiver 
 
Study characteristics. Of the 24 studies, 23 were RCTs19,26,27,29,39-43,54-67. In one 
study18, a quasi-experimental design was used. Four studies were pilot RCTs54-56,62 in 
preparation for larger studies40,63,66. In two of these pilot studies55,62, statistically significant 
effects were found. 
Participants: A total of 4139 patients were included across the 24 studies and 1041 
in the eleven statistically significant studies. Sample sizes ranged from 30 to 1256 (median 
= 109). In the four pilot studies, sample sizes ranged from 37 to 82. Studies with larger 
samples were not more likely to show statistically significant or larger effects than studies 
with smaller samples. In fact, statistically significant differences were found in three small 
studies (i.e., N = 30-40)26,43,59. In two of these studies, the ESs were large (i.e., -1.56 and 
-0.94)43,59. The effect in the non randomized study (N = 80) was even larger (i.e., -1.87)18. 
Across the 24 studies, the proportion of women (57%) was slightly higher than that 
of men (43%). Various cancer diagnoses were included (e.g., lung, breast, prostate, 
gastrointestinal, gynecological, hematological, head and neck, other cancers). The majority 
of studies (i.e., 14) was conducted in the United States26,29,40,42,54,55,57,58,60,62,64-67, two were 
conducted in Canada18,19, three in Taiwan56,59,63, two in the Netherlands27,39, two in 
Australia41,61, and one in Turkey43. The mean age of participants ranged from 48 to 77 
years. Attrition rates in the 17 studies that reported them ranged from 15% to 69%18,27,29,39-
41,54,55,57-62,64-67.  
Time of follow-up: Time points from completion of the intervention to final evaluation 
(follow-up) ranged from one week60,62 to six months57 with one to six assessments. Mean 
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duration of follow-up, across the 24 studies, was 6.5 weeks and 3.5 weeks for the eleven 
statistically significant studies. Statistically significant effects were found within two weeks 
of follow-up in eight of the eleven studies18,26,41,55,59,60,62,63 and within five weeks of follow-up 
in three studies19,40,43. The three largest ESs were found after two18,59 and four weeks43. 
Pain measurement: In 21 of 24 studies, a 0 (no pain) to 10 (worst imaginable pain) 
NRS was used to measure pain. In the remaining three studies, a 0 (no pain) to 100 (worst 
imaginable pain) NRS26,42 or a 4-point Likert scale were used66. Four different types of pain 
intensity measures were used within the studies while in one study the type of pain 
measurement was not specified56. Across all studies, average pain was used in 12 
studies18,19,27,41,55,57,59-62,65,66, worst pain in 12 studies18,19,41,43,54,57-60,62,63,65, present pain in 
eight studies26,27,29,39,42,43,59,64, and least pain in three studies43,59,60. Composite scores for 
pain intensity measures were used in three studies40,66,67. More than one pain intensity 
measure was used in eleven studies18,19,27,41,43,57,59,60,62,65,66. In seven of these studies, 
statistically significant effects were found18,19,41,43,59,60,62. In four studies, the largest effects 
were found for average pain intensity19,55,60,62, in two studies for worst pain intensity18,63, in 
one study for present pain intensity43, in one study for least pain59, and in one study for a 
composite score40. 
Calculation of ESs: ES calculations could not be done for five of the 24 
studies26,29,41,58,64. According to the calculated Hedges’ Gu, clinically meaningful effects (i. 
e., < -0.3) were found in nine studies with statistically significant results18,19,40,43,55,59,60,62,63. 
In two statistically significant studies26,41, published information was insufficient to calculate 
an ES. Across all studies, one to nine ESs were calculated. The largest ESs within each 
study ranged from -1.8718 to -0.0767. In all statistically significant studies, ESs were 
clinically meaningful and ranged from -1.87 to -0.44, with large ESs in three studies18,43,59; 
and medium ESs in six studies19,40,55,60,62,63. In Tables 1 and 2, studies are ordered from the 
largest to the smallest ES. 
Structure components. “Structure” components of the intervention included how the 
intervention was delivered (i.e., “mode of delivery”); what materials were given to patients; 
receiver and provider of the intervention; whether interactions took place between providers 
and receivers; the level of individualization for each patient (i.e. “structured or tailored”); as 
well as contact time between clinicians and patients and/or FCs and timing of the 
intervention (i.e., “intensity of the intervention”; for details see Table 1). “Total dose of the 
intervention” was defined as the total contact time of the receivers with the intervention 
over all sessions and phone calls. 
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Mode of delivery of interventions: In 20 of the 24 studies, the intervention was 
delivered face to face18,27,29,39,40,42,43,54-66 with or without the combination of phone calls, 
and/or slide, audio, or video presentations. In two studies26,41, the mode of delivery was a 
video presentation and in one study, it was a single phone call67. The mode of delivery was 
not reported in one study19. In eight of the statistically significant studies, the intervention 
was delivered face to face18,40,43,55,59,60,62,63, combined with phone calls in one study60, and 
with video/audiotapes or slide presentations in three studies18,43,62. In both statistically 
significant studies in which the intervention was delivered via video presentation only26,41, 
the information provided was not sufficient to calculate an ES. In terms of the optimal mode 
of delivery, no discernable pattern was found.  
Materials provided to patients: In all but one study40 written materials were given to 
patients and FCs. In addition, patients were given audiotapes of the intervention sessions27,62 
copies of prepared videotapes41,58,62, a pill box60, paper and pencil to write down things patients 
wanted to remember65, or a laminated card with a grease pencil to mark pain intensity 
measures42. In the three statistically significant studies with large ESs18,43,59 and in four of the 
statistically significant studies with medium ESs19,26,55,63, patients were provided only with 
booklets. In two of the statistically significant studies with medium ESs, in addition to the 
booklet, patients were provided with a pillbox60 or video and audio tapes62. In one of the 
statistically significant studies with a medium ES, the type of educational material was not 
reported40. In terms of the optimal material, no discernable pattern was found. 
Receiver of the interventions: In one study, the intervention was directed at elderly 
patients26 and in one study patients from minority groups were recruited58. In 13 studies, 
only patients participated19,27,29,42,43,54-56,59,61,65-67, while in six studies FCs could 
participate18,26,39,41,58,60. In four studies, FCs were included as an integral part of the 
intervention40,57,62,63. In one nonsignificant study, the intervention was solely for FCs64. In 
five of the statistically significant studies19,40,43,55,59, only patients were included, two of 
which yielded a large ES43,59. In two of the statistically significant studies with a medium 
ES62,63, patients and FCs were included. In four of the statistically significant studies in 
which FCs had the option to participate with patients, one yielded a large ES18, one yielded 
a medium ES60, and in two studies the ESs could not be calculated26,41. In one study, that 
attempted to evaluate “FC involvement” specifically (i.e., patient alone, patient and FC, 
versus standard care)40, no significant differences were found between the three groups. In 
terms of the optimal receiver of the intervention, no discernable pattern was found. 
Provider of the intervention: Interventions were performed by specifically trained 
clinicians who had education at Master’s or PhD level in four studies40,43,59,66, Bachelor’s 
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prepared nurses in eleven studies18,27,29,39,54,58,60-62,64,67, research assistants whose 
educational level was not described in two studies56,63, or a medical or a psychology 
student in one study55. In one study a trained actress in a white coat presented the 
information in the video42. In five studies, the provider of the intervention was not 
described19,26,41,57,65. In the three studies with large ESs, the intervention was provided by 
Masters or PhD prepared nurses43,59 or by specially trained home care nurses18. In one 
study with a medium ES, the intervention was provided by a Masters prepared nurse40. In 
the other statistically significant studies, the providers were Bachelor prepared nurses60,62, 
a medical or a psychology student55, or the educational level of the provider was not 
reported19,26,41,63. In terms of the optimal educational level of the provider of the intervention, 
no discernable pattern was found. 
Interaction between provider and receiver: Active participation of patients in the 
intervention session was reported in 13 studies27,29,39,42,54,55,60-62,64-67. In seven studies, 
patients were only allowed to ask questions18,43,56-59,63, and no interaction took place in 
three studies26,41,67. Whether interaction was part of the intervention was not reported in one 
study19. In the three studies with large ESs18,43,59 and in one study with medium ES63, 
patients were allowed to ask questions. In four statistically significant studies, interactions 
were possible40,55,60,62, while in two statistically significant studies no interaction was 
possible (ESs not reported)26,41, and in one statistically significant study interaction was not 
reported19. A discernable pattern for the component “interaction” was not observed. 
Structured versus tailored interventions: Four of the 24 interventions contained only 
structured components19,26,41,58. The remaining 20 interventions contained structured and 
tailored components. Tailored components included: questions during and after the 
intervention, individualized information and skill building. All but three of the statistically 
significant studies19,26,41 used structured and tailored components including the statistically 
significant studies with large ESs18,43,59. A discernable pattern for the component “structured 
or tailored” was not seen. 
Intensity of the interventions: Interventions consisted of single or multiple sessions 
(single or multiple exposures) with or without phone calls. The total dose across 
interventions, calculated as total contact time between patients and/or FCs and the 
provider of the intervention, in the 17 studies with sufficient details26,27,29,39,40,42,43,54-56,58-
62,65,67, ranged from 7 to 270 minutes. Doses of interventions with single sessions ranged 
from 14 to 40 minutes18,19,26,29,55,56, the dose of the single phone call in one study was 7 
minutes67, while doses in those studies in which a combination of sessions and phone calls 
was used ranged from 30 to 270 minutes27,39,40,42,43,54,57-62,64-66. One of the three statistically 
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significant studies with a large ES had only a single session (dose not reported)18, one 
consisted of three sessions (dose 50 to 75 minutes)43, and one of five sessions (dose 40 to 
70 minutes)59. The number of sessions in the other statistically significant interventions 
ranged from one to six, while doses ranged from 14 to 270 minutes19,26,40,55,60,62,63. The 
longest statistically significant intervention (i.e., 260 to 270 minutes)60 had an ES of -0.51. 
In terms of the optimal timing or duration, no discernable pattern was observed. 
Content components. The “content” components of the interventions were divided 
into four elements: cognitive, behavioral, goal setting, and direct contact between research 
staff and clinicians. “Cognitive” refers to addressing patients’ and FCs’ knowledge, beliefs, 
and attitudes about pain and its management. Auditory or visual information on desired 
behaviors was evaluated here. “Behavioral” refers to behavioral suggestions in combination 
with active skill building and skill rehearsal. Pain monitoring was included in “behavioral” 
whenever patients were taught how to perform it as a regular part of their self-
management. “Goal setting” means that reachable individual aims were set as part of the 
intervention. “Contact” means that pain-related information or advice about pain 
management was given to patients’ clinicians by research staff (for details see Table 2). 
Single versus combined content components: Ten studies involved only cognitive 
components29,40,54,56-59,63,66,67 while 14 studies included both cognitive and behavioral 
components18,19,26,27,39-42,55,60-62,64,65. Of these 14 studies, three contained goal setting40,55,64 
and in three studies research staff contacted the patients’ clinicians18,27,39. None of the 
studies combined all four content components. Three of the statistically significant studies 
contained only cognitive components43,59,63, with two yielding large ESs43,59. One of the 
statistically significant studies with a large ES included cognitive and behavioral 
components and “contact with clinicians by research staff”18. The other statistically 
significant studies contained cognitive and behavioral components19,26,40,41,55,60,62, and two 
of these included goal setting40,55.  
Cognitive content components: Across all studies, the number of cognitive components 
ranged from two to nine. In all but one study, “cognitive barriers” were addressed42. Other 
frequently addressed components were information about “pain medications” (20 
studies)18,19,26,27,29,39,41,43,54-65, “behavioral suggestions about communication with clinicians” (18 
studies)18,19,26,27,39,41-43,55,57-62,64,65,67, and “side effects” (16 studies)26,27,29,39-41,43,54,57,59,60,62,64-67. In 
one of the statistically significant studies 41, the intervention contained all of the nine cognitive 
content components (ES calculation not possible). In one of the statistically significant studies 
with medium ES63, only two cognitive components were included. Statistically significant 
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studies with large ESs contained three to seven cognitive components18,43,59. In terms of 
cognitive components, no discernable pattern was observed. 
Behavioral content components: In 14 studies, behavioral components were 
included18,19,26,27,39-42,55,60-62,64,65. The most frequently included behavior was “communication with 
clinicians”18,19,27,39,42,55,60,61,64,65. Across these 14 studies, one to four behavioral components 
were included. No study included all five behavioral components. Eight studies that contained 
behavioral components yielded statistically significant results18,19,26,40,41,55,60,62. Across these 
eight statistically significant studies, the number of behavioral components ranged from one to 
four. The study with a large ES that contained behavioral components included both 
“communication with clinicians” and “pain monitoring”18. In terms of behavioral components, no 
discernable pattern was observed. 
Goal setting: The first study to use goal setting was published in 200155. This 
component was not integrated in any other intervention until 200764 and 200940, when it 
was added to an already existing program. Two of the statistically significant studies with 
medium ESs contained goal setting40,55. However, the three studies with large ESs did not 
contain goal setting18,43,59. The number of studies that contained “goal setting” was too 
small to detect any pattern. 
Contact between research staff and patients’ clinicians: Clinicians were contacted 
directly by research staff to report findings or give advice about medication regimens in 
three studies18,39,44. One study yielded statistically significant results with a large ES of 
-1.8718. The number of studies that contained “contact between research staff and patients’ 
clinicians” was too small to detect any pattern. 
Discussion 
To our knowledge, this systematic review is the first to provide a detailed description 
of structure and content components of interventions aimed at improving patients’ self-
management of cancer pain, as well as an evaluation of the efficacy of various components 
of these interventions. Across the 24 studies, nine demonstrated not only statistically 
significant, but clinically meaningful ESs in the moderate19,40,55,60,62,63 to large18,43,59 range.  
Patterns associated with structure and content components and ESs. Across 
the seven structure and 16 content components, no discernable patterns for any single 
component or for any combination of components was observed within studies that 
demonstrated statistically significant and clinically meaningful effects. The lack of 
discernable patterns may be related to the heterogeneity in study designs (e.g., 
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heterogeneous patient populations or time of follow-up) as well as variability in the number 
of structure and content components included as part of the intervention. In addition, other 
factors may have influenced the interventions’ efficacy such as empathy of the provider68 or 
setting of the intervention (e.g., clinic or home)69,70. 
Dose of intervention and comparison of single versus multiple exposure 
interventions. The two longest interventions, while comparable in terms of total dose (180 to 
270 minutes versus 263 to 272 minutes) and timing (three sessions over six weeks)39,60, did 
not result in the largest ESs. This finding suggests that spending more time with patients 
does not automatically result in increased knowledge or changes in patients’ behaviors. 
However, the smallest ES was found for the shortest intervention that was provided via 
telephone67 which suggests that a minimum amount of time needs to be spent with the 
patient in order to increase patients’ knowledge and change behavior. This hypothesis is 
strengthened by several studies of smoking cessation71 and exercise promotion72,73. 
However, to date, the optimal dose and timing of an intervention to improve cancer pain 
management are not known. Considering the financial benefit of short versus long 
interventions, we agree with Bennett et al.9 that the implementation of more cost effective 
interventions that use standardized material need to be explored in future clinical trials. 
Consistent with Bennett’s meta-analysis9, multiple exposure interventions were not 
associated with larger ES than single exposure interventions. This finding is confirmed in a 
systematic review of 20 tailored interventions that were designed to change health 
behaviors related to nutrition, smoking cessation, obtaining mammograms, and exercise 
that were compared with structured interventions74. While Ryan and Lauver74 did not give 
any explanation for this finding, we agree with Bennett et al.9 who stated that this finding 
may be related to other factors that were not incorporated into the interventions. 
Structured or tailored interventions. In this review, differences in the efficacy of 
tailored versus structured interventions were not observed. To date, findings on the 
benefits of tailored versus structured interventions in supporting self-management are 
inconsistent, e.g., one systematic review74 did not show a benefit of tailored versus 
structured interventions while a second review in cancer patients73 did. We agree with Ryan 
and Lauver74 that these inconsistent findings may relate to moderating effects of 
sociodemographic or clinical characteristics of patients and providers. 
Evaluating single components of interventions. Some authors investigated the 
effect of a single component within a complex intervention, such as telephone contact 
following the intervention57, coaching patients to report their pain42, or the effect of FC 
involvement40. None of these studies yielded a statistically significant effect for the single 
Systematic Review of Interventions to Improve Self-Management of Cancer Pain 
- 54 - 
intervention component. The explanation for this lack of effect remains unclear. It may be 
that the “whole” is greater than “the sum of the parts” (i.e., effects of interventions are 
based on the combination of components). Alternatively, the lack of statistically significant 
results may be due to insufficient power. Researchers who want to test single components 
within complex interventions need to base power calculations on potentially smaller ESs for 
the single components. 
Comparison of the three studies with the largest ESs. The largest ES (-1.87) 
was found for worst pain intensity at four weeks after the intervention in a non-randomized 
trial (N = 80) in Canada18. The cognitive behavioral intervention for oncology pain patients 
and FCs was provided by home care nurses who had direct contact with patients’ 
clinicians. The structured and tailored single exposure intervention of 15 minutes entailed a 
video and a booklet that was given to patients. Patients were allowed to ask questions. 
The second largest ES (-1.56) was found for present pain intensity at four weeks after 
the intervention in a small RCT (N = 40) in Turkey43. The intervention contained only cognitive 
components and was delivered in three sessions of 5 to 40 minutes duration over seven days 
by PhD prepared nurses or a physician to oncology pain inpatients who were due to be 
discharged from the hospital. The structured and tailored intervention entailed a slide 
presentation and a booklet that was given to patients. Patients were allowed to ask questions. 
The third largest ES of -0.94 was found for least pain intensity at two weeks after 
the intervention in a small RCT (N = 30) conducted in Taiwan59. This cognitive, structured 
and tailored intervention included five sessions of 10 to 15 minutes duration provided by 
Master’s prepared clinicians to oncology inpatients who were to be discharged from 
hospital. A booklet was given to patients and patients were allowed to ask questions. 
Findings from these three studies need to be interpreted with caution due to several 
methodological limitations. In the study of Aubin et al.18, a non-randomized non-equivalent 
control group was used. In addition, patients in the intervention group showed a tendency 
to have higher baseline pain intensity scores and a shorter pain treatment history than 
patients in the standard care group. Subsequently, effects may have been over-
estimated10. The other two studies43,59 investigated relatively small, quite homogenous 
samples in Turkey and Taiwan, contained only cognitive components, and were both 
performed within an inpatient setting as part of the patients’ preparation for pain self-
management at home43,59. As health care systems and standard care approaches to pain 
management may differ substantially among countries, system factors may have 
contributed to the large ESs in these studies. Furthermore, the interventions in these small 
studies may have been tailored specifically to these patients’ cultural backgrounds. For 
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example, previous research found that Taiwanese patients tend to think fatalistically about 
pain18,75. Finally, the fact that these studies were conducted with inpatients suggests that 
this transition (i.e., from hospital to home) may be an optimal time to begin an intervention. 
Limitations. Four limitations of this review need to be acknowledged. First, it was 
based on published descriptions of the interventions. Therefore, unpublished details may 
have influenced the efficacy of the interventions. Second, a quantitative analysis of the 
intervention components’ efficacy was not possible due to the number of studies in relation 
to the amount of intervention components. However, findings from this review provide 
specific details on ES associated with structure and content components of various 
interventions tested to date. Third, other factors (e.g., environmental and cultural factors) 
not included in publications may have influenced the efficacy of interventions. Finally, our 
analyses may represent an overestimation of ESs. Of note, in over half of the evaluated 
studies, more than one pain outcome was assessed at more than one time point while no 
corrections for multiple testing were reported in any of these studies. 
Conclusions 
We agree with Bennett et al.9, that clinicians should integrate interventions to 
support oncology patients’ and FCs’ pain self-management into routine practice. This 
systematic review provides researchers and clinicians with a detailed overview of the 
various structural and content components as well as various combinations that were 
tested in intervention studies to improve cancer pain management. Because it was not 
possible to clearly discriminate the efficacy of various intervention components, only a 
limited number of recommendations can be made to clinicians and researchers. Based on 
the findings from this review, clinicians and researchers need to balance the costs with the 
benefits when designing an intervention to improve cancer pain management. Culturally 
appropriate interventions need to include, at a minimum, the provision of written material 
and a face-to-face educational session of not less than 15 minutes that includes three 
cognitive components: information on pain treatment, cognitive barriers towards pain 
management, and information on how to implement pain self-management strategies. 
Interventions may be implemented for inpatients as well as for outpatients. However, 
because of a variety of limitations the most efficacious intervention components or 
combination of components remain to be determined in future studies. Additional research is 
needed, that evaluates critical components, as well as the optimal intervention doses. Finally, 
patient, provider and system factors, such as variations between different health care systems 
or empathy between patients and providers, need to be evaluated in order to provide clinicians 
with the optimal approaches to improve the care of oncology patients with pain. 
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Chapter 4 
 
  
Preparation, Translation, and Adaptation of Intervention and Study 
Materials for the Pilot RCT 
 
During the preparation phase of this pilot randomized controlled trial (RCT), the 
German version of the PRO-SELF© Plus Pain Control Program (PCP) was developed in three 
steps. First, the principle investigator (AK) learned details about the PRO-SELF© Plus PCP 
from Miaskowski’s research group during a study visit at the University of California in San 
Francisco (UCSF). Second, in close collaboration with the PRO-Self© PCP research group at 
the UCSF and the PhD committee of this thesis, research and intervention materials were 
translated, improved, and adapted for differences between the United States (U. S.) and 
German health care systems, resulting in the adapted German PRO-SELF© Plus PCP. Third, 
materials were tested for understanding and usability with two German patients. 
Learning PRO-SELF© Study Procedures 
The U. S. PRO-Self© PCP research team provided all of the study instruments and 
intervention materials that were used successfully in the previous and ongoing PRO-Self© 
PCP studies. These materials included self-report questionnaires that were to be 
completed by patients and family caregivers (FCs), written instructions for study nurses, 
and written information for patients. In addition, AK accompanied a PRO-Self© PCP 
intervention nurse on study visits over a three weeks period to gain insight into recruitment 
and to learn how to implement the intervention that was used in the ongoing U. S. PRO-
Self© PCP study. 
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Translation and Adaptation of U. S. PRO-SELF© PCP  
Materials and Intervention 
Detailed descriptions of study and intervention materials and procedures are 
provided in Chapters 1, 5 and 6 of this thesis. The U. S. PRO-Self© PCP study instruments 
were evaluated for use in the German pilot study. Of the self-report instruments that were 
planned to be used in this pilot study (see Table 1), some were available in German. Some 
questionnaires could be replaced with other self-report instruments that were available in 
German and measured similar concepts.  
Table 1: Instruments Used in the U. S. and the German PRO-Self© PCP Study 
Variable English Version Instrument Used in the Pilot Study 
Cognition  DemTect1,2 & Trail Making Test A and B3,4 
Average and worst pain Brief Pain Inventory5 Brief Pain Inventory5,6 
Pain interference with 
function 
Brief Pain Inventory5 Brief Pain Inventory5,6 
Quality of life 
Medical Outcomes Study-Short 
Form (SF-12)7 
Medical Outcomes Study-Short Form (SF-36)8-10 
Anxiety and depression 
State-Trait Anxiety Inventory11; 
Center for Epidemiologic Studies 
Depression Scale12,13 
Hospital Anxiety and Depression Scale14,15 
Fatigue Lee Fatigue Scale16 Fatigue Assessment Questionnaire17 
Functional status Karnofsky Performance Scale18 
Eastern Cooperative Oncology Group 
Performance Status (ECOG-PS)19-21 
Cancer-related symptoms 
Memorial Symptom Assessment 
Scale22 
Memorial Symptom Assessment Scale21,22 
Backward-Forward Translation 
Self-efficacy Self-Efficacy Questionnaire23 
Knowledge of cancer pain Patient Pain Questionnaire24 
Translated by Study Group 
Demographics Patient and FC Information Questionnaires 
Pain self care behavior Pain Self Care Behavior Questionnaire 
As needed analgesics Pain Management Diary 
Around the clock 
analgesics 
Pain Management Diary 
Constipation Pain Management Diary 
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Two questionnaires, the Self-Efficacy Questionnaire23,25 and the Patient Pain 
Questionnaire26,27, were translated in a culturally sensitive way following a translation 
protocol28-30. Each instrument was independently translated by two bilingual translators, 
who then resolved disagreements to create one German version. It was back-translated by 
two other bilingual translators who again resolved discrepancies until agreement was 
achieved. Finally, all translators discussed and agreed on a final version of each 
instrument28-30. These instruments were tested with two German native speakers and only 
minor revisions were necessary. 
In addition, the Program contained other materials such as written instructions for 
the study nurses, a script with information for patients on how to talk to a physician if pain 
was not alleviated sufficiently, and additional teaching materials. These materials were 
translated by AK and checked for plausibility and quality by ESp.  
Some adaptations were made to the German PRO-SELF© Plus PCP. The schedule 
of the intervention visits and phone calls was adjusted. In the pilot RCT, 6 visits and 4 
phone calls were done over a 10 week intervention period. Intervention protocols for the 
intervention and the control groups were adapted according to this schedule. 
Further adjustments included a baseline cognitive assessment; personalized, 
reachable goal setting; and the stepwise engagement of FCs and home nurses if the 
patient was unable to implement the pain and side effect management plan. First, because 
cognitive deficits affect self-management, a baseline cognitive assessment was added and 
measured with the DemTect1,2 and with the Trail Making Test A and B3,4. 
Second, individual goal setting was added to the intervention as a result of 
observations during the study visit at the UCSF and in accordance with social cognitive 
theory31. For goal setting, each patient was asked whether they had a specific goal they 
wanted to achieve over the next week with their pain and side effect management plan. 
Examples of possible goals were “Being able to walk in the woods for 30 minutes with 
tolerable pain,” or “Being able to vacuum clean the living room for ten minutes.” Strategies 
to achieve these goals were written down in the pain and side effect management plan, 
and were evaluated, and adapted if necessary, during subsequent visits. In accordance 
with Bandura31, goals were intended to be highly individual and achievable in order to 
provide patients with mastery experience. Furthermore, goal setting allowed, pain self-
management strategies to be directly linked with practical daily life objectives specific to 
patient’s environment and situation31. In order to assess whether individual goal setting was 
an effective approach within the intervention, the item “The pain hindered me to do the 
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things that I wanted to do today” was added. Patients could rate this item daily on a scale 
from 0 (not at all) to 10 (completely) to the pain diary. 
Because daily function of patients with cancer pain can be impaired enough to hinder 
their ability to perform optimal pain management activities themselves, a staged plan was 
developed for practical support. The staged plan was intended for patients who were 
repeatedly found to be unable to follow the pain medication and side effect management plan 
and continued to experience high pain levels. If not already included, FCs were to be asked 
to take part in the teaching sessions whenever possible and to provide support to the patient. 
If improvement in pain and side effects did not occur, visiting nurses were to be 
recommended. A physician prescription is required for medication management by visiting 
nurses. Consequently, teaching patients how to communicate their need for visiting nurses to 
their treating physician was included in the intervention for these patients.  
Testing Understanding and Usability of the First Version of the German 
PRO-SELF© Plus PCP 
As the last step in the preparation phase, after the written materials were translated 
and adapted, they were tested with two German patients, one chronic pain patient and one 
patient with pain related to bone metastasis. Questionnaires for the FCs were quite similar 
to the materials for the patients. Therefore, they were not tested separately. The first 
session of the PRO-SELF© Plus PCP was performed with both patients and was regarded 
as feasible and helpful by both of them. In addition, both patients completed the 
questionnaires and rated them as feasible and comprehensible. As a result, only a few 
orthographic adaptations were made to the materials. After the conclusion of the 
preparation phase, a German version of the PRO-SELF© Plus PCP was available for 
testing in a pilot RCT which was conducted during the second phase of this thesis. 
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Abstract 
Purpose of the research: The purposes of this paper are to describe the methods 
used and the knowledge gained during a pilot study that evaluated the effects of a self-
management intervention for cancer pain, as well as the adaptations that were made for a 
larger clinical trial. 
Methods and sample: In a randomized controlled pilot trial (pilot RCT), the adapted 
German version of the PRO-SELF© Plus Pain Control Program, a 10-week intervention to 
support self-management of pain in adult oncology outpatients and their family caregivers, 
was compared to attention control. Primary endpoints were average and worst pain 
measured at 6, 10, 14, and 22 weeks after enrollment. 
Key results: A total of 39 patients (19 intervention, 20 control) were recruited over 
18 months. During the study, inclusion criteria were expanded. Furthermore, the structured 
timing of the intervention visits was too static for a dynamic symptom like cancer pain. The 
intervention was expanded to include symptoms that severely impacted pain self-
management including chemotherapy-induced nausea and vomiting.   
Conclusions: Apart from the provision of information and skills building, coaching 
cancer patients across a complex treatment is an important function of an intervention to 
support pain self-management. The pilot study proved to be highly useful in order to adapt 
planned study procedures, to balance burden and benefit for participants, and to customize 
the intervention to patients’ needs and abilities in order to enhance feasibility and 
effectiveness. Findings from this pilot study will be fully integrated in a larger RCT. 
 
Lessons Learned from Pilot RCT in Oncology Pain Patients 
- 72 - 
Introduction 
Testing interventions that support pain self-management in cancer patients is 
important. Even though effective treatment options exist, more than 40% of cancer patients 
do not achieve adequate pain control1-3. Lack of knowledge and misconceptions about pain 
self-management and difficulties putting pain management strategies into practice hinder the 
efficacy of pharmacologic and nonpharmacologic interventions in cancer patients4-6. 
While studies that address this issue are needed, researchers are confronted with 
many challenges, not the least of which is the impact that cancer and pain have on a 
patient’s functional abilities, which can limit their ability to participate in clinical trials7,8. 
Furthermore, interventions that support self-management in this population are complex. 
They are not only the “sum of their parts” but also consist of individually interacting 
components9,10. 
While theoretical knowledge can be gained from the literature, specific knowledge of 
settings and samples must be derived from the researcher’s direct involvement11,12. Pilot 
studies are important to determine feasibility, adequacy, methodology, and costs of clinical 
trials11,13. First, methodological questions, such as the effect size of an outcome measure, 
can be answered. Second, procedural questions including sampling, study design, 
appropriate methods, and conceptual questions about the intervention can be 
addressed14-16. Despite the potential information that can be gained from pilot studies, in 
the four pilot studies of self-management of cancer pain published to date17-20 few feasibility 
issues were described even though high attrition rates (2 to 22 patients per week) and the 
mean recruitment rate (53%) suggested some procedural concerns. In only one 
randomized controlled trial (RCT)15 of a psychoeducational stress management 
intervention, low recruitment (5.5%) and high attrition rates (38.9% over the 12-week study 
period) were analyzed. The authors concluded that patients needed to be recruited from a 
broad patient base and that study burden needed to be limited. No papers were identified 
that critically analyzed the results of a pilot study of a self-management intervention for 
cancer pain and reported “lessons learned” from the pilot study. 
The PRO-SELF© Plus Pain Control Program (PCP) is an intervention that was 
developed in the United States21 to support self-management of pain in cancer outpatients 
and their family caregivers (FCs). The pilot study reported in this paper was designed to 
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test a German version of the PRO-SELF© Plus PCP in cancer outpatients in terms of its 
effect size to reduce pain and related symptoms as well as to test its feasibility in a German 
speaking context. The purposes of this paper are to describe the methods used and the 
knowledge gained during a pilot study that evaluated the effects of this self-management 
intervention for cancer pain, as well as the adaptations that were made for the 
implementation of a subsequent sufficiently powered RCT. 
Methods 
Design, sample, and setting. In this single center pilot RCT, the German version 
of the PRO-SELF© Plus PCP, a 10-week intervention designed to support self-
management of cancer pain in patients and FCs, was compared to an “attention control 
intervention”. A convenience sample of 60 patients with breast, lung, and prostate cancer 
and their FCs were to be recruited from a large Comprehensive Cancer Center (CCC) in 
Freiburg, Germany. This number of participants was calculated in order to have 40 patients 
with complete data at all measurement points assuming an attrition rate of 35% over the 
study period of 22 weeks21. Based on oncologists’ estimates of eligible patients, a one year 
recruitment period was planned (July 2009 to June 2010). 
Inclusion and exclusion criteria. Inclusion criteria included: adult outpatients with 
lung, breast, or prostate cancer with a pain intensity rating ≥ 3 on a 0 (no pain) to 10 (worst 
imaginable pain) numeric rating scale (NRS) related to bone metastasis during the last two 
weeks; an estimated life expectancy of > 6 months as assessed by the physician; who 
were able to understand, read, and write German; had access to a telephone; lived within 
30 kilometer (km) from the CCC; were willing to participate; and provided written informed 
consent. Patients were asked whether they had an FC who was actively involved in their 
pain self-management. Patients with a named FC who was not willing to participate in the 
study were excluded. Patients without a named FC could participate as individuals. If a 
patient was hospitalized for > 2 weeks during the 10-week intervention period, the patient 
was excluded from the study. 
Recruitment procedures. The intervention nurse in charge of the study took part in 
weekly tumor boards for the respective tumor types to identify potential participants. In 
addition, oncologists in the specialized clinics of the CCC referred patients. The 
intervention nurse contacted potentially eligible patients before or after their next scheduled 
clinic visit. Patients who consented to participate were asked whether a FC was actively 
involved in their pain self-management. If a FC was involved, they were asked to 
participate in the study. Patients and FCs who agreed to participate provided written 
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informed consent. Patients were randomly assigned 1:1 stratified by tumor diagnosis (lung, 
breast, or prostate) to the intervention or control group using a computer generated 
permuted blocks procedure. The allocation sequence was concealed from the nurse who 
enrolled the patients. The study was approved by the local ethics committee. 
Description of the intervention. The PRO-SELF© Plus PCP was designed to 
support self-management of pain in cancer patients. The German version of the 10-week 
Program consisted of six visits and four phone calls. All patients in the intervention group 
were visited and called by the same intervention nurse (AK) who was trained to do the 
intervention and followed a detailed intervention protocol.  
Patients were seen in their homes or in the clinic. Visits were planned to last no 
more than an hour while phone calls were designed to last 5 to 10 minutes. Patients 
completed a pain and symptom diary each evening before bedtime. This diary was used as 
an integral part of the intervention to monitor and evaluate pain and side effect self-
management. The diary contained questions about worst and average pain intensity, pain 
relief, duration of pain episodes, the use of around the clock (ATC) and as needed (PRN) 
analgesics, as well as constipation and other side effects. 
The Program contained structured and tailored components and was based on three 
key strategies: provision of information, skills building, and ongoing nurse coaching. 
Information regarding patient-related barriers was provided using academic detailing, an 
educational approach that was used effectively to change physician prescribing behaviors22. 
The Patient Pain Questionnaire23 was used to determine knowledge and attitudes of patients 
and FCs about nine common barriers regarding pain self-management. Knowledge deficits 
identified using the Patient Pain Questionnaire were used as the basis for the academic 
detailing session. To reinforce the education, patients and FCs received a teaching booklet 
with the correct information. In addition, each patient received individualized information (e.g., 
dose ranges, side effects, and combinations of analgesics with other medications). 
Skills building was based on individual assessments and goal setting that were 
discussed and documented in a pain and side effect management plan. During the first 
intervention visit, an evaluation of pain and side effect self-management was done. 
Symptom intensity and errors in the intake of ATC and PRN medications served as 
indicators of whether changes were necessary. The feasibility of changes in the pain and 
symptom management plan (such as: “I will take …mg of … [name of prescribed ATC 
medication] at 8 am and at 8 pm each day”) was evaluated with the patient and written 
down in a pain and side effect management plan. If essential changes were not agreed to 
by patients in the first discussion, the intervention nurse resumed discussions during the 
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next visit but did not document them until the patient agreed to the changes. In addition, if 
patients had any personal goals they wanted to achieve through more effective pain 
management (i.e., “I want to be able to go for a walk with tolerable pain twice a week”), 
these goals were included in the written pain and side effect management plan, such as 
“Twenty minutes before I go for a walk, I will take one dose of … (name of prescribed PRN 
medication)”. Patients were given a script with suggestions about how to communicate with 
their clinicians about unrelieved pain and the need for changes in their analgesic 
prescriptions. Patients were given a weekly pillbox and instructed on how to use it. 
Nurse coaching was performed throughout the 10-week intervention period. 
Patients were coached on how to adapt and implement strategies according to their pain 
and symptom scores and their pain and side effect management plan was evaluated and 
adapted, if necessary. At each visit, patients were assessed for any new or unusual pain. If 
FCs were included, they were asked to take part in all sessions and were explicitly 
addressed as participants in the discussions and as resources if problems occurred. 
The intervention nurse kept field notes of each visit. To ensure protocol fidelity, 
visits and phone calls were tape recorded. A PhD prepared nurse (ESp) listened to the 
tapes and gave feedback if the intervention protocol was not followed correctly. She 
continued with this procedure until an agreeable adherence rate with the intervention 
protocol was achieved21 and then listened to randomly selected tapes until the study ended 
in order to ensure that protocol adherence was maintained. 
Control group. In the control group, “friendly visits” were made by the same 
intervention nurse with the same frequency and of approximately the same duration as in 
the intervention group (attention control). During the six visits and four phone calls, patients 
and FCs were asked about their general health but were referred to their clinician if they 
complained of a problem. Patients in the control group received standard medical treatment 
that did not include any standardized support for pain self-management. 
Variables and measurement. Table 1 provides an overview of variables, 
questionnaires for patients and FCs, time needed to complete questionnaires, and 
assessment times. Questionnaires included in this study have established validity and 
reliability. The main outcomes were average and worst pain intensity scores during the last 
24 hours which were reported by the patients each evening before bedtime using 11-point 
NRS. Secondary outcomes were knowledge and attitudes of the patients and their FCs 
about pain management, analgesic intake, pain interference with daily function, and quality 
of life. In addition, demographic and clinical data, constipation and other cancer-related 
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symptoms, depression and anxiety, fatigue, functional status, self-efficacy, and cognitive 
function were measured as covariates. 
Table 1. Overview of Questionnaires Used to Measure Outcomes and Covariates in 
Patients and FCs, Approximate Time Needed to Fill in Questionnaires,  
and Measurement Time Points 
Variable Measurement Min. Time points of measurement 
Demographics Patient and FC Information Questionnaires* 6 Baseline 
Cognition DemTect31,32 & Trail Making Test A and B33,34 15 Baseline 
Average pain and worst pain Brief Pain Inventory35,36   
ATC analgesic 
prescribed and taken Pain Management Diary 3 
Daily at baseline 
and at weeks 6, 
10, 14 and 22 
PRN analgesic  
prescribed and taken Pain Management Diary   
Constipation Constipation Assessment Scale37 2 
Baseline and at 
weeks 6, 10, 14 
and 22 
Pain interference with function Brief Pain Inventory35,36 3 
Baseline and at 
weeks 6, 10, 14 
and 22 
Pain location Brief Pain inventory35,36 2 
Baseline and at 
weeks 6, 10, 14 
and 22 
Knowledge of cancer pain Patient Pain Questionnaire38* 10 
Baseline and at 
weeks 6, 10, 14 
and 22 
Quality of life Medical Outcomes Study-Short  Form (SF-36)39-41* 10 
Baseline and at 
weeks 6, 10, 14 
and 22 
Anxiety and depression Hospital Anxiety and Depression Scale42  4 
Baseline and at 
weeks 6, 10, 14 
and 22 
Fatigue Fatigue Assessment Questionnaire43 8 
Baseline and at 
weeks 6, 10, 14 
and 22 
Functional status Eastern Cooperative Oncology Group Performance Status (ECOG-PS)1,44,45 3 
Baseline and at 
weeks 6, 10, 14 
and 22 
Cancer-related symptoms Memorial Symptom Assessment Scale1,46 10 
Baseline and at 
weeks 6, 10, 14 
and 22 
Self-efficacy Self-Efficacy Questionnaire47 5 
Baseline and at 
weeks 6, 10, 14 
and 22 
Pain self care behavior Pain Self Care Behavior Questionnaire 4 
Baseline and at 
weeks 6, 10, 14 
and 22 
Min. = Minutes approximately needed to fill out questionnaires; ACT = around the clock; PRN = as needed 
*also assessed in FCs 
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Data collection. Data collection was done concurrently in both groups at 
enrollment, at weeks 6 and 10 (intervention period), and at weeks 14 and 22 
(sustainability). At enrollment, cognitive screening was performed and all questionnaires 
were explained to patients and FCs. Current analgesic medication prescriptions were noted 
in the daily pain diary. If changes were made to the analgesic prescription, patients were 
instructed how to write these changes in their diary. Questionnaires were collected and 
checked for missing data at the following visit. Questionnaires for week 6 were distributed 
during the intervention visit and collected and checked for missing data at the subsequent 
visit. At the last visit (week 10), the intervention nurse provided the patient with the study 
questionnaires and a pre-stamped addressed envelope. Outcome assessors who 
performed the follow-up data collection at weeks 14 and 22 were blinded to the patient’s 
group assignment. At weeks 13 and 21, patients were called in order to ask for and to write 
down their current analgesic medication in the questionnaires which were then sent with an 
extra pre-stamped addressed envelope to the patient and FC. Patients received a reminder 
call on the first day of weeks 14 and 22, respectively. After the questionnaires were 
returned, they were checked for completeness. A few patients were called by the same 
outcome assessor to complete any missing data. 
Analysis of study and intervention procedures. The evaluation of sampling and 
research procedures, study design, and conceptual questions regarding the intervention is 
based on field notes. In the field notes, the intervention nurse recorded the content of each 
visit and phone call including topics that were covered in the discussions with the patients 
and needed resources. In addition, general observations regarding study procedures, such 
as successful and unsuccessful strategies to recruit patients, or observations such as 
common side effects that influenced pain self-management, were recorded. Descriptive 
statistics were used as appropriate for the analysis. 
“Lessons Learned” 
The pilot study provided an opportunity for learning from the procedural issues that 
were evaluated and addressed during the course of the study. These issues included 
sampling procedures, study design, research procedures, and conceptual questions 
regarding the intervention. Recruitment procedures required adaptation during the pilot 
study while other procedures will be adapted for the larger RCT. 
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Sampling procedures. After five months, only five patients were recruited, about 
20% of the anticipated recruitment rate. Challenges occurred on three levels. First, a low 
number of patients were eligible due to the restrictive inclusion criteria. Second, screening 
patients during tumor boards was limited because specific eligibility criteria could not be 
determined during the presentations. We learned that in order to confirm eligibility criteria, a 
large number of patients needed to be approached by the recruitment nurse directly in the 
clinic before or after their routine appointments which exceeded anticipated resources. 
Third, a low number of eligible patients (recruitment rate = 25%) agreed to participate in the 
study (Figure 1). 
Figure 1: Flow of Participants During the Course of the Study 
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Changes were implemented in order to enhance recruitment. Inclusion criteria were 
expanded to include all types of cancer pain rated ≥ 3 (on a 0 [no pain] to 10 [worst 
imaginable pain] NRS) except neuropathic pain as defined by the treating physician. 
Neuropathic pain was excluded because its treatment strategies differ substantially from 
that of nociceptive pain. The distance to the home of the patient was expanded from 30 km 
to the duration of a car ride of one hour or less. In addition, recruitment was intensified. 
Additional research assistants were hired which resulted in an increased presence at the 
recruitment sites during different times of the day. At the same time, the Department of 
Radiation Therapy, as well as four inpatient units, and two interdisciplinary centers of the 
CCC were added as recruitment sites. Recruitment at tumor boards was stopped. Third, 
the duration of the recruitment period was expanded to 18 months. Using these strategies, 
a recruitment rate of approximately 3 patients per month was achieved, which resulted in a 
sample of 39 patients (19 intervention, 20 control). 
Based on verbal reports of the study nurses, the main reasons for declining 
participation (n = 118) included: a strong belief that the cancer treatment would reduce the pain 
very soon; that the involvement of yet another person in the treatment team was not helpful; not 
knowing how a “pain Program” could help; not feeling comfortable in dealing with 
questionnaires; or no interest in taking part in clinical studies in general. Reasons for 
participation, on the other hand, included the appreciation of specialized support and attention; 
not feeling well understood by clinicians about one’s pain and daily concerns; a desire to try 
everything that was seen as helpful; or curiosity about the novel consultation service. 
The attrition rate was high in this longitudinal study. Of the 39 patients who 
consented to participate in the study, 27 (12 intervention, 15 control) finished the 10-week 
intervention while 18 (8 intervention, 10 control) provided full data sets after 22 weeks. The 
attrition rate was 31% at 10 weeks, 44% at 14 weeks, and 54% at 22 weeks (Figure 1). 
Study design: Randomization. In general, randomization worked well and resulted 
in an even distribution of patients in the intervention and the control groups in terms of 
demographic and clinical characteristics. However, during the course of the study, an 
uneven distribution of pain exacerbations (e.g., acute rib fracture) was seen (n = 4 
intervention, n = 1 control). In addition, two patients with curative treatment goals were 
assigned to the control group while none were assigned to the intervention group. This 
uneven distribution was most probably due to the small number of participants but still 
needs to be considered as a stratification criterion in the larger RCT. 
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Second, even though patients were aware of the 50% chance of being assigned to 
the control group, some were disappointed about their assignment. This feeling was true 
mostly for those patients who had wished for a specialist to become involved in their 
treatment to help them get their pain under control. However, “assignment to control group” 
was not given as reason for withdrawal by any patient. 
Research procedures. Patient burden with data collection: Patients with complete 
data sets spent approximately 10.7 hours completing questionnaires over the 22-week 
study period. The quantity of questionnaires was given as reason for withdrawal from the 
study by one patient in the control group. Cognitive screening procedures at baseline were 
declined by 18 patients (46%). 
Resources needed for travel. Most patients preferred home visits. Only one 
patient who lived close to the study site preferred to meet at the clinic for all visits. At 
inclusion, patients frequently stated that additional study appointments at the clinic would 
be a reason for declining study participation. However, a combination of routine 
appointments and home visits at the clinic during the course of the study was acceptable to 
most patients. A total of 198 (93 intervention group, 105 control group) home visits were 
made. The mean distance from the patients’ homes to the clinic was 34.7 km (31 km 
intervention, 38 km control; range 1 to 90 km). The total distance travelled for all home 
visits was 6768 km (2897 km intervention, 3871 km control). 
Twenty-five additional home visits were completed for 19 patients for recruitment 
and data collection procedures. The total distance travelled for these additional visits was 
690 km (140 km intervention, 550 km control). 
Conceptual questions regarding the intervention: Duration of the intervention. 
The duration of the intervention sessions ranged from 15 to 90 minutes with a median 
duration of 49 minutes (25/75 percentile = 37/62 minutes) overall and 65 minutes (25/75 
percentile = 60/80 minutes) for the first visit. The duration of the intervention sessions 
seemed appropriate and a limit of approximately one hour per intervention session was 
feasible for 89% of the intervention visits. The median duration of the intervention phone 
calls was 8 minutes (25/75 percentile = 6/10 minutes; range 1 to 20 minutes). The median 
total time of exposure to the intervention nurse was 283 minutes [25/75 percentile = 
229/372 minutes] in the intervention group and 305 minutes [25/75 percentile = 230/390 
minutes] in the control group. 
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Timing of the intervention. The 10-week time frame of the intervention and the 
timing of the six intervention sessions and four phone calls were fixed factors for every 
participant in the study. However, cancer pain is a dynamic process that consists of chronic, 
acute, and pain-free episodes that are highly individual and unpredictable as can be seen in 
the individual pain trajectories of those patients who finished the 10-week Program (Figure 
2). At week 6, nine patients (60%) in the intervention group were not or were only slightly 
distressed by their pain indicating that their pain was under control and that they no longer 
needed support for their pain self-management. On the other hand, at the last visit, four 
patients (33%) in the intervention group continued to experience severe pain. 
In addition, weekly intervals between contacts delayed progress in patients who 
experienced acute pain episodes and needed to implement significant changes such as 
stepwise titration of analgesic medications in their self-management plan. In these cases, 
evaluation of the patient’s pain self-management and nurse coaching in shorter intervals 
may have accelerated the patient’s progress. 
Figure 2: Individual Trajectories of Weekly Means of Worst Pain in Intervention 
Patients Over the Intervention Period of 10 Weeks 
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Setting of the intervention. If intervention visits were done outside the patients’ 
homes, the evaluation of patients’ and FCs’ experiences with pain management (e.g., 
names of previous medication) or issues regarding the practical implementation of pain 
self-management at home (e.g., placing the pill box in the bathroom) was hindered. 
Content of the intervention. The intervention was planned to support self-
management of pain and common side effects of pain medication, such as constipation. 
However, most patients who participated in the study were undergoing active treatment 
(chemotherapy or radiation therapy) and had treatment-related symptoms that could severely 
impact pain self-management. In particular, moderate to severe nausea was prevalent at 
enrollment in 11 (58%) and vomiting in 7 (37%) patients in the intervention group. As a result, 
the intervention nurse had to include information about antiemetic treatment which decreased 
the prevalence of nausea to 4 (33%) of the 12 patients and the prevalence of vomiting to 3 
(25%) of the 12 patients at the end of the 10-week intervention period.  
The intervention did not include contact between the intervention nurse and treating 
physicians. When planning the trial, the complexity of the treatment team involved in pain 
management was not anticipated. Most cancer patients with pain had a treatment team that 
involved an oncologist, surgeon, or radiation therapist, and the family doctor. In addition, 
other consultants such as orthopedists or neurologists were involved in the patient’s pain 
management. As a result, some patients received prescriptions for different pain 
medications from different physicians over the course of their treatment. Furthermore, 
patients seemed reluctant to contact their oncologists for problems that they thought were 
not directly related to their cancer treatment such as pain or nausea. However, primary 
care physicians tended to have limited specialized knowledge of cancer pain management. 
Regarding knowledge of pain self-management strategies, academic detailing was 
a suitable way to efficiently assess and discuss misconceptions and individual questions. In 
addition, discussions and written instructions about changes in the pain and side effect 
management plan were perceived as useful strategies. 
Ethical questions regarding the control group. The control group schedule proved 
to be feasible. However, when conducting home visits with patients in the control group, the 
intervention nurse was confronted with ethical dilemmas as soon as patients experienced 
severe difficulties with their pain self-management. She was limited by the study protocol in 
the information that she could provide to these patients. 
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Discussion 
During the course of the pilot study, several challenges occurred. Some of the 
challenges were addressed immediately while others will be considered in the design and 
implementation of the larger RCT. 
The low recruitment rate in this pilot study was comparable to previous reports of 
intervention trials for cancer pain management19,24,25. The recruitment rate was improved 
using the strategies described previously15. In future research, recruitment procedures 
need to be linked with or formally integrated into the clinical environment to ensure optimal 
collaboration between clinicians and research staff. Likewise, it is important that sufficient 
resources are allocated to achieve the number of participants needed for the larger trial.  
To improve recruitment rates, several strategies have been recommended that can be 
used in future trials15. Furthermore, in this pilot study, we think that the balance between benefit 
and burden was not apparent to patients when they were approached for study participation. In 
many non-European and European countries nurse-led interventions to support pain self-
management are well established. However, even though home nursing is well established in 
Germany for outpatients who need support with activities of daily living, nurse-led interventions 
that support pain self-management from an early point in the patient’s treatment are extremely 
novel. Therefore, the benefits of involving nurses in outpatient self-management might not be 
well known to patients with cancer and their FCs or to clinicians who are involved in the care of 
these patients. The provision of information about the intervention and its potential benefits to 
patients and clinicians might increase enrollment rates26. 
Second, patient burden needs to be kept at a minimum by reducing the amount of 
self report data. Third, in our study, the number and duration of intervention sessions and 
phone calls followed a specific structure regardless of the patient’s clinical and functional 
status. However, the challenge of reducing respondent burden in terms of both, outcome 
measures and study visits needs to be evaluated within the context of maintaining the 
scientific integrity of the study. Researchers need to consider the number and length of the 
questionnaires that need to be completed to answer the study aims. In addition, a balance 
needs to be achieved in terms of the structured and tailored components of the intervention 
to be able to ensure that the attention control group receives a similar number and duration 
of visits. An advantage of tailoring interventions is to save costs by limiting the use of 
resources. Furthermore, tailored interventions can be implemented more easily into clinical 
settings because they account for each patient’s clinical status27. However, in research, 
tailoring of the intervention needs to be balanced with study quality, always assuring its 
trialability and reproducibility27.  
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Besides tailoring the duration of the intervention, the sessions need to meet the 
patient’s needs. At least one home visit needs to be included as an integral part of the 
intervention because the patient’s previous experiences with pain self-management and 
the integration of pain self-management tasks into daily life was easier to assess in the 
patient’s home. Moreover, if study visits cannot be synchronized with routine clinic 
appointments, home visits are an appropriate way to reduce patient burden26. 
Losing approximately three participants per week during the course of this pilot RCT 
resulted in a relatively high attrition rate. However, the overall attrition rate of 31% over the 
10-week intervention period was comparable to two studies that were conducted over 8 
weeks in cancer patients with pain20,28. In the previous PRO-SELF© study21, the attrition 
rate was 18% over the six week study period. Due to disease progression, attrition in 
longitudinal studies of patients with cancer may not be avoidable. Reducing respondent 
burden may be an effective strategy to retain participants. Alternatively, this attrition rate 
needs to be included into sample size calculations. Finally, newer methods of longitudinal 
data analysis, that include all participants, regardless of the number of assessments 
completed, will facilitate the evaluation of the efficacy of cancer pain self-management 
interventions. 
Another consideration identified in the pilot study was that not only side effects of pain 
management but symptoms that severely impacted pain self-management (e.g., nausea or 
vomiting associated with cancer treatment) should be included as an integral part of 
interventions that support cancer pain self-management. The complexity of the treatment team 
is another challenge. Many patients and their FCs needed to acquire skills to structure and 
manage multiple consultations and prescriptions during the course of treatment. Interventions 
that support self-management of cancer pain can become an essential component of chronic 
illness management29. As a first step, patients benefit from guidance about who to contact 
about unrelieved pain and for changes in analgesic prescriptions. This guidance across the 
complex treatment team is an important component of self-management interventions. While 
patients and their FCs are the key persons in interventions that support pain self-management, 
the efficacy of having the intervention nurses contact clinicians directly needs to be evaluated in 
future RCTs. For example, future RCTs could include the coordination between the patient, the 
FC, the intervention nurse, and the physician about changes in the patient’s pain management 
plan as part of the intervention. In addition, having the intervention nurse provide direct 
feedback to clinicians on patient’s progress might improve the efficacy of the intervention. 
However, in order to control for individualized contacts of intervention staff with clinicians in a 
RCT, a well structured intervention protocol must define clear criteria, for this type of contact. 
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Furthermore, “contact with the clinician” needs to be included as a covariate in subsequent 
analysis. 
Even though the “attention control intervention” proved to be a feasible approach for 
the control group, ethical questions were raised about withholding the potential benefits of 
the intervention30. In Germany, usual care generally does not entail standardized support of 
cancer pain self-management. In future studies, once the efficacy of the intervention is 
established, different doses of the intervention or modes of delivery of the intervention 
could be tested without the use of a control group.   
Conclusions 
Apart from the provision of information and skills building, coaching cancer patients 
within a complex treatment team is an important function of an intervention to support pain 
self-management. This pilot study proved to be highly useful in order to adapt planned 
study procedures, to balance burden and benefit for participants, and to customize the 
intervention to patients’ needs and abilities in order to enhance feasibility and 
effectiveness. Findings from this pilot study will be fully integrated in a future RCT. 
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Abstract 
Purpose of the research: This paper reports findings from a randomized controlled 
pilot study (pilot RCT) that evaluated feasibility and effect sizes for a cancer pain self-
management intervention. 
Methods and sample: Thirty-nine oncology outpatients were randomized to the 
intervention (n = 19) or control (n = 20) groups. Patients in the intervention group received 
the PRO-SELF© Plus Pain Control Program in 6 visits and 4 phone calls over 10 weeks. 
The intervention was based on three key strategies: provision of information, skills building, 
and ongoing nurse coaching. Primary outcomes were average and worst pain intensity. 
Secondary outcomes included pain-related knowledge, opioid intake, and self-efficacy. 
Data were collected at enrollment, weeks 6, 10, 14, and 22 after randomization. 
Key results: The group by time effect was statistically significant for knowledge 
scores (week 10: p = 0.04; week 22: p < 0.01), but not for pain, opioid intake, or self-
efficacy. The mean difference at week 10 between the intervention and the control groups 
was -0.55 (Cohen’s d = -0.26) for average pain and -0.73 (d = -0.29) for worst pain. At 
week 22, it was -0.51 (d = -0.35) for average pain and -0.47 (d = -0.20) for worst pain. 
Conclusions: This study is the first to evaluate and demonstrate the feasibility of a 
cancer pain self-management intervention developed in the United States in Germany. 
Pain self-management related knowledge improved significantly and effect sizes 
associated with pain reduction were determined. Findings from this pilot RCT provide the 
basis for planning a larger RCT. 
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Introduction 
Even though effective treatment options exist, over 40% of cancer pain patients do 
not receive adequate pain management1-3. In addition to inadequate assessment and 
undertreatment, several patient-related barriers interfere with optimal pain management. 
First, oncology patients’ lack of knowledge and misconceptions regarding analgesic 
medications (e.g., fear of addiction, tolerance, fatalism) are associated with 
undertreatment4-6. Second, because the implementation of pain self-management 
strategies into daily practice at home is a complex process, patients may experience 
inadequate pain relief. Oncology patients and their family caregivers (FCs) must acquire 
knowledge and skills on how to obtain, take, and titrate analgesic regimens; deal with side 
effects; and know what to do if pain is not relieved7. Third, patients’ lack of adherence with 
the analgesic regimen contributes to inadequate pain control8. 
In a recent meta-analysis of 21 experimental studies, educational interventions to 
support pain self-management by oncology patients were found to result in significant albeit 
modest benefits9. In this meta-analysis, a weighted mean difference of -1.1 (95% 
confidence interval [CI]: -1.8/-0.41) on a 0 (no pain) to 10 (worst imaginable pain) numeric 
rating scale (NRS) was found for average pain, and a difference of -0.78 (95% CI: -1.21/ 
-0.35) was found for worst pain intensity. Bennett et al.9 concluded that additional studies 
were warranted due to the magnitude of the problem and the paucity of intervention 
studies. 
The pilot study described in this paper is based on the PRO-SELF© Pain Control 
Program (PCP) that demonstrated efficacy in patients with pain from bone metastasis10,11. 
In this randomized controlled trial (RCT) with 174 patients (n = 81 control group [CG]; 
n = 93 intervention group [IG]), patients participated either alone (55%) or with a FC (45%). 
In the IG, specially trained nurses conducted three home visits and three phone calls with 
patients and FCs over 6 weeks. The PRO-SELF© PCP was based on three key strategies: 
provision of information using academic detailing12, skills building, and ongoing nurse 
coaching, and consisted of structured and tailored components. 
While average (weighted mean difference = -0.98 [95% CI: -1.56/-0.40]) and worst 
(weighted mean difference = -1.1 [95% CI: -1.81/-0.39]) pain intensity scores decreased 
significantly9,10, a more detailed evaluation revealed that only 50% of patients in the IG had a 
 Pilot RCT of Intervention on Pain Self-Management 
- 93 - 
complete response (decrease in pain intensity scores ≥ 30%), 25% had a partial response 
(decrease in pain intensity scores between 1% and 29%), and 25% did not respond to the 
educational intervention13. These three groups did not differ on any demographic or clinical 
characteristics. A qualitative analysis of audio-taped interactions between patients, FCs and 
intervention nurses revealed numerous difficulties with putting pain management regimens 
into practice at home. In fact, the majority of the patients were still actively involved in 
problem-solving to achieve better pain control at the final home visit7. 
Both, the quantitative and qualitative analyses provided the foundation for refinements 
that resulted in the PRO-SELF© Plus PCP. For example, it was noted that patients needed 
additional time in the coaching/problem-solving process to achieve optimal pain control. 
Hence, the PRO-SELF© Plus PCP was extended to 10 weeks. To assess sustainability of 
effects, the follow-up period was extended to 22 weeks after enrollment. This “second 
generation” PRO-SELF© Plus PCP is being tested in a RCT in the United States (U. S.). 
To our knowledge, in the German speaking population, no intervention that 
supported oncology patients’ pain self-management has been tested to date. The PRO-
SELF© Plus PCP served as the foundation for this pilot study that was conducted in 
Germany. The overall framework for both the U. S. and the German studies was the 
symptom management theory developed at the University of California in San 
Francisco14,15. Symptom management theory places the patient’s experience of symptom 
management within the context of the person, health and illness, and the environment. In 
addition, Bandura’s social cognitive theory16, an adult learning theory that establishes that 
human behavior is reciprocally influenced and affected by the individual, behavior, and 
environment, provides the underlying theoretical foundation for the intervention. As part of 
social cognitive theory, the concept of self-efficacy was introduced which is defined as 
one's belief in one's ability to succeed in specific situations16.  
The purpose of this paper is to report findings from this pilot RCT that was designed to 
pilot test the adapted German PRO-SELF© Plus PCP in oncology outpatients and their FCs, in 
terms of feasibility and effect sizes for the main outcome variables (i.e., worst and average pain 
intensity) for subsequent power calculations. Furthermore, findings for secondary outcomes 
(i.e., pain management related knowledge, opioid intake) are reported. 
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Methods 
Design. In this single-center pilot RCT, the PRO-SELF© Plus PCP was adapted for 
the German speaking population. Study instruments and the intervention were translated 
and adapted for the German healthcare system. Improvements to the intervention included 
setting of individual, achievable goals and the stepwise engagement of FCs and home 
nurses if the patient was not able to manage the pain by themselves. Details of the study 
and intervention procedures will be reported elsewhere. 
Sample and setting. In brief, a convenience sample of oncology outpatients was 
recruited from a large Comprehensive Cancer Center in Freiburg, Germany. Patients were 
included if they had cancer pain ≥ 3 on a 0 (no pain) to 10 (worst pain imaginable) NRS; 
were ≥ 18 years; able to read, write and understand German; had an estimated life 
expectancy of more than 6 months; access to a telephone; and lived within a one hour car 
ride from the clinics. Patients with a FC who was involved substantially in their pain self-
management and who was not willing to participate in the study were excluded. Patients 
who did not have a FC who was involved substantially in their pain self-management could 
participate as individuals. If a patient was hospitalized for > 2 weeks during the 10-week 
intervention period, the patient was excluded from the study. The study was approved by 
the local ethics committee.  
Study procedures. Patients were approached during a routine visit at the clinic. If 
according to the patient a FC was involved, they were asked to participate in the study. If 
interested, patients and FCs provided written informed consent, were stratified by cancer 
diagnosis (i.e., breast, lung, or other), and randomized 1:1 to the PRO-SELF© Plus IG or 
the CG. A permuted blocks procedure was used to create a computer generated 
randomization list. Sequentially numbered opaque envelopes concealed the allocation 
sequence from the recruitment nurse. Clinicians were blinded to the patients’ assignment. 
At enrollment, medical records were reviewed, and both groups of patients completed a 
demographic questionnaire and a brief cognitive screening test. For one week prior to the 
first intervention visit and at 6, 10, 14, and 22 weeks, patients completed a daily pain diary 
and a set of questionnaires. Data collection was performed as an integral part of the visits 
in both groups until week 10. At weeks 14 and 22 (i.e., sustainability period), 
questionnaires were sent to the patient’s home with pre-stamped and self-addressed 
envelopes by outcome assessors who were blinded to the patient’s group allocation. 
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Interventions. All participants received 6 visits and 4 phone calls over 10 weeks by 
the intervention nurse (AK), who was specifically trained for the study, and who followed a 
detailed intervention protocol. The CG received visits and phone calls of approximately the 
same duration as the IG (attention intervention). During these visits, patients were asked 
about their general health but were referred to their physician if any problems with pain self-
management were reported. Apart from this attention intervention, the CG received standard 
care by their treating clinicians without any standardized pain self-management support. 
Visits in the IG were designed to last for no more than one hour. Phone calls lasted 
5 to 10 minutes. The German PRO-SELF© Plus PCP consists of a structured and a 
tailored part and is based on three key strategies: provision of information, skills building, 
and ongoing nurse coaching. Provision of information began at the first visit using 
academic detailing12 which allowed the intervention nurse to focus the education on a 
patient’s individual knowledge deficits. Skills building (e.g., titration of analgesic 
medications) was based on individual needs and achievable goals. Nurse coaching was 
performed during subsequent visits and phone calls. Individual information was reinforced 
and the effectiveness of the pain and side effect management plan was evaluated with the 
patient and FC. Patients and FCs were given written information about pain self-
management, a weekly pill-box, and a script on how to communicate with their physician 
about unrelieved pain and the need for changes in their analgesic prescription. Sessions 
and phone calls were tape recorded and checked by the last author in order to ensure that 
protocol adherence was maintained11. 
Variables and measurement. To obtain primary outcome measures, patients rated 
their average and worst pain on 11-point NRSs (0 = no pain to 10 = worst imaginable pain) 
in the last 24 hours each evening before bedtime. Secondary outcomes were knowledge 
and attitudes towards pain management and opioid intake.  
The Patient Pain Questionnaire (PPQ) was used to evaluate patients’ knowledge of 
cancer pain management4. The mean of this 9 item instrument yields scores from 0 to 10 
with higher scores representing better knowledge. The scale underwent extensive 
psychometric testing and the Cronbach’s α from the previous PRO-SELF© PCP study was 
0.9110. It was translated for our pilot study in a culturally sensitive backward forward 
procedure17. In our study, Cronbach’s α for the German version of the PPQ was 0.59. 
Patients noted the amount and timing of their analgesic intake (around-the-clock 
and as needed medication) each day in a pre-written pain diary. All opioid analgesics were 
converted to morphine equivalent doses18 as was done in the previous PRO-SELF© 
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study10. Total daily doses were calculated for around the clock and as needed daily opioid 
intake separately and then averaged for each week. 
In addition, to evaluate whether individual goal setting was an effective approach to 
help patients to focus more on their preferred activities, the item “The pain has hindered me 
to do the things I wanted to do today” was added to the pain diary. Patients rated this item 
daily on a 0 (not at all) to 10 (completely) NRS. 
Demographic data included age, gender, FC inclusion, marital status. Clinical data 
included type of cancer diagnosis, months since diagnosis, and current cancer treatments. 
Additional covariates were: depression and anxiety, measured with the German version of 
the Hospital Anxiety and Depression Scale19,20; number of cancer-related symptoms, 
evaluated using the German Memorial Symptom Assessment Scale1,21; fatigue assessed 
with the Fatigue Assessment Questionnaire22; cognitive function, measured with the 
DemTect23,24; and functional status, measured with the Eastern Cooperative Oncology 
Group Performance Status (ECOG-PS)25. Finally, self-efficacy was evaluated with the Self-
Efficacy Questionnaire, which is a self-report 15-item instrument26. Patients rate each item 
regarding their perceived ability to manage various aspects of their pain on a scale of 10 
(very uncertain) to 100 (very certain). A composite score is obtained by calculating the 
mean of the 15 items. In a previous study27, Cronbach’s α for this scale was 0.95, in our 
study, it was 0.92. 
Data analysis. For the demographic and clinical characteristics of the patients, 
measures of central tendency and variability as well as frequency distributions were 
calculated as appropriate based on the measurement level and distribution. All daily ratings 
were averaged on a weekly basis. Eleven weekly means of pain scores were imputed if one 
or two pain scores were missing within a week. If more than two pain scores were missing, 
this week was not included in the analysis. Student’s t-tests, Χ2 statistics, or Mann-Whitney-
U-tests were used as appropriate to evaluate for baseline differences between the IG and 
CG. Patients who dropped out of the IG and the CG were assessed for differences in pain 
scores and demographic and clinical variables. Furthermore, those patients who dropped out 
of the study were compared to those who finished the study for baseline differences. 
An intent-to-treat approach was used for all analyses. We quantified the effect of the 
intervention by calculating the difference between average and worst pain intensity scores 
between initiation and end of the intervention (week 10) and the end of the study period 
(week 22) for both study groups, and then subtracted the values of the study groups from 
each other. In addition, we calculated Cohen’s d by using the groups’ means and pooled 
standard deviations. We applied a linear mixed model approach in order to determine 
 Pilot RCT of Intervention on Pain Self-Management 
- 97 - 
whether changes in pain, knowledge, opioid intake, and the item “The pain has hindered 
me to do the things I wanted to do today” that occurred over time differed between the two 
groups by adding a group by time interaction term into the equation. Anxiety, depression, 
fatigue, functional status, number of symptoms, and self-efficacy scores were controlled for 
in these analyses. 
In order to gain further insights on specific aspects of some outcomes, changes in 
ratings of single items of the PPQ were explored descriptively. In addition, self-efficacy was 
investigated as outcome variable, using a linear mixed model approach that controlled for 
anxiety, depression, fatigue, functional status, and number of symptoms.  
Results 
Of the thirty-nine patients (n = 19 in the IG, n = 20 in the CG) who were included in the 
study from July 2009 until December 2010 (recruitment rate = 25%), 27 patients completed the 
10-week intervention and 18 patients completed the 22-week study period (Figure 1). Twenty-
one patients (n = 11 in the IG, n = 10 in the CG) did not complete the entire study for a variety 
of reasons, including increased severity of illness or hospitalization. Patients who did not 
complete the study were more likely to have lung cancer (p = 0.02); were receiving fewer 
chemotherapeutic regimens (p = 0.003); and had a lower baseline functional status (p = 0.04) 
than those who finished the 22-week study period. The percentage of patients who did not 
complete the entire study did not differ significantly by treatment group (i.e., 44% for the IG and 
55% for the CG; p = 0.43). Baseline demographic and clinical characteristics of the patients in 
the IG and CG are summarized in Table 1. No significant differences were found in any of the 
demographic or clinical characteristics between patients in the two groups or between the 
patients who dropped out of the IG and CG. 
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Figure 1: Flow of Participants During Course of the Studya 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a  Figure derived from: Koller A, Miaskowski C, de Geest S, Opitz O, Spichiger E. Supporting oncology patients’ 
pain self-management: Methods and lessons learned from a randomized controlled pilot study. Eur J Oncol 
Nurs, in press. 
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Table 1: Demographic and Clinical Characteristics of Patients in the Intervention  
and Control Groups 
Demographic and clinical characteristics PRO-SELF Plus©(n = 19) 
Control 
(n = 20) p 
Age in years; mean (SD) 60.5 (11.1) 58.5 (10.8) 0.65 
Men / women; n 9 / 10 11 / 9 0.44 
Living alone; n 5 3 0.32 
Participation of family caregiver; n 6 3 0.15 
Highest school education; n    
 Elementary school (≈ 9 years) 10 11 
 High school (≈ 10 years) 2 1 
 University entrance diploma (≈ 12-13 years) 7 8 
0.97 
Highest professional education; n    
 None 2 0 
 Vocational training 11 12 
 University 5 5 
 Other 1 2 
 Missing 0 1 
0.37 
Cancer diagnosis; n    
 Lung 6 6 0.92 
 Breast 3 5 0.48 
 Other  10 9 0.58 
Months since diagnosis; mean (SD) 
 Median (25/75 percentiles, range) 
43.1 (44.6) 
29 (9/71, 1-151) 
54.85 (91.0) 
18(6/52,1-313) 0.47 
Therapeutic goal; n; curative / palliative 0 / 19 2 / 18 0.26 
Current anticancer therapy; na    
 Chemotherapy 6 8 0.42
 Radiotherapy 11 11 0.56 
Steroids 3 8 0.09 
Bisphosphonates 11 11 0.64 
Functional statusb; mean (SD) 1.74 (0.8) 1.85 (0.9) 0.71 
Cognition; n    
 Age appropriate cognition 10 6  
 Slight cognitive impairment 2 2 0.26 
 Dementia suspected 1 0  
 Declined test 6 12 0.08 
Number of cancer-related symptoms; mean (SD) 14.21 (6.4) 14.17 (6.2) 0.73 
Fatiguec; median (25/75 percentile) 35.5 (20.8/47.3) 37.0 (30.0/44.0) 0.71 
HADS anxiety scored; mean (SD)  6.6 (3.5) 6.7 (4.5) 0.91 
HADS depression scoree; mean (SD) 7.9 (3.3) 7.8 (3.4) 0.88 
SD = standard deviation; p = p-value; HADS = Hospital Anxiety and Depression Scale;  
a  Not all patients received anticancer treatment 
b  Scores can range from 0 = fully active to 4 = completely disabled 
c  Scores can range from 0 to 60 with higher scores representing more fatigue 
d  Scores can range from 0 to 21 with higher scores representing more anxiety 
e  Scores can range from 0 to 21; patients scoring > 10 on the depression scale are considered to suffer from a 
depressed mood 
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Pain scores. Effect size calculations showed that on the 0 to 10 NRS at week 10, the 
mean difference of change between the IG and the CG was -0.55 (95% CI: -2.31/1.20; 
Cohen’s d = -0.26) for average pain and -0.73 (95% CI: -2.74/1.28; Cohen’s d = -0.29) for 
worst pain. At week 22, the mean difference of change between the IG and the CG was -0.51 
(95% CI: -1.95/0.94; Cohen’s d = -0.35) for average pain and -0.47 (95% CI: -2.81/1.87; 
Cohen’s d = -0.20) for worst pain. Weekly mean pain scores are shown in Table 2. Neither 
average nor worst pain scores demonstrated statistically significant group by time interaction 
effects between the IG and the CG over the 10-week intervention period (p = 0.48 / p = 0.60) 
or over the 22-week study period (p = 0.89 / p = 0.90).  
Table 2: Weekly Mean Scores of Average and Worst Pain Intensity, Pain-Related 
Knowledge, Analgesic Intake, and Self-Efficacy in the Intervention and Control 
Groups 
Week  Baseline 6 10 14 22 
N IG  CG 19 / 20 15 / 17 12 / 15 11 / 11 8 / 10
IG 3.80 (2.01) 2.58 (1.73) 2.54 (1.87) 2.74 (1.59) 2.60 (2.21)
Mean average pain (SD) 
CG 4.18 (1.79) 2.66 (1.89) 2.98 (2.31) 2.42 (1.84) 2.81 (2.07)
IG 5.07 (2.48) 3.31 (2.04) 3.23 (2.37) 3.51 (2.18) 3.56 (3.14)
Mean worst pain (SD) 
CG 5.75 (2.00) 3.49 (2.26) 4.09 (2.66) 3.44 (2.25) 4.20 (2.67)
IG 5.56 (1.24) 6.44 (1.34) 6.89 (1.53) 7.17 (1.35) 7.22 (1.00)Mean pain-related 
knowledge (SD) 
CG 5.96 (1.13) 5.91 (1.19) 6.07 (1.19) 6.10 (1.25) 6.03 (1.02)
IG 13.0 (10.0/30.0)
10.0 
(5.4/75.0)
6.7
(3.3/60.0)
20.0 
(5.0/46.7) 
20.0 
(1.7/26.7)Total ME  
(25/75 Percentile) 
CG 20 (3.8/46.7)
20.0 
(3.3/30.0)
16.7 
(5.0/30.0)
26.7 
(7.9/70.0) 
33.3 
(6.7/70.0)
IG 20 (10.0/60.0)
10.0 
(6.7/60.0)
20.0 
(5.0/106.0)
20.0 
(5.0/40.0) 
20.0 
(1.7/26.6)Median ATC ME  
(25/75 Percentile) 
CG 23.3 (7.5/69.6)
20.0 
(13.3/40)
26.6 
(10.0/70.0)
30.0 
(20.0/70.0) 
51.7 
(13.3/107.5)
IG 0.0(0.0/13.3)
1.7 
(0.0/26.7)
5.0 
(0.8/41.7)
6.7 
(0.0/160.0) 
0Median PRN ME  
(25/75 Percentile) 
CG 3.5 (0/6.7)
1.3 
(0.0/5.0)
3.3 
(0.0/5.0)
1.7 
(1.25/3.3) 
1.7 
(0.4/1.7)
IG 57.7(46.7/66.3)
69.3 
(56.0/86.7)
68.3 
(58.5/82.7)
67.3 
(59.3/75.3) 
70.0 
(59.2/85)Median SEQa 
(25/75 Percentile) 
CG 59.3 (52.0/64.7)
63.3 
(52.0/73.0)
70.0 
(61.3/77.3)
68.7 
(53.3/75.5) 
64.3 
(54.2/78.7)
IG = Intervention group; CG = control group; SD = standard deviation; ATC = around the clock;  
ME = daily intake morphine equivalence in mg / day; PRN = as needed; SEQ = Self-Efficacy Questionnaire  
a Scores can range from 10 to 100 
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Secondary outcomes. As shown in Figure 2, the group by time interaction effect of 
knowledge scores was statistically significant at 10 weeks (p = 0.04) and at 22 weeks 
(p < 0.01). In the IG knowledge scores improved by approximately 24% at week 10 and 
approximately 30% at week 22 (mean improvement CG: 2% at week 10 and 1% at week 22). 
Even though inferential statistics could not be performed to evaluate each item separately 
because of the small sample size, a detailed descriptive evaluation of the nine items of the 
PPQ revealed that the significant effect was most probably due to three items: fear of 
addiction (week 10 IG: 17% improvement, CG: 0% improvement; week 22 IG: 26% 
improvement, CG: 40% reduction); patients’ awareness that analgesic medication should be 
taken on a regular basis (week 10 IG: 69% improvement, CG: 13% reduction; week 22 
IG: 57% improvement, CG: 1% improvement); and the belief that patients are often given too 
much pain medication (week 10 IG: 8% improvement, CG: 4% improvement; week 22 
IG: 24% improvement, CG: 4% reduction). 
Figure 2: Changes Over Time in Mean Knowledge Scores in the Intervention and 
Control Groups. Values Are Plotted as Means and 95% Confidence Intervals. 
 
 
 
 
 
 
 
 
 
 
Scores of the other secondary outcomes are shown in Table 2. No significant group 
by time interaction effect was found in the total daily dose of opioid analgesic between 
patients in the IG and the CG at week 10 (p = 0.13) and week 22 (p = 0.87). The item “The 
pain hindered me to do the things that I wanted to do today” showed a significant group by 
time interaction effect between the IG and the CG until week 10 (p = 0.02) but the effect was 
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not sustained until week 22 (p = 0.19; Figure 3). No significant group by time interaction 
effect was found in self-efficacy scores between patients in the IG and the CG at week 10 (p 
= 0.21) and week 22 (p = 0.21). 
Figure 3: Changes Over Time in Mean Scores for the Intervention and Control Groups 
of the Item: “The Pain Hindered Me to Do the Things That I Wanted to Do”. Values Are 
Plotted as Means and 95% Confidence Intervals. 
  
Discussion 
This pilot RCT is the first study in which a cancer pain self-management intervention 
developed in the U. S. was transferred and tested in a German population. Effect sizes for 
average and worst pain were slightly lower in this pilot RCT than those found in the previous 
PRO-SELF© RCT10 and a recent meta-analysis on cancer pain self-management 
interventions9. However, all effect sizes in this pilot RCT must be interpreted with caution 
because of the small sample size. 
To further explore the intervention’s effect, secondary outcomes were evaluated in 
this pilot RCT. For patients’ pain management related knowledge, the group by time 
interaction effect was a statistically significant improvement of approximately 20% at week 
10 and nearly 30% at week 22. Compared with findings from the previous PRO-SELF© 
RCT in the U. S., initial knowledge scores were slightly lower in the German sample (total 
PPQ score at enrollment: 6.83 [SD ≈ 1.5] versus 5.76 [SD ≈ 1.19])28. In accordance with the 
previous PRO-SELF© RCT, patients’ knowledge increased regarding the need to take their 
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analgesics on a fixed schedule. This item requires a change in the patients’ behavior6 and 
was the focus of the nurse coaching in the IG. Furthermore, in both studies, patients’ 
general fear of taking too much analgesic medication decreased which suggests that this 
topic was addressed adequately in the IG. Patients’ belief in the efficacy of alternative 
treatments (e.g., heat, relaxation) did not improve in both studies indicating that more 
emphasis may have been put on analgesics within both interventions. In this pilot RCT, fear 
of addiction improved greatly, while it did not improve in the U. S. study. In contrast, in the 
U. S. study, scores for fear of tolerance, physical dependence, and that analgesics can 
often interfere with breathing were improved, while they were not in this pilot RCT. These 
differences may indicate a need to focus more intensely on these barriers in the German 
PRO-SELF© Plus PCP. For example, according to social cognitive theory16, fear of 
tolerance might be improved by addressing it more often in the day-to-day context of the 
patients’ analgesic regimen. On the other hand, German patients may be more reluctant to 
take analgesic medications compared to the U. S. population29.  
The PPQ’s low Cronbach’s α in this study may be due to the small sample. 
However, it may reflect that patients’ knowledge increased in only three of the items while it 
was unchanged in the others. Further confirmatory statistical testing was not performed 
because of the small sample size. However, in a larger German study, psychometric 
properties of the German PPQ need to be re-evaluated. 
The median daily opioid dose for patients with cancer pain was 60 mg30. Patients in 
the IG of this pilot study took lower daily doses of opioids across the entire study (i.e., median 
doses ranged from 6.7 to 20 mg across the study period). Consistent with previous 
reports30,31, a wide range of 0 to 666 mg daily opioid intake was found and a strong right 
skewness of the data indicated that a few patients were taking very high doses while most 
patients were taking relatively low doses of opioid analgesics for their cancer pain. 
Baseline daily opioid intake in this study was comparable to the previous PRO-
SELF© study10. In contrast to the previous PRO-SELF© study in the U. S., daily opioid 
intake did not increase over time for patients in the IG despite high pain intensity scores. It 
is not entirely clear why patients in the IG did not increase their daily analgesic intake. In 
the larger RCT, the nurse coaching component about patients’ communication with the 
physicians about their analgesic regimen needs to be reinforced to assist patients to obtain 
and take a dose of analgesic medication that will provide improved pain relief. 
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Surprisingly, the group by time interaction effect for the item “The pain hindered me 
to do the things I wanted to do today” was significant during the intervention period. One 
possible explanation is that with the item, two aspects of individual goal setting were 
evaluated. First, in accordance with Bandura16, patients seemed to be coached effectively 
by the intervention nurse to set meaningful, achievable goals. This coaching may have 
helped them set realistic priorities for what was really important for them to achieve during 
the next week. Second, patients were coached to use feasible strategies to achieve these 
goals. This approach warrants additional testing in the larger RCT. 
Changes in patients’ self-efficacy may be one potential mediator to reduce pain with 
self-management interventions32. In this study, self-efficacy scores at enrollment were 
comparable to scores reported by patients with lung and prostate cancer27,33,34. While self-
efficacy scores did not change in this pilot RCT, this concept warrants evaluation in larger 
studies because improvements in self-efficacy were found in another study of cancer pain 
self-management35. In a larger RCT, the potential to provide patients with a positive sense 
of mastery of their pain, (e.g., verbal persuasion)16 should be reinforced during the 
intervention. During coaching sessions, the intervention nurse could target barriers to 
effective pain management more intensely. 
This pilot RCT has several limitations. Most importantly, findings need to be 
interpreted with caution given the small sample size. In addition, in this study, recruitment 
and retention was challenging. A low number of eligible patients (25%) agreed to 
participate in the study (Figure 1) which suggests that recruitment procedures need to be 
modified. Furthermore, even though the planned sample size for this pilot study included an 
attrition rate of 30% based on findings from previous studies10,36, the attrition rate was 
higher than expected (31% at 10 weeks, 54% at 22 weeks [Figure 1]). An analysis of drop-
outs showed that patients who did not finish the study were more ill than those who were 
retained. However, these patients and their FCs might benefit most from an intervention 
that is designed to reduce cancer pain. Measures to retain fragile patients in a study need 
to focus on the reduction in respondent burden37. This approach may help to balance 
attrition because of deterioration with the retention of patients who are most in need of self-
management support.  
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Furthermore, in this pilot study, one could not evaluate whether the low opioid 
intake was due to patients’ lack of adherence with the intervention or because physicians 
did not adapt the analgesic prescription. In future studies, two additional outcome 
measures warrant consideration, assessment of patients’ adherence with the intervention 
as recommended in a recent exploratory review38 and an assessment of the 
appropriateness of the patient’s analgesic regimen as suggested in a previous study39. 
Conclusions 
This pilot RCT is the first to adapt and demonstrate the feasibility of an intervention 
that supports cancer pain self-management that was developed in the U. S. for a German 
health care system. Pain self-management related knowledge was significantly improved 
and effect sizes for pain intensity scores were established. Findings from this pilot RCT 
provide the basis for the planning and execution of a larger RCT.  
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Chapter 7 
 
 
A Qualitative Substudy of Patients‘ Experiences of  
a Self-Management Intervention for Cancer Pain and Participation 
in a Randomized Controlled Pilot Study 
 
Introduction 
In spite of effective treatment options, more than 40% of cancer patients do not 
receive adequate pain management1-3. Besides system- and clinician-related barriers, 
patient-related barriers impede effective pain management4. These patient-related barriers 
include several components5,6: Cognitive barriers refer to oncology patients’ concerns about 
analgesic use, communication with treating clinicians, and pessimistic beliefs about the 
possibility of adequate pain control. Affective barriers relate to patients’ emotional changes, 
such as depression, anxiety, or stress. Sensory barriers refer to distressing side effects of 
analgesic treatment (e.g., constipation)5. Finally, practical barriers can hinder effective pain 
management because patients and their family caregivers (FCs) need to acquire and 
process a complex array of knowledge and skills (i.e., how to obtain, take, and titrate various 
analgesic medications, deal with side effects, and what to do if pain is not relieved)6. 
While several interventions designed to support cancer pain self-management have 
shown potential to reduce pain intensity, the effects were moderate. Heterogeneity in study 
and intervention procedures may have weakened the results7. Until now, it remains unclear 
which components of pain self-management interventions for oncology patients are 
effective7-10. Furthermore, only two studies were found in which the patients’ perspectives 
regarding interventions that support pain self-management were evaluated6,11. In both 
qualitative studies, patients and their FCs had difficulties dealing with the complex 
processes involved in pain self-management. In addition, patients reported that problem 
solving is a process that takes place over time and needs support from clinicians. However, 
these studies did not explore how patients and FCs experienced support from clinicians. 
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The German PRO-SELF© Plus pilot randomized controlled trial (RCT)12,13 provides an 
opportunity to close this gap. Furthermore, the patients’ perspective is an essential 
component to assess feasibility of study and intervention procedures which was one of the 
aims of the German PRO-Self© Plus pilot study. 
With the pilot study, the German PRO-SELF© Plus Pain Control Program (PCP), an 
intervention that was designed to support cancer pain self-management was tested for the 
first time in a German population. The PRO-SELF© PCP demonstrated efficacy for pain 
reduction in a large RCT in the United States with 174 oncology outpatients and their 
FCs14. The refined version of the Program, the PRO-SELF© Plus PCP6,15,16 was translated 
and adapted for the German health care context and then tested for effect sizes and 
feasibility in a Comprehensive Cancer Center in Southern Germany. 
For the German PRO-SELF© Plus PCP pilot RCT, a convenience sample of 39 
(n = 19 intervention, n = 20 control) adult oncology outpatients with pain ≥ 3 on a 0 (no 
pain) to 10 (worst pain imaginable) numeric rating scale, and 8 FCs (n = 4 intervention, 
n = 4 control) was recruited from July 2009 until December 2010. Patients were recruited if 
they had an estimated life expectancy of > 6 months, were reachable by phone and within 
a one hour car ride, were able to read and write German, and provided written informed 
consent. FCs were included if they were actively involved in the patient’s pain self-
management. Patients were excluded if they had an actively involved FC who did not want 
to participate in the study. Furthermore, patients were excluded if they had neuropathic 
pain or were hospitalized > 2 weeks during the study. The study was approved by the local 
ethics committee. All patients provided written informed consent. 
The German PRO-SELF© Plus PCP consisted of 6 visits and 4 phone calls over ten 
weeks. These visits were performed by AK who was specially trained to provide the 
intervention. The Program was based on three key strategies (i.e., provision of information, 
skills building, and nurse coaching) and consisted of structured and tailored components. 
For data collection, patients needed to complete a set of questionnaires in addition to the 
daily pain diary one week prior to the first intervention visit and at 6, 10, 14, and 22 weeks. 
Because patients and their FCs are essential partners in pain management and 
patient-related barriers can hinder optimal pain control, it is vital to assess patients’ views 
of and experiences with the implementation of a study designed to test a self-management 
intervention in oncology outpatients and their FCs. The purpose of this qualitative substudy 
was to explore patients’ and FCs’ experiences with their pain management, with the 
educational intervention, and their view of burden and benefit from study participation. 
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Methods 
Design. In this study, a qualitative approach was used because it allows for the 
exploration of subjective views and experiences. The rule-governed method of content 
analysis according to Mayring17 was used in this substudy to systematically summarize and 
structure the data. 
Sample and recruitment. Twelve patients and 4 FCs finished the intervention. The 
first five of these patients were asked at the last visit whether they would agree to take part 
in a debriefing interview. Subsequently, five additional patients were selected purposefully 
to achieve a heterogeneous sample regarding age, living conditions, and pain situation. 
Additional informed consent was obtained from those patients and FCs who agreed to take 
part in the interview. 
One of the 10 patients who were asked to participate did not participate in the 
debriefing interview because she went on vacation for the two weeks after the intervention. 
Therefore, debriefing interviews were conducted with 9 patients and 4 FCs. The mean age 
of the patients was 52 (SD = 8.4) years and median time since diagnosis was 37 months 
(25/75 percentile = 18.5/100.5 months). Five patients were male, 2 patients lived alone, 
and 7 were married. Two patients had lung cancer, three breast cancer, one colon cancer, 
one renal cell cancer, one bladder cancer, and one had a malignant melanoma. Patients 
were employed in a variety of professions (e.g., truck driver, pastry chef, teacher, 
engineer). Mean average pain at enrollment was 4.2 (SD = 1.96) on a scale from 0 (no 
pain) to 10 (worst pain imaginable). Mean average pain at the end of the intervention was 
2.3 (SD = 1.59). However, two patients had average pain levels above 4 at week 10. Mean 
worst pain at enrollment was 5.8 (SD = 2.0). At 10 weeks, it had decreased to 3.1 
(SD = 2.26). At inclusion, 7 patients had an ECOG performance status18 score of 1 (i.e., 
only slight restrictions in functional status). One patient had an ECOG score of 2 (i.e., able 
of self-care but not able to work, confined to bed < 50% of daytime) while one patient had a 
score of 3 (confined to bed > 50% of daytime). After the intervention, the ECOG score was 
1 for four patients and 2 for five patients. 
Of the FCs, three were female, one was male. All FCs were married to and lived 
together with the patient. Mean age of the FCs was 50.8 years (SD = 13.4). All FCs had 
nine to ten years of education and vocational training. 
Data collection. Interviews were conducted in the patients’ homes by two trained 
nurses who were not the intervention nurse within two weeks after the completion of the 
intervention. The nurses followed a semi-structured interview guide with open-ended 
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questions about the patients’ and FC’s experiences with the study and intervention 
procedures. Participants were invited to talk freely. While all patients and one FC actively 
took part in the discussion, 3 FCs remained relatively silent or affirmed information given by 
the patient. The interviews lasted between 10 and 55 minutes. Interviews were recorded and 
transcribed verbatim. During the study, ESp read transcribed interviews, discussed content 
and technique with the nurses, and added new topics to the interview guide for subsequent 
interviews. Demographic and clinical data were collected as part of the pilot RCT. 
Data analysis. Interviews were analyzed using content analysis as described by 
Mayring17. The analysis included several steps. First, original data were paraphrased to a 
homogeneous linguistic level. Second, in two steps, passages were generalized and 
reduced to obtain short phrases that reflected the original texts as authentically as possible 
and identical phrases were summarized. Third, data were grouped systematically so that 
emerging topics were reflected. Finally, these themes were checked against the original 
data. The analysis was mainly performed by AK; in order to improve the rigor of the 
analysis each step was critically reviewed by ESp and discussed with AK until consensus 
was reached.  
Results 
Asked about their experiences with the intervention and study procedures, patients 
and FCs reflected on their prior experience with pain self-management and how the 
intervention and procedures had influenced their pain self-management. Patients’ attached 
great importance to the atmosphere created and the trust in a patient-clinician relationship 
as well as to the intervention’s focus on their pain self-management. Furthermore, patients 
reflected on their view of burden and benefit that came with taking part in the study and 
how cancer pain self-management support may be realized for themselves after the study 
and for other patients in the future. 
Previous experiences with pain and its treatment. During the interviews, several 
patients reflected on their pain and pain self-management. Both positive and negative 
experiences were compared to experiences during the intervention. All patients had 
experienced pain for some time prior to enrollment. For some patients, pain was controlled 
before the study. However, most patients experienced inadequate pain managements. 
Patients remembered that pain had interfered with their daily life, sleep, emotional well-being, 
and quality of life. “For weeks, I ran around with the pain, could barely walk. … It wears you 
down.” For some patients, pain was occasionally so bad that they did not want to live 
anymore. “Pain can sometimes make you say: ‘Now I actually don’t want to live anymore’.”  
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Regarding previous experience with pain self-management, only one patient 
expressed that years of experience with cancer pain had made him proficient in the 
effective use of analgesics and other methods of pain management. “After so many years, I 
knew what painkillers can do for me.” However, several patients described that they felt 
very insecure about pain self-management and were unable to get their pain under control. 
“You can neither get a grip on it by yourself… and so it (the pain) goes up and down.” 
In this context, patients contemplated their previous experiences with pain 
management by their physicians. Despite the latter’s advice to take the prescribed 
analgesics or increase the dose of their analgesics, patients did not change their behaviors. 
“From the beginning, the dosage of my medication was adjusted too low. The physician 
told me to take more, but I did not do so.” Only one patient said that adherence to her 
physicians’ analgesic prescriptions had worked well for her. “I took the pills as they had 
prescribed them and that worked out perfectly.” On the other hand, questions regarding this 
patient’s pain medication were not answered adequately by another physician who was 
involved in her pain treatment. “When I got radiation therapy in X, I once asked this doctor 
about these pills and she said: ‘All of them are painkillers, you have to do this by yourself’.” 
Experiences with the intervention. When patients were asked how they had 
experienced the intervention, they reflected whether their expectations were met by taking 
part in the study; what they learned during the intervention; who else was involved in their 
pain self-management during the intervention; the adequacy of the visits’ and phone-calls’ 
form; and the value of print materials. 
Were patients’ expectations met? Pain reduction and a gain in knowledge about 
pain management were stated as patients’ primary expectations for the intervention. All but 
one patient said that they had experienced a significant reduction in pain during the 
intervention while two patients experienced new pain episodes immediately after the 
intervention. 
All of the patients, even the one who did not experience adequate pain control, 
expressed high satisfaction with the Program. “The Program was ingenious.” Furthermore, 
all patients and FCs stated that they benefited greatly from the study because they had 
learned so much about pain and its treatment. “It was very useful for me because I learned 
a lot out of it.” 
What did patients learn? According to the patients, the intervention addressed 
their analgesic medications and side effects; their concerns and attitudes towards pain self-
management; and how to apply strategies in daily life. Patients said that in the beginning, 
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the intervention seemed intense, complex, and challenging. “In the beginning, it was all 
Greek to me.” “I found it (the Program) very intense.” At the end of the intervention, patients 
felt well informed and more secure with their pain self-management. “It provides a sense of 
security if you can discuss or experience it (pain self-management).”  
Patients particularly appreciated that the intervention was tailored to their current 
situation, needs, and concerns. “It is tailored for each patient individually depending on his 
disease and his pain.” Furthermore, the intervention nurse was present and answered 
every question that arose until no further questions remained. “You’re not left to your own.” 
“Everything that I wanted to know was explained.” 
Patients recalled information about their analgesics. All patients had internalized 
taking analgesics according to a fixed schedule in order to obtain adequate blood levels of 
the medication. “I learned for example that you actually build up a level … I have developed 
a routine now to take pills regularly.” In addition, patients and FCs felt comfortable that they 
had learned how to titrate their medications to meet individual needs and circadian pain 
patterns. “It gives you a certain latitude.” Patients felt secure enough to increase their pain 
medication in line with their prescription during acute pain episodes. With little pain, 
patients had learned to taper their analgesics slowly while self-monitoring pain. “That you (if 
analgesics are reduced) do not omit too much at once; if you slowly taper and test if pain 
becomes worse or not.” 
Patients mentioned that they needed repeated encouragement by the intervention 
nurse to take their prescribed analgesics and that the coaching helped them to overcome 
concerns like fear of addiction or tolerance. “This is where Mrs. K. has always supported 
me and said that I can really take it and that it’s no problem … and that was good to hear 
because sometimes I was afraid of it.” 
Although several patients had not experienced side effects from their analgesics, 
they felt very well informed about side effects such as fatigue, gastric disorders, or 
constipation. “We always discussed the side effects and she has given several pieces of 
advice.” Some patients mentioned opioid-induced constipation as debilitating but that the 
Program had helped to alleviate this side effect. “Because the hard stools were attributable 
to the medications, I actually had an additional alleviation of my pain when I had a bowel 
movement … And that was what she had recommended.” 
Patients particularly valued support to implement pain self-management in daily life. 
They appreciated that the intervention nurse discussed options about the “how-to” 
application of self-monitoring and analgesic intake in specific situations during daily life. “It 
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is good if someone tells you how it is done.” In this context, the weekly pillbox organizer 
was mentioned as a helpful tool. 
Who was involved and how? Patients and FCs mentioned the role of the 
intervention nurse in effective self-management support; the need for physician 
involvement; and compared the physician’s and the intervention nurse’s roles in pain 
management. Furthermore, they reflected on their own contribution to their pain 
management, and that of their FCs. 
Patients and FCs emphasized important skills and attitudes of the intervention nurse. 
First, the intervention nurse embodied and demonstrated profound knowledge and expertise 
regarding pain self-management “It is an advantage to know that someone is sitting in front of 
you who is knowledgeable about what she says. Someone who can also give tips and tricks.” 
Second, the intervention nurse focused in detail on self-management topics directly related to 
their daily life. “Then I was glad that Mrs. K. said: ‚OK, we are doing it this way, … and I 
would do this like that’.” “I had the feeling that she is knowledgeable about the situation, that 
she very well understands the patient’s and family’s current disease-related situation.” Third, 
the intervention nurse created an atmosphere of trust by showing a pleasant, understanding, 
and caring attitude and that she had enough time and patience to answer all questions. “I 
know that she fully supports it. You could really sense that. Time was also never a problem. 
Thus I received so much help. That really did me good.” Participants frequently missed these 
three aspects in routine treatment by physicians.  
During the intervention, patients and FCs appreciated if their analgesic treatment 
was coordinated between both their physicians and the intervention nurse. “It was good 
that we adjusted the pills and drops again with the doctor.” It was particularly reassuring for 
patients if the information that they had gained from their treating physician was repeated 
and confirmed by the intervention nurse. “Mrs. K. said that I really may take it (analgesic 
medication) and that it is no problem and that was the same what the doctors had told me, 
but it was a relief that she could give me additional support to that.” 
Regarding their own contribution, patients stated that participation in the intervention 
required openness and the willingness as well as the ability to learn new things. “If you start 
something new or hear something new, it is a new learning process each time in which you 
really have to engage.” Furthermore, FCs and patients agreed that cancer pain affected the 
family as a whole, that it was important for the FC to understand the patient’s situation, and that 
FCs greatly influenced decisions about the patient’s pain self-management. However, patients 
took care of their pain self-management themselves for as long as they could while FCs carried 
out “back-up” tasks such as reminding patients to take their around the clock medication. On 
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the other hand, FCs required up to date information about the patient’s pain management in 
case the patient’s health status deteriorated. FC: “I need to know somehow what I have to do if 
he is not feeling well or something like that. That provides a sense of security.”  
Was the form of visits and phone calls adequate? Participants specifically 
commented on additional aspects of the intervention, that is, on the duration of the 
intervention, the setting of the visits, and the meaning of the phone calls. 
Duration of the intervention. The intervention consisted of 6 visits and 4 phone calls 
alternating over ten weeks. The median duration of the visits was 49 minutes and ranged 
from 15 to 90 minutes depending on the patient’s pain situation and individual questions of 
the patients and FCs. Phone calls were short with a median duration of 8 minutes and a 
range of 1 to 20 minutes. The duration of the intervention as a whole and of the single visits 
was evaluated by the patients during the interviews. 
Patients appreciated that the intervention went on for ten weeks for two reasons. 
First, it allowed them to gain a sense of trust in the intervention nurse. “Because it (building 
up a relationship) does not happen so quickly. First you need a basis. Then you can give 
away more of yourself and this is how it increased each week and with each phone call.” 
Second, the period of ten weeks gave patients the opportunity to get support for problems 
that occurred over time. For example, questions that occurred during the implementation of 
new self-management strategies into daily life or during new pain episodes could be 
answered and strategies revised, if necessary. Patients appreciated that visits and phone 
calls lasted as long as needed to discuss problems in detail and think of all questions they 
had. “Of course, if you can sit together like this and, let’s say, can talk without time pressure 
then you can bring up more things than in a consultation with the physician.”  
However, some patients experienced a point at which they thought it would have 
been appropriate to stop the intervention. For example, patients who had gained some 
experience in their pain self-management and achieved good pain control during the study 
stated that the intensive dose of weekly contacts was more of a burden than benefit. “For 
me this is a point (when pain self-management stabilized) at which I actually do not want to 
continue anymore. At which I thought that nothing new was added anymore.”  
Setting of visits. Most intervention visits took place in the patients’ homes. At times, 
patients met with the intervention nurse during routine appointments at the clinic (e.g., 
during chemotherapy treatment in the infusion center). Some patients said that they 
preferred intervention visits in their homes for several reasons. One reason was that they 
felt more relaxed in the home environment. An FC stated that meeting in her familiar home 
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environment contributed to the fact that the relationship with the intervention nurse was 
more at ease than the relationship with the physician. FC: “This somewhat more relaxed 
relationship… the reason could well be that she comes over here.” Furthermore, a patient 
remarked that driving to the clinic for intervention visits would not have been possible for 
him unless they were combined with routine appointments. On the other hand, one patient 
first needed to get used to someone external coming to his home but he got accustomed to 
it quickly. 
Meaning of the phone calls. Regarding the phone calls, one patient said that they 
were not really necessary. For others, the phone calls provided them with the support 
needed to maintain strategies over time which was particularly helpful in the beginning of 
the intervention. “It was a good check, if you were slightly ‚sloppy’ in the beginning and 
thought about taking less painkillers and she said: ‚Well, you need to take some more to be 
free of pain’, that was actually ideal. Especially during the first three to four weeks it was 
very good, afterwards it worked out by itself.” Furthermore, phone calls were perceived as a 
considerate gesture of the intervention nurse and increased the sense of trust. Phone calls 
were described as an additional opportunity to ask questions that had arisen over the 
previous week. 
How useful were print materials? The written information included the PRO-
SELF© booklet that entailed written information about nine common barriers that were 
addressed during the academic detailing session, short leaflets about common side effects 
of analgesic medication (e.g., constipation), and a script how to communicate with the 
physician if pain control was not adequate. In addition, patients were asked to complete a 
pain diary, a booklet that was printed in A4 size, which took about two minutes to be 
completed each evening before bedtime and five minutes at the end of each week. 
When asked about written information material in the interviews, it became clear 
that the PRO-SELF© booklet was not an important source of information for the patients 
although it was considered informative and understandable. Patients and FCs appreciated 
verbal information by the intervention nurse more than the written information. “Information 
materials were not so important, I think, I got most information from her personally.” Most 
patients did not refer to the PRO-SELF© booklet but commented they appreciated the daily 
pain diary as a tool that supported self-monitoring of pain. “’How was it today’, something 
like recapping shortly. What you probably would not do otherwise. I liked that.” 
Only one patient had kept a weekly pain diary before the study. Patients needed to 
develop a routine to fit the completion of the pain diary into their daily schedule. “In the 
beginning, I thought it was tough to get used to keeping a pain diary. Have never done that 
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before. … It worked out in the end, yes, then something like a mechanism developed.” 
Once the pain was under control, the diary was not considered necessary anymore. “If 
nothing changes at large over a period of time, I think, I would not do it anymore.” For most 
patients, the diary was understandable. However, in the beginning repeated instructions 
were necessary in order to help patients to correctly apply some items to their individual 
situation. Two patients reflected on how the pain diary could be improved by including a 
section about nighttime sleep and a rubric for special situations (e.g., operations), as well 
as printing it in a handier size than A4. 
Experiences with study participation. In addition to the burden due to the 
intervention, further efforts of the participants were necessary to provide data for the 
scientific evaluation of the Program. For data collection in the pilot RCT, patients needed to 
complete a set of questionnaires three times during the intervention period of 10 weeks. 
The completion of one set of questionnaires took approximately 90 minutes and patients 
were advised to complete the questionnaires over several days, not all at once. 
How patients anticipated the burden benefit ratio of the study, contributed to their 
decision-making process regarding study participation. Some patients described initial 
skepticism that was finally outweighed by the expected gain. “I simply took my time in the 
beginning when Mrs. K. approached me and I thought about whether I actually wanted to 
do it.” Factors that increased study participation included prevailing questions about pain 
management, unrelieved pain, the hope that benefits would outbalance the burden, and 
openness to learning and new situations. Furthermore, it was crucial for patients to 
experience that they were not only part of “yet another study” but that their individual 
situation was the main focus. 
Regarding their experience of study burden, patients said that they needed to get 
used to the amount of questionnaires they were asked to complete over the course of the 
study and that their ability to complete the questionnaires depended largely on their 
functional status. “If I had to do it now, it would be strenuous for me. I am not feeling like it 
at the moment. At that time I was feeling relatively well and it was not strenuous for me.” 
The option to complete questionnaires over one week rather than at once helped patients 
to get adjusted to the amount. “I have divided it in three little bits.” In the end, study burden 
was well balanced with the benefit for the participants. “The effort was OK each time. 
Because it is good if someone comes and tells you how to actually do it…. If it is important 
for you, you just do it.” FCs did not mention any problems with data collection. 
Patients and FCs were aware that the intervention would not continue after study 
completion. The participants’ positive experiences with the burden benefit ratio triggered a 
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reflection on how the Program could be continued on two levels. First, how continuing 
support of pain self-management may be realized for themselves right now and for other 
patients in the future. Regarding their own situation, patients and FCs were aware that their 
pain episodes were not over when the study ended and reflected about sustainability of the 
Program. “The study is finished now; one must wait and see if it is working.” One patient 
and their FC stated that they now would consult their primary physician if questions arose. 
Regarding the continuation of the Program, some patients said that the Program should 
become part of routine care for oncology patients with pain. “One should do this pain study 
more frequently because many people are walking around in pain.” In order to implement 
the Program in routine care, patients suggested a routine referral to an intervention nurse 
as soon as pain management was necessary, a reevaluation of pain management every 3 
to 4 weeks, and the availability of an intervention nurse for patients if any questions about 
pain self-management arose. “If you have something like this, like me now, you should right 
away ‘slide’ into such a (Program) so that you get your pain under control immediately, not 
only after two or three months.” “Then I would like …that it (the Program) continues 
regularly, that you meet every three or every four weeks… or get in touch with the clinic 
and discuss the pain or what could be changed. That you stay under supervision.” All six 
patients who were asked whether they would recommend the intervention to a close friend 
or family member said that they would do so. 
Discussion 
Findings from this qualitative substudy of participants’ experiences with study and 
intervention procedures showed that a trustful relationship with the intervention nurse was 
of utmost importance. The focus of the intervention on self-management, expert 
knowledge, and the caring attitude of the intervention nurse, as well as sufficient time to 
discuss problems resulted in high satisfaction and significant pain reduction for patients. 
Furthermore, participants considered the study burden acceptable as long as they had 
good functional status, and they experienced continuing improvement of their pain and 
knowledge gain about pain self-management. 
Consistent with the literature1,2, patients in this study experienced inadequate pain 
control prior to enrollment. With the intervention, most patients achieved a considerable 
improvement in their pain and reported a substantial increase of knowledge and skills 
about pain monitoring, correct intake and titration of analgesics, as well as side effect 
management. The intervention focused on the main components of effective pain self-
management6,19.  
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In accordance with previous research20,21, one of the most supportive factors for 
patients’ pain self-management was a trusting and credible relationship with the 
intervention nurse. As in previous studies20,22, participants in this study particularly valued 
repeated consultations with ample time to discuss questions in combination with the 
intervention nurse’s expert knowledge and a caring attitude. Furthermore, findings from this 
study suggest that clinician driven phone calls could contribute to patients’ trust because 
they may see them as a sign of the clinician’s consideration for their wellbeing. This finding 
contrasts somewhat with findings from our systematic review8, in which phone calls did not 
add considerably to the efficacy of cancer pain self-management interventions. In future 
research as well as clinical practice, emphasis needs to be placed on the development of a 
trustful relationship between patients and clinicians. The benefit of phone calls in cancer 
pain self-management interventions needs to be explored in future research. 
For participants in this study, the intervention’s focus on cancer pain self-
management was quite novel and filled a gap that they had experienced during episodes of 
uncontrolled pain under routine care. After the intervention, patients felt more in control of 
their pain self-management. This effect was shown to be positively related with quality of 
life and pain control in previous research23. As suggested by patients during the interviews, 
clinicians are encouraged to integrate self-management support in their routine care.  
Findings from this study confirmed that the coordination of cancer pain 
management between relevant clinicians is essential to improve the congruence of both 
analgesic prescriptions and provision of information. The coordination of cancer pain 
treatment was recommended in international guidelines19. Moreover, patients in this study 
described that matching information by the intervention nurse with their clinicians proved to 
be a strongly supportive factor to overcome patient-related barriers towards pain 
management. 
Several patient-related barriers towards pain self-management that were addressed 
as part of the intervention did not play a major role for patients according to the interviews. 
Issues that were repeatedly discussed and practiced as part of the nurse coaching 
component of the intervention were very well internalized by patients and their FCs (e.g., 
taking the prescribed medication according to a fixed schedule) while other issues (e.g., 
fear of tolerance) were not mentioned by the patients. This finding may explain why, in this 
study, the information leaflet was irrelevant for the participants. Information is better 
processed by participants if it is repeated24 which holds true for information in print 
material25. As Abrams et al.25 stated, patients may most likely read and adhere to print 
materials which are periodically reinforced in consultations with clinicians. In addition, 
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information may best be put into a meaningful context for patients and their FCs26. While all 
of the topics in the information leaflet in the German PRO-Self© Plus PCP were discussed 
once during the academic detailing session27, only those immediately related to the 
patient’s pain problem were reinforced repeatedly in subsequent coaching sessions. In 
future research and practice, additional barriers to pain self-management such as fear of 
tolerance may be addressed effectively by using this method of repetition and practice. 
Furthermore, the use of alternative methods to reduce pain (e.g., the use of 
relaxation or distraction) was not mentioned by participants even though alternative 
methods were used by the patients as was noted in the second qualitative substudy of this 
thesis28. One possible explanation may be that the use of alternative methods was self-
evident for patients and did not need to be mentioned. Another explanation may be that this 
topic was not evaluated during the interviews. Further exploration of the participants’ use of 
alternative methods may be integrated in a future RCT. 
This qualitative substudy had several limitations. Only patients who finished the 
intervention were included in the interviews. Patients who did not finish the intervention 
because of deterioration of their health status or for other reasons were excluded. It is 
possible that these patients may have added different perspectives with a somewhat more 
critical view on study burden and benefit. Furthermore, the recruitment rate for the pilot RCT 
was low (25%)13. Patients who took part in the study may have been more open and willing to 
integrate changes in their daily routine than those who declined study participation. Finally, 
the number of participants in this substudy was quite small, and interviews were rather short, 
so that some issues may not have been explored comprehensively. 
Conclusions 
In this qualitative substudy, patient satisfaction with the German PRO-SELF© Plus 
PCP was high. The Program helped the participants’ to “get a grip” on their pain self-
management while the study burden was considered tolerable. The participants particularly 
valued a trustful relationship with the intervention nurse. Furthermore, the focus on pain 
self-management was a novel and appreciated approach for the patients and their FCs. 
Clinicians are encouraged to integrate active building of a trustful relationship with patients 
and FCs and to focus on the implementation of treatment recommendations in routine care. 
The participants’ views in this qualitative substudy provide additional information on how 
the German PRO-SELF© Plus PCP may be adapted for a larger RCT including repetition 
of the information in the PRO-SELF© booklet as part of the nurse coaching component. 
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Summary 
Unrelieved pain affects up to 75% of cancer patients. Possible reasons for the 
undertreatment of pain are, amongst others, patient-related barriers towards cancer pain 
management. However, the way patients decide on the use of analgesics remains unclear. 
The purpose of this qualitative study was to explore decision-making processes of four 
women and four men with diverse cancers concerning their pain medications. Audiotaped 
protocols of the 10-week intervention and interviews of the PEINCA-pilot study provided 
data for a secondary analysis. This pilot study was conducted at a comprehensive cancer 
center in Germany to test for the first time the German version of a cancer pain self-
management intervention to support oncology patients’ pain self-management. The data of 
purposively selected patients were analyzed using content analysis. The results showed 
that cancer patients were very ambivalent about their analgesic use. The need to relieve 
severe pain conflicted with the desire to avoid opioids at any price. Decisions were 
reconsidered and overturned even after good experiences with analgesics. This study 
seems to provide a first look into decision-making processes over a longer time period. 
Individually tailored counseling by a professional within the cancer pain self-management 
intervention helped the patients adopt new attitudes towards analgesics and gradually 
reduce their pain levels. Previous experiences and attitudes of cancer patients should be 
considered in planning a pain therapy, and even after starting a pain therapy patients 
should be followed by professionals. 
 
Decision Processes of Cancer Pain Patients to Take Analgesic Medication 
- 128 - 
Zusammenfassung 
Bis zu 75% der onkologischen Patienten leiden trotz wirksamer Therapiemöglich-
keiten unter Schmerzen. Gründe dafür sind unter anderem Barrieren auf Patientenseite. 
Unklar bleiben jedoch die Entscheidungsprozesse von Patienten bezüglich ihrer 
Schmerzmitteleinnahme. In dieser qualitativen Arbeit wurden Wege von vier Frauen und 
vier Männern mit verschiedenen Krebserkrankungen erkundet, die zu Entscheidungen 
bezüglich der Schmerzmedikamente führten. Dazu boten die Protokolle der zehnwöchigen 
Intervention und Interviews aus der PEINCA-Pilotstudie Daten für eine Sekundäranalyse. 
Mit dieser Pilotstudie wurde ein Edukationsprogramm zur Unterstützung onkologischer 
Patienten in ihrem Schmerzmanagement erstmals in der deutschen Version an einem 
Tumorzentrum in Deutschland getestet. Die Daten von zielgerichtet ausgewählten 
Patienten wurden mittels Inhaltsanalyse ausgewertet. Ergebnisse zeigten, dass Patienten 
in ihren Entscheidungen bezüglich der Schmerzmittel zwischen dem Wunsch nach 
Schmerzlinderung und dem Vermeiden von Medikamenten zerrissen waren. Zweifel 
liessen sie getroffene Entscheidungen trotz guter Erfahrungen mit Schmerzmitteln immer 
wieder umstossen. Nach unserem Wissen beschreibt diese Studie erstmals solche 
Prozesse über einen längeren Zeitraum. Dank individuell angepasster Intervention verhalf 
das Edukationsprogramm den meisten Patienten zum Umdenken und zu einer 
verbesserten Schmerzsituation. Persönliche Ansichten und Erfahrungen onkologischer 
Patienten sollten in die Therapieplanung einbezogen und die Betreuung auch nach Beginn 
einer Schmerztherapie fortgesetzt werden. 
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Einleitung 
Die Zahl der jährlichen Neuerkrankungen an Krebs in Deutschland wird vom 
Robert-Koch-Institut1 auf ca. 436‘000 Personen geschätzt. Während sich diese 
Inzidenzrate in den letzten Jahren stabilisiert hat, konnten verbesserte Diagnoseverfahren 
und Therapien die 5-Jahres-Überlebenschance kontinuierlich erhöhen1. Diese eigentlich 
erfreuliche Entwicklung bedeutet jedoch auch, dass die Anzahl der Personen, die mit 
chronischen Krebsleiden und den damit verbundenen Einschränkungen, Belastungen und 
Schmerzen leben, stetig zunimmt. Laut Marcus2 leidet über die Hälfte der Betroffenen im 
Verlauf ihrer Krankheit unter erheblichen Schmerzen, welche die Bewältigung des Alltags 
und die Lebensqualität einschränken. 
Zur Behandlung von Tumorschmerzen stehen wirksame Medikamente und mit dem 
Stufenplan der World Health Organisation (WHO) auch ein effizientes Behandlungsschema 
zur Verfügung. Eine Schmerztherapie gemäss Stufenplan sollte bei 80-90% der 
Betroffenen Schmerzfreiheit erzielen3,4. Trotzdem leiden 30-50% der Patientena während 
der Therapie und über 75% der Patienten mit fortgeschrittener Krankheit unter Schmerzen5.  
Als Gründe für diese oft ungenügende Schmerztherapie wurden neben anderen 
Ursachen Barrieren bei den Patienten festgestellt. In ihrer Literaturreview beschreiben 
Jacobsen et al.6 folgende Hindernisse: Ungenügende Schmerzäusserung dem Arzt 
gegenüber, aus Angst, diesen von der Krankheitsbehandlung abzulenken, oder um als 
„guter“ (nicht klagender) Patient angesehen zu werden; die Ansicht, dass Schmerzen bei 
Krebs unumgänglich sind; Verbindung von Opiateinsatz mit nahem Tod; Angst vor Sucht, 
Abhängigkeit und Nebenwirkungen; Angst, dass die Medikamente bei stärker werdenden 
Schmerzen keine Wirkung mehr haben; Angst, dass neue Schmerzen unentdeckt bleiben; 
Angst, dass zunehmende Schmerzmitteldosierung Krankheitsprogression bedeutet, sowie 
Angst vor Spritzen. Resultate aus qualitativen Studien zeigen zudem, dass Schmerzmittel 
abgelehnt werden aufgrund früherer Erfahrungen der Patienten oder ihrer Angehörigen, 
aus Angst vor Stigmatisierung als Drogensüchtige, wegen Erziehung zu Tapferkeit oder 
aus Überzeugung, für begangene Schuld im Leben sühnen zu müssen7-9. 
a Die maskuline Form steht jeweils stellvertretend für beide Geschlechter. 
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Viele der patientenbezogenen Barrieren beziehen sich auf die Einnahme von 
Opiaten. Als mögliche Faktoren, die den Einsatz von Opiaten begünstigen, identifizierten 
Reid et al.10 das Drängen von Angehörigen und die intensive Schmerzerfahrung der 
Patienten. Ein weiterer Grund zum Einnehmen von Opiaten war das Bedürfnis der 
Patienten, Aufgaben im Alltag erfüllen zu können7.  
Querschnittstudien, welche Jacobsen et al.6 in ihrer explorativen Review 
zusammenfassten und qualitative Untersuchungen beschreiben Gründe gegen oder für 
eine Opiateinnahme zu einem bestimmten Zeitpunkt. Unklar bleibt jedoch, wie 
Entscheidungsprozesse im Zeitverlauf aussehen. Eine Literatursuche ergab nur wenige 
Hinweise darauf, welchen Einflüssen die Patienten in ihren Entscheidungen im Zeitverlauf 
ausgesetzt waren. Donovan11 stellte in einer Langzeitstudie fest, dass Patienten mit 
rheumatologischen Erkrankungen mit vorgefassten Ansichten und Theorien über die 
Krankheit den Arzt aufsuchten und sich bezüglich ihrer Medikamenteneinnahmen aktiv und 
wohlüberlegt entschieden. Sie erwähnt, dass Ansichten der Patienten nicht statisch seien, 
sondern aufgrund von Erfahrungen oder glaubwürdigen Informationen wechseln könnten, 
beschreibt jedoch den Verlauf solcher Haltungsänderungen nicht. In einer Literaturreview 
betont Donovan12 weiterhin, dass vorangegangene Erfahrungen der Patienten mit 
Medikamentenwirkungen und ihre Fähigkeit, Verordnungen und ärztliche Informationen mit 
ihrer Haltung in Einklang zu bringen, die Medikamenteneinnahme wesentlich beeinflussten. 
Weitere Autoren bestätigen die Bedeutung persönlicher Ansichten und früherer 
Erfahrungen bezüglich der Medikamenteneinnahme bei onkologischen Patienten8,13,14. 
Zusammenfassend lässt sich sagen, dass Gründe ungenügender Schmerz-
behandlung bei onkologischen Patienten in zahlreichen Studien untersucht wurden. Dabei 
lag der Fokus darauf, welche patientenbezogenen Barrieren vorkommen. Einige Unter-
suchungen betrafen die Motivation für eine Medikamenteneinnahme. Es liessen sich keine 
Studien finden, die den Verlauf der Entscheidungsfindung über einen längeren Zeitabschnitt 
erforschten. Deshalb werden mit der vorliegenden Studie jene Prozesse untersucht, die aus 
der Sicht onkologischer Patienten zur Entscheidung bezüglich ihrer Schmerztherapie führten.  
Um diese Entscheidungsprozesse im zeitlichen Verlauf zu explorieren, standen aus 
den Interventionsprotokollen und Abschluss-Interviews der kürzlich durchgeführten PEINCA-
Pilotstudie15 umfangreiche Daten für eine Sekundäranalyse zur Verfügung. Mit der PEINCA-
Pilotstudie kam das PRO-SELF© Plus Pain Control Program (PCP) erstmals im 
deutschsprachigen Raum zum Einsatz. Dieses wurde als Edukationsprogramm durch eine 
von Prof. C. Miaskowski geleitete Forschungsgruppe in den USA entwickelt, um Patienten 
mit einer Krebserkrankung beim Optimieren ihrer Schmerztherapie zu unterstützen16. Die 
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Wirksamkeit der ersten Programmversion wurde in einer randomisiert kontrollierten Studie 
überprüft, wobei sich eine statistisch signifikante Abnahme der Schmerzen in der 
Interventionsgruppe nachweisen liess17. Die weiterentwickelte Version des PRO-SELF© 
PLUS PCP wurde im Rahmen der PEINCA-Pilotstudie in die deutsche Sprache übersetzt 
und an den deutschsprachigen Kontext angepasst. Ziel war es, Machbarkeit und Effektstärke 
der deutschen Version in einer randomisiert kontrollierten Studie zu überprüfen. Dies erfolgte 
an einem Tumorzentrum einer Universitätsklinik in Süddeutschland. 
In die PEINCA-Pilotstudie eingeschlossen wurden 39 ambulante Patienten mit 
Krebs, die in den vorausgehenden zwei Wochen Schmerzen von ≥ 3 auf einer 
numerischen Rangskala (NRS; 0 = kein Schmerz bis 10 = stärkster vorstellbarer Schmerz) 
angaben. Die Patienten mussten mindestens 18 Jahre alt sein, gemäss ärztlicher 
Einschätzung eine voraussichtliche Lebenserwartung von > 6 Monaten haben und 
telefonisch sowie in weniger als einer Stunde Autofahrt erreichbar sein. Pflegende 
Angehörige wurden einbezogen, wenn sie massgeblich am Schmerzselbstmanagement 
beteiligt waren. Wollten diese Angehörigen nicht teilnehmen, wurde auch der jeweilige 
Patient von der Studienteilnahme ausgeschlossen. Ausgeschlossen wurden auch 
Patienten, die unter neuropathischen Schmerzen litten, die Diagnose einer psychischen 
Erkrankung aufwiesen oder kognitive oder kommunikative Einschränkungen hatten, die 
das Verstehen der Einverständniserklärung unmöglich machten. Die Rekrutierung der 
Patienten erfolgte durch die Studienleiterin der PEINCA-Pilotstudie. Die zuständige 
Ethikkommission bewilligte sowohl die PEINCA-Pilotstudie als auch die sekundäre 
Datenanalyse. Alle Patienten gaben ihre schriftliche Einwilligung. 
Das Programm beruhte auf drei Schlüsselstrategien: 1. Informationsvermittlung; 2. 
Aufbau von Fertigkeiten in Schmerzerhebung und Planung einer individuellen 
Schmerztherapie; 3. fortlaufende Unterstützung, um Nebenwirkungen der Schmerztherapie 
und der Krankheit zu verhindern oder zu behandeln. Die Informationsvermittlung basierte 
wesentlich auf dem Besprechen der PRO-SELF©-Broschüre16, in der neun häufige 
patientenbezogene Barrieren in der Schmerztherapie thematisiert wurden. Die Intervention 
umfasste mit 6 Hausbesuchen und 4 Telefonanrufen einen Zeitraum von 10 Wochen und 
wurde durch eine speziell geschulte Pflegende mit Masterabschluss und klinischer 
Erfahrung in onkologischer Pflege durchgeführt (AK). Bei 9 der 12 Patienten der 
Interventionsgruppe, welche das Programm abschlossen, folgte innerhalb von zwei 
Wochen nach dem letzten Besuch ein Abschluss-Interview, um zu erfahren, wie sie Nutzen 
und Aufwand des PRO-SELF© PLUS PCP und die PEINCA-Pilotstudie erlebt hatten.  
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Die Interventionsgespräche bei Hausbesuchen und Telefonanrufen wurden 
während der Pilotstudie zur Qualitätskontrolle auf Tonband festgehalten. Diese Daten und 
die Abschluss-Interviews bildeten die Basis für die Sekundäranalyse. Konkret wurde 
folgender Frage nachgegangen: Wie beschreiben ambulante onkologische Patienten den 
Prozess der Entscheidungsfindung bezüglich ihrer Schmerzmedikamente im Rahmen der 
PEINCA-Pilotstudie? 
Methodisches Vorgehen 
Zur Beantwortung der Forschungsfrage im Rahmen einer Sekundäranalyse wurde ein 
qualitativer Forschungsansatz gewählt. Aus den 19 Studienteilnehmern der Interventions-
gruppe der PEINCA-Pilotstudie wurden in Absprache mit der Studienleiterin zielgerichtet 8 
Teilnehmer gewählt, deren Interventionsgespräche Angaben zum Umgang mit Schmerz-
medikamenten und zum Entscheidungsprozess bezüglich Schmerztherapie aufwiesen. Dabei 
handelte es sich um 4 Frauen und 4 Männer im Alter von 44 bis 74 Jahren (Durchschnitt 56.5 
Jahre). Bis auf eine Patientin, die verwitwet war, lebten alle mit ihren Ehepartnern zusammen. 
Bei 4 Patienten wohnten auch Kinder im gleichen Haushalt, bei 3 waren die Kinder 
ausgezogen, und ein Ehepaar war kinderlos. Die Schulbildung der Teilnehmer reichte von 
Hauptschul- bis Fachhochschulabschluss. Sie hatten Berufsausbildungen als Konditorin, 
Sekretärin, Sicherheitsfachmann, Heizungsmonteur, Lehrerin und Projektleiter Anlagebau. 
Während der PEINCA-Pilotstudie arbeiteten 2 Teilnehmer in Teilzeit, 4 waren 
krankgeschrieben und 2 Rentner. Die Diagnosen umfassten Bronchus-, Mamma-, Nieren- und 
Pleura-Karzinome und malignes Melanom. Zu Beginn der Intervention gaben 7 Teilnehmer ihre 
höchsten Schmerzen mit Werten zwischen 7 und 9 auf der NRS (0 = keine Schmerzen; 10 = 
schlimmste vorstellbare Schmerzen) an, und einer nannte den Wert von 5. Eine Patientin hatte 
zu diesem Zeitpunkt noch nie Schmerzmittel eingenommen, 5 Patienten nahmen nicht-
opiathaltige Schmerzmedikamente und 2 nahmen Opiateb. Drei Patienten nahmen mit einem 
Angehörigen teil, 5 alleine. Die Aussagen der 3 Angehörigen ergaben eine zu geringe 
Datenmenge und wurden nicht in die Resultate einbezogen. 
Aus den aufgezeichneten Interventionsgesprächen wurden alle Sequenzen 
transkribiert, welche Schmerzmedikation, den dazugehörigen Entscheidungsprozess und 
patientenbezogene Barrieren thematisierten. Diese transkribierten Sequenzen aus den 
Interventionsgesprächen und Transkripten der Abschluss-Interviews dienten als Datenquellen 
für die vorliegende Sekundäranalyse. 
b Im Text wird der Begriff Opiat verwendet. Darin eingeschlossen werden auch Opioide, sowie halb- 
oder vollsynthetisch hergestellte Alkaloide aus dem Opium (Herdegen, 2008). 
 Decision Processes of Cancer Pain Patients to Take Analgesic Medication 
- 133 - 
Die Auswertung der Daten erfolgte in Form einer qualitativen Inhaltsanalyse in 
Anlehnung an Mayring18. Zentrale Aussagen der Teilnehmer wurden auf eine einheitliche 
Sprachebene paraphrasiert, generalisiert und in zwei Schritten auf die inhaltstragenden 
Aspekte reduziert, ohne das Grundmaterial aus den Augen zu verlieren. Daraus wurden 
induktiv Kategorien gebildet, untereinander in Verbindung gebracht und aus der 
Perspektive der Fragestellung interpretiert. In einem letzten Schritt wurde die Nähe der 
Resultate zu den Ausgangsdaten überprüft. Zitate aus den Gesprächen illustrieren die 
einzelnen Ergebnisse und stellen dadurch einen Bezug zu den Originaldaten her. 
Zur Qualitätssicherung wurden Transkriptauswahl und Analyseschritte mit AK und 
Studierenden des Instituts für Pflegewissenschaft, Universität Basel, kritisch diskutiert. AK 
reflektierte die Resultate aufgrund ihrer Erfahrungen während der Durchführung der 
Interventionen. ESp brachte dank ihrer ausgewiesenen Fachkenntnisse eine weitere 
Sichtweise ein.  
Resultate 
Aussagen der acht Teilnehmer im Verlauf der zehnwöchigen Intervention und im 
Abschluss-Interview zeigten, dass der Entscheidungsprozess onkologischer Patienten im 
Umgang mit ihren Schmerzmedikamenten von einem Widerstreit zwischen Zustimmung 
und Ablehnung geprägt war und Entscheidungen wiederholt umgestossen wurden. Die 
Kategorien „sich gegen Schmerzmedikamente wehren“ und „es mit Alternativen versuchen“ 
widerspiegeln die ablehnende Haltung und Versuche, eine Einnahme von Schmerz-
medikamenten hinauszuschieben. „Sich doch für Medikamente entscheiden“ beschreibt 
Aspekte, die eine Einnahme von Schmerzmedikamenten förderten. Persönliche Haltung 
und ursprüngliche Bedenken verdrängten wiederholt sachliche Argumente und liessen 
Patienten „immer wieder zweifeln.“ Am Schluss äusserten die meisten Patienten, durch 
„Umdenken und Lernen“ ihre Haltung gegenüber Schmerzmitteln geändert zu haben. Einer 
Mehrzahl der Teilnehmer gelang es schliesslich, ihre Schmerzen im Rahmen der 
Intervention erheblich zu senken. In der Folge werden die Kategorien der Entscheidungs-
findung genauer beschrieben. Sie beeinflussten sich oft gegenseitig und gaben dem 
Prozess einen individuellen Verlauf, der alle erdenklichen Formen annehmen konnte. 
Sich gegen Schmerzmedikamente wehren. Obwohl die meisten Patienten ihre 
Schmerzen als stark und belastend empfanden, sträubten sich fast alle dagegen, 
Schmerzmittel einzunehmen, sie höher zu dosieren oder auf ein Opiat zu wechseln. Ihre 
Bedenken blieben oft mit grosser Hartnäckigkeit präsent und beeinflussten im Verlauf 
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wiederholt Entschlüsse bezüglich der Schmerzmitteleinnahme. Eine einzige Teilnehmerin 
lehnte Opiate nicht grundsätzlich ab und setzte besprochene Massnahmen konsequent um. 
Mehrere Patienten wollten mit der Einnahme von Schmerzmedikamenten oder 
Opiaten warten, bis die Schmerzen in einem kürzeren Intervall auftreten, noch schlimmer 
würden oder bis sie es nicht mehr aushielten: „Aber so lange es nicht unbedingt sein muss, 
will ich damit gar nicht anfangen. Erst, wenn es einmal nicht mehr geht.“ Ein Patient 
schilderte, wie er Schmerzen aushielt und mit eisernem Willen dem Bedürfnis widerstand, 
ein Opiat einzunehmen, das er noch zur Verfügung hatte: „Da beiss’ ich mich einfach 
durch. Ich habe gelernt, die Schmerzen zu unterdrücken oder hinzunehmen.“ 
Gemäss ihren Antworten auf die Fragen in der PRO-SELF©-Broschüre glaubten die 
meisten der acht Teilnehmer zwar nicht, dass Patienten mit Krebs, die Schmerzmittel 
nehmen, süchtig davon würden. Abweichend davon kam Sucht jedoch zur Sprache, wenn 
Patienten Erfahrungen mit Opiaten erwähnten, die sie selbst oder bei Verwandten oder 
Bekannten erlebt hatten: „Ich habe einfach Angst, von Morphium abhängig zu werden. Ich 
glaub’, ich war süchtig.“ „Der ist abhängig, der ist abhängig mit dem Spray.“ In der Literatur 
beschriebene Vorbehalte gegenüber Opiaten, wie Angst vor Toleranzentwicklung, 
Verknüpfung mit dem nahen Tod und Angst vor Nebenwirkungen wie Obstipation, 
Müdigkeit oder „verwirrt sein“, fanden sich in den Äusserungen der Teilnehmer wieder: 
„Wenn man so daran gewöhnt ist, dann wirkt es gar nicht mehr.“ „Für mich war klar, dieses 
Pflaster ist Endstation.“ „Die älteren Leute spinnen doch immer so (nach 
Schmerzmitteleinnahme).“Allgemein bestand eine grosse Hemmung gegenüber Opiaten. 
Eine Patientin meinte: „Ich bin einfach blockiert, was das Morphin angeht.“ 
Einige Patienten wollten bewusst mit Schmerzen umgehen. Sie zogen leichte 
Schmerzen sogar kompletter Schmerzfreiheit vor. Auf diese Weise blieben Schmerzen 
gegenwärtig und übernahmen verschiedene Signalwirkungen. Einige Patienten wollten 
einen Hinweis für ihre körperlichen Grenzen. Sie befürchteten bei Schmerzfreiheit nach der 
Einnahme von Schmerzmedikamenten, nicht mehr durch Schmerzen gebremst zu werden, 
sich zu übernehmen und ihrem Körper damit zu schaden. So äusserte eine 
Teilnehmerin:„Ich habe manchmal das Gefühl, es ist besser, ich habe Schmerzen, weil ich 
dann weniger mache. Wenn ich nichts habe, dann mache ich alles. So wie immer.“ 
Patienten wollten auch spüren, dass eine eingeleitete Therapie, wie Bestrahlung oder 
Chemotherapie, Wirkung zeigte und dass etwas mit dem Körper geschah. Sie glaubten, 
dies sei bei Schmerzfreiheit unter Medikamenten nicht möglich: „Wenn ich jetzt keine 
Schmerzen habe, dann weiss ich, dass die Bestrahlung was gebracht hat. Mit den 
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Schmerzmitteln weiss ich es ja nicht.“ Das Spüren von Schmerzen verlieh einem Patienten 
das Gefühl von Lebendigkeit: „Also für mich sagt er (Schmerz) immer, ich lebe.“ 
Es mit Alternativen versuchen. Um ihre Schmerzen bei Vermeiden oder 
Hinausschieben der Schmerzmitteleinnahme irgendwie in den Griff zu bekommen, 
versuchten es Patienten mit Alternativen. Sie setzten Mittel auf natürlicher Basis ein, zu 
denen sie zu Hause Zugang hatten oder die sie ohne Rezept beziehen konnten, wie 
Cremes, Sprays, Ergänzungsnahrung oder Salze. Dabei entwickelte jeder Patient seine 
ganz persönlichen Strategien und wusste schliesslich genau, welche Linderung er erwarten 
konnte: „Ich finde den Traumeel-Spray (homöopathisches Arzneimittel) eigentlich ganz gut. 
Es nimmt den Reiz weg.“ 
Die meisten Patienten wandten Wärme an, die sie als entspannend oder wohltuend 
empfanden. Dafür setzten sie Bäder, Duschen, Kirschsteinsäckchen, Körnerkissen oder 
Wärmflaschen ein. Ein Patient berichtete, dass er manchmal mehrmals täglich ins Bad 
stieg, um die Schmerzen für etwa eine Stunde auf ein erträgliches Niveau zu bringen. 
Bewegung oder dem Körper Ruhe gönnen, waren weitere Strategien zur 
Schmerzreduktion. Mit Bewegung meinten die Patienten zügig marschieren, den 
betroffenen Körperteil durchbewegen oder Sport treiben, sei dies Fahrrad fahren, Walking 
oder Krafttraining. Im Gegensatz dazu half anderen Teilnehmern Ruhe, zum Beispiel sich 
ins Bett zu legen. 
Sich doch für Medikamente entscheiden. Unerträgliche, an die Grenze des 
Vorstellbaren gehende Schmerzen bewegten schliesslich die Teilnehmer im Verlauf der 
Intervention zur Einnahme von Schmerzmitteln, zu einer Dosiserhöhung oder einem 
Versuch mit Opiaten. Als zermürbend wurden vor allem nächtliche Schmerzen erlebt. 
Diese beeinträchtigten die Nachtruhe der meisten Patienten erheblich. Sie wachten 
schmerzbedingt wiederholt auf oder blieben stundenlang wach. Mangelnde nächtliche 
Erholung führte zu grosser Müdigkeit tagsüber und erschwerte das Verrichten von 
Tätigkeiten im Alltag. Für mehrere Patienten war der Wunsch, schlafen zu können ein 
entscheidender Grund, es mit einem Schmerzmedikament oder einem stärkeren 
Analgetikum zu versuchen: „In der Nacht habe ich Knochenschmerzen, das ist der Grund, 
denke ich, weshalb ich die eine Tablette genommen habe.“ 
Wagten sich Patienten einmal an Schmerzmedikamente, gestanden sie sich erst 
nur die kleinste Menge zu oder verhandelten um eine geringere Dosierung. Sie halbierten 
oder viertelten ihre Tabletten oder nahmen sie nur jeden zweiten Abend ein. Dies betraf 
neben Opiaten auch nichtsteroidale Antirheumatika. Auf diese Weise wollten sie die 
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Wirkung abwarten und eventuell später die Dosierung steigern: „Vielleicht nehme ich mal 
nur eine halbe und schaue, ob ich damit durchschlafen kann.“  
Gute Erfahrungen mit Schmerzmitteln, mit einer höheren Dosierung oder mit 
Opiaten bestärkten Patienten in der Entscheidung, Schmerzmedikamente regelmässig 
einzunehmen: „Ich habe es selber gemerkt, dieser Schlaf hat mir einfach gut getan. Wenn 
es mir gut tut, mach ich es (ein schwach wirksames Opiat einnehmen).“ Neben der 
Schmerzlinderung erlebten sie auch Erleichterung und neuen Schwung: „Da blühe ich 
richtig auf, wenn man keine Schmerzen hat.“   
Immer wieder zweifeln. Patienten waren im Zeitverlauf immer wieder hin und her 
gerissen bei ihren Entscheidungen, zu Schmerzmitteln zu greifen. Einerseits hatte ihnen 
die Einnahme von Schmerzmedikamenten eine verbesserte Lebensqualität durch 
Schmerzlinderung gebracht, andererseits meldeten sich wiederholt ursprüngliche 
Vorbehalte gegenüber Schmerzmedikamenten und verdrängten rationale Argumente. Die 
Patienten überdachten getroffene Entscheidungen und stiessen sie oft wieder um. Dabei 
fehlten häufig fassbare Begründungen: „Es ist halt so, dass Morphium ein Reizwort ist, und 
das möchte man eigentlich nicht so gern.“ Trotz grosser Erleichterung durch Morphium 
schilderte eine Patientin wiederkehrende Angst vor diesem Medikament. Ihr half die 
Unterstützung von professioneller Seite. Sie wurde darin bestärkt, das Medikament weiter 
einzunehmen: „Es ist halt dieses Morphium enthaltende Mittel. Da hat mich Frau K. immer 
unterstützt, weil ich da manchmal Angst davor hatte.“ Bei einem Patienten kamen Zweifel 
indirekt zum Ausdruck. Einerseits bestätigte er grösseres Vertrauen Schmerzmitteln 
gegenüber, andererseits nahm er die möglichen Bedarfsmedikamente kaum ein und ertrug 
extreme Schmerzattacken, obschon er mit Morphin Linderung erfahren hatte: „Heute ist 
das Vertrauen in die Schmerzmittel sowieso viel grösser wie früher. Ja, ich hatte schon 
(eine Schmerzattacke), aber da habe ich kein Morphin genommen.“ 
Sobald ihre Schmerzen etwas nachgelassen hatten, wollten die meisten Patienten 
Schmerzmedikamente reduzieren. Teilweise äusserten sie diese Absicht bereits zu einem 
Zeitpunkt, als die Schmerzen noch ungenügend behandelt waren und nahmen dadurch 
wieder intensivere Schmerzen in Kauf. Ein Teilnehmer beschrieb die eigene Zerrissenheit 
zwischen Wunsch nach weniger Schmerzmitteln und den empfundenen Schmerzen: „Mein 
Gedanke ist grundsätzlich, von diesen Mitteln wegzukommen, dies ist ein bisschen 
widersprüchlich (lacht), klar. Ich habe Schmerzen, auf der anderen Seite möchte ich gern von 
den Mitteln runterkommen.“ Eine Patientin musste sich richtig zureden, Schmerzmittel 
einzunehmen: „Ich tendiere immer dazu zu denken: ‚Nicht so viele Schmerzmittel‘ und dann 
denke ich wieder: ‚Nein, nimm's lieber. Du hast eine bessere Lebensqualität‘." Um die Menge 
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Schmerzmittel zu verringern, unternahmen einige Patienten im Verlauf Auslassversuche, 
reduzierten die Dosierung, zögerten die Einnahme hinaus oder versuchten es mit 
schwächeren Schmerzmedikamenten. Mit solchen Experimenten erlebten sie die Grenzen 
der Wirksamkeit: „Zwischenzeitlich habe ich gedacht, es wäre alles ziemlich gut, hab dann 
mal versucht, das Sevredol (stark wirksames Opiat) wegzulassen, und es bekommt mir gar 
nicht.“ Diese Erfahrungen schafften Klarheit, bestätigten oft die Notwendigkeit von 
Schmerzmitteln und unterstützten Patienten in ihren Entscheidungen. 
Umdenken und lernen. Im Abschlussinterview betonten die meisten Patienten, 
durch das deutsche PRO-SELF© PLUS PCP viel über Schmerzmedikamente und deren 
Handhabung gelernt zu haben. Sie äusserten Zweifel immer seltener und meinten, nun 
anders mit den Medikamenten umzugehen oder zu „spielen“, wie sich eine Patientin 
ausdrückte. Neu war für fast alle, dass sie Schmerzmedikamente regelmässig rund um die 
Uhr einnehmen sollten, um einen konstanten Wirkstoff-Spiegel im Blut zu erhalten: „Ich 
habe gelernt, dass man Tabletten regelmässig nehmen soll, zur gleichen Zeit.“ 
Ein wichtiger Aspekt des Umdenkens betraf auch die Einsicht, dass die Angst vor 
Sucht nicht gerechtfertigt war. Dies erlaubte den Patienten, Opiaten gelassener zu 
begegnen: „Diese Ängste sind genommen worden, gerade was im Bereich Abhängigkeit 
ist.“ Einer Patientin, die im Vorfeld jede Einnahme von Schmerzmedikamenten verweigert 
hatte, wurde bewusst, dass sie dem Körper mit Schmerzmitteln keinen Schaden zufügte: 
„Man kann den Körper doch besser in den Griff kriegen mit Medikamenten. Das macht 
mich jetzt nicht abhängig, aber man unterstützt den Körper für einen alltäglich besseren 
Halt.“ Dies entsprach einer grundlegenden Haltungsänderung.  
Eine angemessene Medikamentendosierung tat gut. Das bestätigten Patienten, 
nachdem sie von der Haltung abgewichen waren, möglichst wenige Tabletten 
einzunehmen. Ein Patient scheute auch vor höherer Dosierung nicht mehr zurück: „Wenn 
wirklich dieser Schmerz da ist, lieber eine Tablette zu viel nehmen als zu wenig.“ Das 
zusätzliche Wissen vermittelte den Patienten mehr Sicherheit. Sie wussten, wie sie bei 
ungenügender Schmerzbehandlung die Medikation anpassen und wie sie diese bei 
nachlassenden Schmerzen wieder reduzieren konnten: „Ich nehme dann auch etwas dazu, 
wenn ich merke, okay, das reicht nicht.“  
Für ihre Haltungsänderung gegenüber Schmerzmedikamenten nannten die Patienten 
verschiedene Gründe. Einer Patientin war es sehr wichtig, die Informationen zu einer 
Schmerztherapie mehrmals zu hören und bestätigt zu erhalten, was schon der Arzt gesagt 
hatte. „Die Schmerztherapeuten hatten mir das zwar irgendwann mal gesagt, aber ich hatte 
das nicht wirklich so verinnerlicht.“ Im Gegensatz dazu war ein Patient froh, auch einmal eine 
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andere Meinung als jene des Hausarztes zu hören. Einige Patienten erhielten beim 
Verschreiben eines Medikamentes keine Informationen zu dessen Handhabung. Ihnen halfen 
die zusätzlichen Erläuterungen und praktischen Hinweise. „Zu Beginn habe ich Frau Doktor X 
gefragt: ,Diese Tabletten?‘ Da hat sie gesagt, das seien alles Schmerztabletten, das muss ich 
selber machen. Da war ich schon froh, dass mir Frau K. gesagt hat: ,Das machen wir jetzt so‘.“ 
Das Besprechen ohne Zeitdruck erwies sich als sehr wertvoll für die Patienten. Dies 
ermöglichte es, auf persönliche Anliegen oder die individuelle Situation einzugehen. 
Alle Patienten hatten im Laufe der Intervention die Schmerzmitteldosierung mindestens 
einmal angepasst. Es konnte nicht bei jedem Teilnehmer ein idealer Schmerzmitteleinsatz 
erreicht werden. Trotzdem erzielten bei Abschluss fast alle eine eindrückliche 
Schmerzreduktion auf Werte von 1-2 auf der NRS. Neben der Studienintervention war dies 
natürlich auch auf Chemotherapien oder Bestrahlung zurückzuführen. Während des 
Abschlussinterviews äusserten die Patienten jedoch übereinstimmend, durch das Programm 
viel rund um Schmerzmittel gelernt zu haben und diese nun gezielter einsetzen und bei neu 
auftretenden Schmerzen anpassen zu können.  
Diskussion 
Nach unserem Wissen werden in dieser Studie erstmals die sehr individuell 
verlaufenden Entscheidungswege onkologischer Patienten bezüglich ihrer Schmerztherapie 
über einen Zeitabschnitt von zehn Wochen beschrieben. Diese waren von Ambivalenz 
zwischen dem Bedürfnis nach Schmerzlinderung und den Bedenken gegenüber 
Schmerzmedikamenten geprägt.  
Patientenbezogene Barrieren, die onkologische Patienten an der Schmerzmittel-
einnahme hindern, wurden bisher vor allem in Querschnittstudien detailliert beschrieben6,19. 
Die Ergebnisse dieser Langzeitstudie zeigen zusätzlich, wie die Patienten einmal getroffene 
Entscheidungen, Schmerzmittel einzunehmen, wiederholt anzweifelten und umstiessen. 
Diese beharrliche Ambivalenz könnte eine weitere Erklärung dafür sein, dass einmalige 
Interventionen bisher nur eine moderate Verbesserung bei den Einstellungen der Patienten 
zu ihrem Schmerzmanagement und dem schmerzbezogenen Wissen gezeigt haben20. Die 
meisten Patienten erlebten jedoch, dass das deutsche PRO-SELF© PLUS PCP ihnen über 
die Zeit zum allmählichen Umdenken und einer Verbesserung ihrer Schmerzsituation 
verholfen hat. Im Verlauf äusserten sie ihre Zweifel seltener und lernten routinierter mit ihren 
Schmerzmedikamenten umzugehen. Hilfreiche Faktoren waren hierfür zunächst eine 
detaillierte, individuell angepasste und kompetente Beratung. Als essentielle Bestandteile der 
Intervention zeigten sich weiterhin die immer wiederkehrende Bestärkung in der getroffenen 
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Entscheidung und die Notwendigkeit, genügend Zeit zur Verfügung zu haben. So konnten 
die persönliche Situation genauer betrachtet und Details in der Schmerzbehandlung 
besprochen werden, was während regulärer Arztbesuche oft zu kurz kam. Diese Ergebnisse 
decken sich mit der Studie von Matthias21, die darauf hinweist, dass Zeit und Zuhören bei 
Patienten mit chronischen Schmerzen für den Behandlungserfolg von grosser Bedeutung 
sind. Weiter bestätigt Schmalenbach22, dass Wiederholungen zu den häufigsten 
Lernstrategien gehören. 
Die in dieser Studie gefundenen patientenbezogenen Barrieren stimmten weitgehend 
mit den in der Literatur beschriebenen überein6-9. Auffallend war in dieser Untersuchung 
jedoch, dass Teilnehmer Fragen zu Sucht in den zur Studie gehörenden Fragebogen häufig 
richtig beantworteten, jedoch weiterhin während der Interventionen Bedenken diesbezüglich 
äusserten. Dies spiegelt möglicherweise eine Diskrepanz zwischen kognitiven und 
emotionalen Prozessen in der Entscheidungsfindung wider, wie es schon Donovan11 
beschrieb. Forscher und Kliniker, die mit Fragebogen Wissen zu Schmerzselbstmanagement 
und patientenbezogenen Barrieren ergründen, sollten diese Diskrepanz zukünftig bedenken. 
Eine zusätzliche Barriere stellte der bewusste Verzicht einiger Teilnehmer auf eine 
vollständige Schmerzlinderung dar, um den Schmerz als Signal zu nutzen. Hierbei wurden 
Schmerzen nicht nur als Signal für Verschlechterung der Erkrankung genannt, wie in vorigen 
Untersuchungen dargestellt6, sondern auch als Signal, damit sich die vormals häufig 
äusserst aktiven Personen im Alltag nicht „übernehmen“ würden. Schmerz könnte hier eine 
wichtige Funktion für die Krankheitsverarbeitung darstellen23. In zukünftigen Interventionen 
könnte mit Patienten exploriert werden, ob sie Schmerzen als erwünschtes Signal sehen und 
wie diese Sichtweise in eine bestmögliche Schmerztherapie integriert werden kann.  
Wie von Reid et al.10 beschrieben, führten auch in unserer Studie extreme, 
zermürbende Schmerzen dazu, dass Patienten schliesslich doch Schmerzmedikamente 
einnahmen. Bei unseren Studienteilnehmern waren jedoch vor allem nächtliche Schmerzen 
ausschlaggebend. Dies ist nicht erstaunlich, da gestörte Nachtruhe, erheblich einge-
schränkte Lebensqualität und Schmerz bei Krebspatienten häufig eng zusammenhängen24. 
Für künftige Forschungsprojekte und die klinische Praxis könnte das bedeuten, dass ein 
durch Schmerz gestörter Nachtschlaf verstärkt als Ansatzpunkt in Interventionen dienen 
könnte, um Patienten bei der Entscheidung zu einer Schmerzmitteleinnahme zu 
unterstützen. Weiter beeinflussten sowohl persönliche Ansichten wie auch frühere 
Erfahrungen die Studienteilnehmer, in bestärkender oder zurückhaltender Weise, in ihrem 
Umgang mit Schmerzmedikamenten, wie dies von anderen Autoren bereits beschrieben 
wurde8,12-14.  
Decision Processes of Cancer Pain Patients to Take Analgesic Medication 
- 140 - 
Limitationen. Für diese Sekundäranalyse wurden Daten verwendet, die während der 
Intervention zur Qualitätskontrolle und mittels Interviews zu Erfahrungen mit der Pilotstudie 
erhoben wurden. Die hier untersuchte Fragestellung war folglich nur indirekt Thema in 
Interventionsgesprächen und Interviews. Direkte Nachfragen zu unklaren Aussagen waren 
nicht möglich. Positiv betrachtet konnten aber mit der Sekundäranalyse reale 
Entscheidungsprozesse im Zeitverlauf exploriert werden. Eine weitere Einschränkung ist die 
kleine Untersuchungsgruppe und die Tatsache, dass möglicherweise eher Patienten, die 
bereit waren, Neues zu lernen, einer Teilnahme an der Pilotstudie zustimmten. Da nur Daten 
aus der Interventionsgruppe zur Verfügung standen, konnten Entscheidungen von Patienten 
mit einer üblichen Schmerzbehandlung nicht untersucht werden. Schliesslich konnte im 
Rahmen dieser Sekundäranalyse keine Rücküberprüfung der Resultate mit den Teilnehmern 
durchgeführt werden. Bei der vorliegenden Studie wurden zwar Angehörige einbezogen, 
jedoch reichte die Datenmenge nicht für eine Analyse aus. 
Schlussfolgerungen 
Mit dieser Sekundäranalyse konnten Entscheidungen einer kleinen Gruppe von 
onkologischen Patienten im Umgang mit Schmerzmedikamenten im Verlauf einer 
Intervention beschrieben werden, die darauf abzielte, das Schmerz-Selbstmanagement der 
Patienten zu verbessern. In zukünftigen grösseren Langzeitstudien sollten Sichtweise und 
Verhalten von onkologischen Patienten mit ihrer Schmerzbehandlung weiter exploriert 
werden. Dabei sollte in zukünftigen Studien auch die Perspektive von Angehörigen 
einbezogen werden, weil sie eine wichtige Rolle im Schmerz-Selbstmanagement spielen. 
In der klinischen Praxis scheint es erforderlich, sich der grossen und manchmal lange 
bestehenden Ambivalenz Betroffener gegenüber Schmerzmitteln bewusst zu sein. Für eine 
erfolgreiche Intervention zur Unterstützung des Schmerz-Selbstmanagements 
onkologischer Patienten scheint es wesentlich, genügend Zeit für Gespräche zu haben, 
Erfahrungen und Verhalten mit dem Patienten zu reflektieren, seine Schmerzbehandlung 
entsprechend anzupassen und Beratungen solange fortzusetzen, bis der Patient eine gute 
Schmerzkontrolle erreicht hat und das Schmerz-Selbstmanagement sicher umsetzen kann.   
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Chapter 9  
 
 
Discussion 
 
Pain remains a major problem in a large proportion of individuals with cancer1,2. 
Patient-related barriers are known to significantly hinder optimal pain control3. Therefore, 
this research project was focused on the support of pain self-management in patients with 
cancer and their family caregivers (FCs).  
First, a systematic review of the literature provided a summary, an evaluation of 
efficacy, and a critique of various components of interventions that were used to support 
oncology patients’ and their FCs’ pain self-management (see Chapter 3). To our 
knowledge, the review was the first to systematically describe seven structure and 16 
content components that were used in 24 different cancer pain self-management 
interventions. The various components were used inconsistently across these studies. 
Furthermore, significant heterogeneity was found in study designs as well as methods that 
were used to test the interventions. As a result, the most effective components of 
interventions designed to support cancer pain self-management remain to be determined in 
future trials. 
As part of this dissertation research, the first mixed methods pilot study was done to 
evaluate the German PRO-Self© Plus Pain Control Program (PCP) for feasibility and 
potential efficacy. To our knowledge, it was the first project in which a cancer pain self-
management intervention that was developed in the United States (U. S.)4,5 was tested in a 
German speaking population. First, translation and adaptation of the PRO-Self© Plus PCP 
were performed successfully. For the mixed methods pilot study, a randomized controlled 
pilot trial (pilot RCT) was combined with two qualitative substudies. Findings from the pilot 
RCT (see Chapters 5 and 6) demonstrated feasibility of study and intervention procedures 
and provided the basis for a multicenter RCT. While pain management related knowledge 
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improved significantly, effect size calculations showed low to moderate reductions in 
average and worst pain.  
In the first qualitative substudy, it was explored how nine patients and four FCs who 
finished the intervention experienced intervention and study procedures. Findings 
confirmed that for patients and FCs, a trustful relationship with the intervention nurse was 
of utmost importance. Furthermore, the intervention’s focus on cancer pain self-
management was novel for and appreciated by the participants. The discussion of 
everyday problems, the intervention nurse’s profound knowledge about pain self-
management, and sufficient time to discuss problems repeatedly resulted in a high 
satisfaction of the participants, as well as a meaningful reduction in pain for most patients 
in this substudy. 
Findings from the second qualitative substudy of eight patients’ decision-making 
processes about taking analgesic medications showed that cancer patients stayed 
ambivalent about the use of analgesics over the whole course of the intervention. The need 
for adequate pain relief contrasted with the desire to avoid analgesic medications. Despite 
positive experiences with analgesics, decisions were reconsidered and overturned. 
Individually tailored counseling helped these patients to adopt new attitudes towards 
analgesics and to gradually reduce their pain levels.  
In the following paragraphs, various aspects of this research project are analyzed 
and critiqued. First, a critical appraisal of the methods is done to determine their 
appropriateness. Next, the German PRO-Self© Plus PCP is put into an international 
context by comparing it with other cancer pain self-management interventions that were 
summarized in a meta-analysis6 and in our systematic review. Furthermore, reflections on 
the conceptual frameworks that guided this research project are presented. In addition, 
limitations of this research project and implications for future research are enumerated. The 
final section includes the conclusions from this dissertation research. 
Critical Appraisal of Methods Used 
Systematic review. An extensive literature search yielded 24 studies of 
interventions designed to support cancer pain self-management (see Chapter 3), two 
systematic reviews7,8, and a meta-analysis6. In the systematic reviews and meta-analysis, 
the major conclusion was that cancer pain self-management interventions may be 
efficacious in improving patients’ knowledge and decreasing pain intensity. No conclusions 
could be drawn about the specific components of the various interventions and which 
components were the most efficacious. 
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With the systematic review (see Chapter 3), we thus aimed to describe and evaluate 
the various intervention components within the identified intervention studies. A narrative 
approach was used in which a content analytical approach9 was combined with statistical 
methods (i.e., calculation of effect size) in order to systematically summarize intervention 
components and effect sizes of tested cancer pain self-management interventions. A 
quantitative meta-analytical approach (i.e., meta-regression) may have been the preferred 
method to identify the most effective components as was done in a study of disease 
management interventions for patients with diabetes10. However, such a quantitative meta-
analytic approach was considered to be inappropriate given the number of different 
interventions and intervention components, as well as the heterogeneity of study designs 
that were identified. Our approach proved to be appropriate and valuable to provide the 
basis for future studies in which study designs may be applied that permit the 
discrimination of specific intervention components (e.g., factorial designs). 
Choice of intervention and pilot testing. Interventions designed to support cancer 
pain self-management are largely unknown in German speaking populations. Therefore, 
the decision was made to translate and adapt an effective intervention from the U. S., 
instead of “reinventing the wheel” by developing and testing a new intervention without 
established efficacy. In this thesis, the PRO-Self© Plus PCP was chosen for three reasons. 
First, the Program’s efficacy was established in a large RCT in the U. S.4. Second, 
adaptations after the first RCT were based on extensive qualitative and quantitative 
analyses that suggested that specific revisions would improve its efficacy11,12. Third, the 
authors of the PRO-SELF© Plus PCP agreed to collaborate closely during the 
implementation of the German PRO-SELF© Plus PCP. Before testing the German PRO-
Self© Plus PCP in a large RCT, a pilot study was appropriate in order to evaluate feasibility 
and establish effect sizes. Adaptation and pilot testing of the PRO-Self© Plus PCP was 
overall successful. Moreover, the mixed methods pilot study yielded valuable information to 
be able to plan of a larger multicenter RCT. 
Mixed methods. To evaluate the German PRO-Self© PCP, a nested concurrent 
mixed methods design13 was used in order to augment findings from the pilot RCT with 
data from two qualitative substudies. Initially, a single qualitative substudy was planned in 
order to explore participants’ experiences with study and intervention procedures. 
However, audiotapes of the intervention sessions and the debriefing interviews provided 
rich data for a second qualitative study that yielded additional interesting findings about the 
patients’ decision-making processes regarding their analgesic intake.  
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Inferences in mixed methods research are drawn from the separate quantitative and 
qualitative parts of the study as well as across the two parts13. Thus, interpretability of the 
separate qualitative and quantitative findings are improved and more comprehensive 
conclusions may be drawn by combining qualitative and quantitative findings. Although the 
small sample sizes for both, the pilot RCT and the qualitative substudies, may have 
resulted in a limited variance in findings, the combination of qualitative and quantitative 
methods was found to be highly appropriate to evaluate the German PRO-Self© Plus PCP 
for feasibility and for its potential to reduce cancer pain. The following examples illustrate 
how qualitative findings facilitated the interpretation of quantitative findings and vice versa.  
With the Patient Pain Questionnaire14, nine common knowledge deficits or 
perceived barriers to pain self-management were assessed. While overall improvements 
were statistically significant, a detailed analysis showed that single items of the Patient 
Pain Questionnaire showed no improvement in patients’ knowledge. Patients who 
participated in the debriefing interviews provided an explanation for this finding. They 
reported that the print material was not relevant in assisting them to improve their pain self-
management. Furthermore, for the entire intervention group, pain scores did not improve 
significantly in this pilot RCT. However, participants of the qualitative substudy experienced 
a clinically meaningful reduction in pain. In fact, a subanalysis of their average and worst 
pain scores showed a statistically significant improvement between baseline and week 10.   
Conduction of pilot RCT. In this pilot RCT, the feasibility of research and 
intervention procedures was well established. Furthermore, a pilot RCT was an appropriate 
method to evaluate the intervention’s efficacy and to estimate effect sizes for a larger RCT. 
However, recruitment and retention of participants posed many challenges in this 
population of patients with advanced cancer and their FCs. Moreover, the inclusion of a 
control group that received only an attention intervention and standard care confronted the 
nurse who conducted the attention control visits with ethical dilemmas. The problem was 
increased because, in this pilot study, the same nurse conducted both the attention control 
and the intervention visits. This nurse was a pain expert who identified problems with pain 
self-management in the control group while checking the study questionnaires for 
completeness. If problems with pain self-management were revealed during these visits, 
the nurse referred patients to their clinicians instead of providing education and coaching to 
improve pain control. In future research, the challenges that were identified during the pilot 
RCT will need to be addressed in order for a larger RCT to be successful. For example, to 
address the ethical dilemma, the control group may be offered the intervention after study 
completion (i.e., waiting control group). 
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Comparison of PRO-Self© Plus PCP to Other Interventions in the 
Systematic Review 
Findings from the evaluation of the German PRO-Self© Plus PCP will be discussed 
below in relationship to the findings from the studies that were summarized in a meta-
analysis6 and in our systematic review (see Chapter 3). Compared with the studies in the 
meta-analysis and our systematic review, the German PRO-Self© Plus PCP was an 
intensive and comprehensive intervention in terms of both its structure and its content.  
Structure components. The German PRO-Self© Plus PCP consisted of 6 visits 
and 4 phone calls (i.e., multiple exposures) by an intervention nurse over ten weeks. 
Patients in the intervention group received a median dose of 283 minutes (25/75 percentile 
= 229/372 minutes). Patients completed a daily pain diary and were given a booklet that 
contained information about 9 common patient-related barriers. In the PRO-Self© Plus 
PCP, interaction between patients, their FCs, and the intervention nurse was an integral 
part of all contacts. Interactions included the provision of information and coaching. These 
interactions continued until no further questions remained. In addition participants were 
invited to ask questions at any time during the visits and phone calls. 
As in most of the analyzed studies (15 of the 24), the German PRO-Self© Plus PCP 
was delivered with multiple exposures. However, patients in our pilot RCT were exposed to 
a high dose of intervention compared to those interventions that were included in our 
systematic review. In the pilot RCT, the median dose of the German PRO-Self© Plus PCP 
was higher than the dose of intervention in any of the trials in the systematic review (range 
of 30 to 270 minutes). 
As in most interventions (23 of 24 studies), print materials were used in the Pro-
Self© Plus PCP to reinforce information. Print materials are viewed as a cost effective 
method to deliver information about various types of self-management15. However, during 
the debriefing interviews in our qualitative substudy, participants stated that, except for the 
pain diary, print materials were not important and that they preferred personal and tailored 
information by a trustworthy and competent clinician. This finding supports previous work 
that suggests that the efficacy of print materials for self-management depends on the mode 
of delivery (e.g., contacts in which print materials are discussed with patients) and the 
amount of tailoring of the materials for a specific patient15. In a future study, print materials 
may be integrated repeatedly (e.g., by repeating academic detailing at subsequent visits) in 
the intervention in order to enhance their perceived usefulness. 
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Content components. Except for direct contact of research staff with clinicians, the 
German PRO-Self© Plus PCP included all content components that were found in our 
systematic review. In the systematic review, across interventions, cognitive content 
components were used more frequently than behavioral components. This approach may 
be due to the fact, that provision of information is more easily performed and less costly 
than the support of skills and behavior change16. Regarding cognitive content components, 
most interventions included information on patient-related barriers to pain management (23 
of 24), analgesic medications (20 of 24), communication with the clinicians (18 of 24), and 
information about the side effects of analgesic medications (16 of 24). Tips on how to 
communicate with clinicians about unrelieved pain was the behavioral content component 
included most frequently (10 of 24).  
In contrast to most studies in our systematic review (3 of 24 studies comprised goal 
setting), the PRO-Self© Plus PCP included goal setting as an individually tailored method 
to enhance patients’ sense of mastery and success based on social cognitive theory17. The 
pilot study yielded mixed findings regarding the evaluation of goal setting. The 
intervention’s significant effect on the item “The pain has hindered me to do the things I 
wanted to do today” suggests that goal setting was effective (see Chapter 6). However, 
significant increases in ratings of self-efficacy were not found in this pilot RCT. The effect of 
goal setting within an intervention to support cancer pain self-management needs further 
exploration in future studies. 
The German PRO-Self© Plus PCP is a cancer pain self-management intervention 
directed at patients and their FCs. Therefore, direct contact between the intervention nurse 
and the patient’s clinicians was not a component of the intervention. The coordination of 
cancer pain treatment recommendations and self-management support was noted to be an 
essential component of effective pain management18. In addition, patients in our qualitative 
substudy stated that the concordance of recommendations between their clinician and the 
intervention nurse was a factor that strongly supported changes in their behaviors (see 
Chapter 7). In future trials, it may be useful to evaluate how the coordination of 
recommendations between physicians and the intervention nurse could be optimized. 
Effect sizes. In the context of the intensity of the German PRO-Self© Plus PCP, 
reductions in pain intensity scores in this pilot RCT were relatively small compared to 
findings from a recent meta-analysis6 (i.e., weighted mean differences of average and 
worst pain scores = 0.65 to 1.1). Possible reasons for the small effect sizes include that the 
doses of taken opioid analgesics (i.e., median doses ranged from 6.7 to 20 mg across the 
study period) were relatively low compared to another study of patients with similar levels of 
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cancer pain19. It could not be assessed whether the low opioid intake was due to patients’ 
lack of adherence or because the analgesic prescriptions were not adapted by the patients’ 
physicians. Furthermore, patients’ ongoing doubts and returns to previous attitudes 
regarding analgesic intake that were found in one of the qualitative substudies may explain 
the low effect sizes. In addition, the German PRO-Self© Plus PCP focused mainly on 
patient-related barriers. However, barriers to effective pain management include system- 
and clinician-related barriers3. These types of barriers were not addressed in the German 
PRO-Self© Plus PCP. 
Moreover, not all patient-related barriers were addressed equally over the course of 
the intervention (e.g., only those patient-related barriers that were directly related to the 
patient’s analgesic regimen were repeatedly discussed during the nurse coaching). In 
addition, symptoms that may have impaired analgesic intake (e.g., nausea and vomiting 
associated with therapy) were not addressed as a routine part of the intervention. 
Moreover, the small sample in this pilot study may have resulted in the uneven distribution 
of curative patients in the control (n = 2) and intervention (n = 0) groups. 
Based on the findings from the systematic review, we hypothesized in concordance 
with previous research6, that intervention components not previously described (e.g., 
empathy by clinician) may have influenced the interventions’ efficacy. Interestingly, this 
hypothesis was supported by findings from the qualitative substudy on the participants’ 
experiences with the intervention and study procedures (see Chapter 7). These patients 
and their FCs stressed the importance of a trustful relationship with the intervention nurse 
which was shaped by the intervention nurse’s establishment of a therapeutic relationship 
(e.g., a caring attitude); her expert knowledge of pain management; as well as the repeated 
meetings and the provision of a sufficient amount of time to discuss questions which arose 
during the implementation of pain self-management. This finding is consistent with Rodin et 
al.20 who suggested clinicians need training in communication skills as well as opportunities 
to de-brief after consultations in order to increase the efficacy of communication between 
clinicians and oncology patients. The inclusion of these components in future trials20 may 
improve the patients’ and FCs’ comprehension as well as the efficacy of interventions on 
cancer pain self-management. 
As noted above, the effect size for pain intensity was relatively small in the pilot 
RCT. However, interesting findings were obtained when changes in pain scores of the 
patients in the intervention group who participated in the debriefing interviews of the pilot 
study were analyzed. These patients were found to have statistically and clinically 
significant reductions in pain scores from the beginning to the end of the intervention 
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(compared to baseline, average pain scores decreased by 1.95 [SD = 2.49; p = 0.47] on a 
scale from 0 [no pain] to 10 [worst pain imaginable] and worst pain scores decreased by 
2.67 [SD = 2.84; p = 0.02]). Furthermore, all participants in the qualitative substudy were 
extremely satisfied with the Program and had internalized important aspects of pain self-
management (e.g., around-the-clock intake of analgesic medication). Those patients who 
dropped out of the study had a lower functional status at baseline than those patients who 
remained in the study. Therefore, one possible explanation for this relatively large effect for 
participants in the qualitative substudy was that these patients received the entire dose of 
the intervention. In addition, these patients were in better health and may have been more 
capable to participate actively in the intervention as well as make the required behavior 
changes. Future studies, need to develop different types of interventions for patients with 
lower levels of physical function. 
Reflections on the Conceptual Frameworks  
In mixed methods research, cancer pain self-management interventions need to be 
evaluated within the context of a theoretical framework in order to outline possible cues for 
action or guide thoughts and inferences13,21. Because an all-inclusive conceptual framework 
is not available for self-management interventions, two frameworks were chosen to guide 
this thesis (see Chapter 1). First, symptom management theory (SMT)22,23 was chosen to 
guide the study and intervention procedures. Second, social cognitive theory17,24 was used 
to guide the development and delivery of the intervention. 
Overall, SMT was a useful framework for the pilot RCT because it guided the 
selection of appropriate outcomes and the placement of the intervention within a broad 
context. In SMT, adherence is placed as a link between the two dimensions “Symptom 
management strategies” and “Symptom status outcomes”. Even though the inclusion of 
adherence in SMT is unquestioned, a discussion is occurring in the literature about the 
correct placement for adherence within SMT23. Rather than being related to only two 
dimensions of SMT (i.e., “Symptom management strategies” and “Symptom status 
outcomes”), adherence may be related with numerous concepts within the entire SMT25. 
For example, distress from high pain intensity may result in the patient’s decreased 
capability to adhere to the intervention nurse’s recommendations. In future research the 
placement of adherence within SMT (e.g., relationship of adherence with patients’ 
experience of cancer pain)25 may be explored in more detail. 
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Social cognitive theory provided a sound basis for planning and conducting the 
German PRO-Self© Plus RCT. However, a surprising finding was that the intervention did not 
have an effect on the participants’ rating of their self-efficacy (see Chapter 6) as reported 
previously26. The intervention may not have included sufficient components that increased 
the patients’ self-efficacy (e.g., verbal persuasion or role modeling)17. These inconsistent 
findings need to be explored in future RCTs. Furthermore, as stated above, the role of goal 
setting in enhancing the participants’ sense of mastery needs further evaluation.  
Another important finding from the qualitative substudy of patients’ decision 
processes was related to their analgesic medication intake (see Chapter 8). In this substudy, 
patients’ answers to some of the items of the Patient Pain Questionnaire14 were not 
congruent with the doubts they expressed during sessions and interviews (e.g., patients 
continued to state their fear of becoming addicted to their analgesic medications even though 
their answers on the Patient Pain Questionnaire improved). This finding suggests that 
cognitive responses to an intervention targeted at cancer pain self-management may differ 
from emotional responses and is congruent with concepts in social cognitive theory24. Social 
cognitive theory emphasizes that the transfer of knowledge and skills into appropriate 
performance in daily life depends on many factors (e.g., self-efficacy) that are influenced to a 
great extent by emotions. The inconsistencies in patients’ emotional and cognitive responses 
to the German PRO-Self© Plus PCP need to be explored in future research. 
Limitations 
This thesis has several limitations. In our systematic review, the description of the 
interventions’ components did not include unpublished components because the analysis 
was based on available publications (see Chapter 3).  
Furthermore, one of the major limitations of the pilot RCT was the low recruitment 
rate which is a serious threat to the external validity of the findings. In addition, a high 
attrition rate limits the generalizability of the findings. Moreover, findings from the qualitative 
substudies were limited to those patients who reported a relatively good health status. 
Even though patients with cancer pain may be unable to complete RCTs because of 
deterioration in their health status, reducing study burden and tailoring the intervention to 
meet patients’ needs may help to decrease attrition rates in future trials. As a result of the 
low recruitment and high attrition rates, fewer patients were included in the pilot study than 
planned (39 instead of 60 patients) and only a small number of patients provided complete 
data (n = 18). Therefore, findings from this study need to be interpreted with caution. 
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Finally, resources in this research project were limited. As a result, all of the study 
visits for both the intervention and the control groups were performed by the same nurse. 
Therefore, an occasional unintentional contamination cannot be totally excluded given the 
ethical dilemma that patients in the control group were not provided with direct support if 
problems with their pain self-management arose. 
Implications for Future Research 
Implications for future research that were derived from this thesis include the need 
for improvements in study and intervention procedures as well as reflections on the 
conceptual frameworks that guided this research project. The systematic review may serve 
as a basis for future trials with appropriate study designs (e.g., factorial designs) to 
evaluate which components of the interventions are the most effective. Experiences with 
the pilot RCT revealed that the clinical setting and the population need to be taken into 
account in order to optimize recruitment and decrease attrition (e.g., reduce study burden).  
To increase effect sizes, improvements of the intervention may be considered in 
future studies as suggested in this thesis (e.g., repeated integration of print materials). 
Furthermore, the coordination of recommendations by patients’ physicians and the 
intervention nurse should be considered in future trials. In addition, it is highly 
recommended that intervention nurses work to build trusting relationships with patients and 
constantly convey professional competence and a caring attitude. 
Moreover, it may be necessary to explore how patients with lower functional status 
could benefit more from the German PRO-Self© Plus PCP. Possible adaptations may 
include the reduction of study burden as well as the tailoring of the intervention more 
closely to patients’ needs and situation. 
In future research, the optimal balance of costs and benefits of a cancer pain self-
management intervention needs to be determined. In this context, the amount of time that 
is spent with the patients needs to be evaluated in view of the optimal pain reduction that 
each patient may gain. Findings from our research project indicate that a cancer pain self-
management intervention with multiple face-to-face contacts may be more efficacious than 
a single exposure intervention even though this hypothesis was not confirmed by findings 
from a recent meta-analysis6. However, the optimal dose of the intervention remains to be 
determined. In the U. S., a second RCT is currently underway by the U. S. PRO-Self© 
study group at the University of California San Francisco that addresses this gap 
(Miaskowski, C., personal communication, January 14, 2012). A low dose PRO-SELF© 
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Plus PCP (8.0 hours over 10 weeks) is being compared with high dose PRO-SELF© Plus 
PCP (12.3 hours over 10 weeks). 
In future studies, some aspects of the theoretical frameworks may be reconsidered. 
For example, within SMT22,23, the role of adherence in cancer pain self-management 
requires further investigation. Furthermore, according to social cognitive theory17, the 
intervention’s lack of effect on self-efficacy may be examined in more detail. An additional 
interesting aspect for further exploration may be the incongruence between cognitive and 
emotional responses regarding some patient-related barriers towards pain self-
management (e.g., fear of addiction). 
Conclusions 
The systematic review in this thesis is the first to provide a comprehensive overview 
of components of cancer pain self-management interventions in the context of their 
potential to reduce cancer pain. Furthermore, the transfer and evaluation of the German 
PRO-Self© Plus PCP, an intervention to support cancer pain self-management, was 
performed successfully. In the pilot RCT, pain self-management related knowledge 
increased significantly and it was possible to calculate effect sizes for the intervention’s 
potential for pain reduction. Findings demonstrated patients’ high satisfaction with the 
German PRO-Self© Plus PCP and showed how patients remained highly ambivalent 
regarding analgesic intake even if they decided to take analgesics. Even though the effects 
were rather small, findings from this mixed methods research project provided valuable 
data on how to improve the intervention and plan a larger multicenter RCT. 
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